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1. Introduction 
Despite the availability of numerous resources for identifying potential therapeutic 
compounds, the current drug discovery process is very tedious, expensive and time 
consuming. It takes about 12-15 years and more than US$800 million for a new molecule 
after being discovered to get approved from FDA and accessible to the public [1, 2]. The 
success rate in this process is very low, i.e. only a single New Molecular Entity (NME) out 
of >10,000 candidates passes the barriers of preclinical evaluations and clinical trials [3]. 
Late stage failures due to biopharmaceutical properties (oral bioavailability and 
formulation issues) and toxicity are also important to be considered. They contribute to 
39% and 21% failures respectively along with 29% of failures occurring from lack of 
efficacy [4]. About 40% of the compounds are tested in humans after preclinical studies 
and out of these only 10% reach the market. This is a major challenge for the research-
based pharmaceutical companies [5, 6].  
Reduction in the late-stage attrition rate of NMEs can be achieved by specifying stringent 
and exhaustive quality assessment criteria at important and early stages of drug discovery 
process. A comprehensive assessment in terms of molecular characterization, chemical and 
functional behavior, integrity, synthetic feasibility, structure-activity relationships (SARs) 
as well as bio-physicochemical and pharmacokinetic properties is crucial in selection and 
prioritization of hits to be progressed into lead series, thus minimizing the research 
timeline in the discovery stage [7]. Technological developments in terms of genomics and 
proteomics, automated protein crystallization and structure determination, pathways and 
protein networks elucidation as well as high throughput screening and combinatorial 
chemistry gave rise to remarkable abundance of new potential therapeutic targets and 
drug candidates. This led in forcing pharmaceutical industries and R&D organizations to 
speed up the productivity and rapidly screening out irrelevant candidates with low 
probability of successful registration and commercialization [8]. 
The increasing role of computer sciences and information technologies in basic research 
and modern drug discovery process is evident since the past 3-4 decades. This maximizes 
productivity in various aspects of research, interpretation, management and collaboration 
within multidisciplinary R&D project teams to arrive at substantiated decisions with 
accelerated pace [9].  New in silico techniques are anticipated to improve the identification 
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of new leads and prediction of activity, bioavailability, safety and efficacy as early as 
possible in the drug discovery and development process. 
1.1 Drug Discovery and in silico Techniques 
An important goal of the drug discovery process is to search for new drug molecules 
which can bind to a specific target known to be involved in causing a disease and change 
the target’s function. In the traditional drug discovery process, identification of the suitable 
drug target is the first and foremost task. These targets are biomolecules which mainly 
include proteins such as receptors, transporters, enzymes and ion channels. Validation of 
such targets is necessary to exhibit a sufficient level of ‘confidence’ and to know their 
pharmacological relevance to the disease under investigation. This can be performed from 
very basic levels such as cellular, molecular levels to whole animal level. Once the target 
validation has performed, effective compounds such as inhibitors, modulators or 
antagonists for such target need to be identified. This process is called lead identification 
where the design and development of a suitable assay is done to monitor the effect on the 
target under study. High-throughput screening (HTS) plays a crucial role in this phase 
where large numbers of chemical compounds are exposed to the target. Compounds 
showing dose-dependent target modulation in terms of a certain degree of confidence are 
processed further as lead compounds. Subsequently, the experiments are performed on the 
animal models in the laboratories and the positive results are then optimized in terms of 
potency and selectivity. Physicochemical properties and their pharmacokinetic and safety 
features are also assessed before they become candidates for drug development [10]. Even 
though most of the processes depend on experimental tasks, in silico approaches are 
playing important roles in every stage of this drug discovery pipeline (Figure 1.1). 
Figure 1.1: Role of in silico approaches in various phases of drug discovery & development pipeline. 
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In the following section, we will briefly highlight some of the challenging issues of data 
generation and advances of in silico techniques from the perspective of target identification 
and discovery of new leads. 
1.1.1 Target identification 
With the ‘omics’ revolution and advancements in the life sciences, especially in the field of  
biotechnology, a large amount  of data is generated every day, starting from the whole-
genome sequencing accompanied by microarray gene expression analysis and x-ray / mass 
spectroscopy of proteins and metabolites.  Enormous data is being produced by an 
increasingly growing number of novel high-throughput and genome-wide bio-techniques 
with nanotechnology and lab-on-a-chip (LOC) applications providing icings on the cake. 
This renders the bioinformatics researchers with great opportunity to study whole genome 
rather than gene-by-gene analysis, guiding life sciences towards more data driven and 
rationalize approach [11]. As the target discovery is a primary and major aspect of in silico 
techniques’ implications, it also helps to reveal all possible targets for therapeutic 
intervention. The haploid human genome contains about 23,000 protein-coding genes with 
~8,000 targets of pharmacological interest and on the basis of ligand-binding studies, ~3,000 
targets are predicted for small molecules opening broad perspective for target 
identification [12]. In another study, Drews and colleagues identified approximately 500 
drug targets, but suggested there are likely as many as 5000- 10000 potential therapeutic 
targets [13, 14]. Although this unfolds a wide range for of biomolecules as drug targets, 
selection of the most relevant ones for a given disease is a big challenge.  
Several sequence and structure-based approaches have been proposed for target 
identification. In the sequence-based method, functional information about the target and 
its positioning in the biological networks is provided to detect unique targets from the 
disease causing pathogens (e.g. bacteria or viruses) by comparing functional genomics of 
humans with corresponding genomics of pathogens [15]. In this way, it is possible to 
distinguish the targets in the pathogens as well as for endogenous diseases, subsequently 
resulting in the discovery of novel targets by genomics difference between normal and 
abnormal tissues. With the increasing number of 3D structures of proteins, structure-based 
approaches are becoming popular. These methods are useful to specify topographies of the 
binding complementarity in the protein for the given ligands and later these results can be 
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validated by experimental procedures in the laboratories. The structure-based methods 
guide the optimization of new leads into drugs and now-a-days employed much earlier in 
the drug discovery process for accessing ‘druggability’ or tractability of targets [16].  
1.1.2 Lead Discovery and Lead Optimization 
Millions of chemical compounds consisting of natural products were synthesized and 
isolated in the past. Lipinski and Hopkins related this vast chemical space to the 
cosmological universe and small molecules are referred as stars. Identification of the 
biologically relevant chemical space, i.e. regions containing biologically active compounds 
from such universe is a challenging task [17]. With the availability of thousands of targets, 
it is not possible to screen these existing targets with all the available compounds. Thus, it 
is important to develop suitable assays to mine the existing huge chemical space for 
exploring a large number of new leads or hits. Although tremendous advances in HTS 
have been made which allow the screening of thousands of compounds every day, the cost 
and time would be greatly saved if the number of randomly tested compounds is reduced. 
Recent improvements in virtual screening have shown its importance in discovering lead 
compounds and the hit rate has enriched by about 100-1000-times over random screening 
[18]. However, virtual screening retrieves the hits from existing compounds or old drugs. 
For the discovery of new molecular entities, several in silico approaches have been 
proposed such as virtual/combinatorial compound library design, fragment-based 
screening, de novo drug design, etc. These methods aim at building new molecules from 
available building blocks/fragments rather than considering whole molecules. Target 
specific focused-libraries can also be generated using known information about three-
dimensional complementarity (i.e. shape, size and physicochemical properties) of target-
binding site to reduce number of compounds needed for synthesis and in vitro HTS 
screening [19]. Such approaches are very useful for the membrane proteins like receptors, 
transporters and ion channels where it is extremely difficult to obtain the x-ray crystal 
structures. In these cases, information about the known ligands for specified target can be 
used to derive e.g. in silico pharmacophore models which are then used for virtual 
screening to specify a subset of lead molecules. The computational demand in these cases 
scales according to the number of candidate molecules as well as the time required to 
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perform these virtual screening experiments and to explore the conformational space of the 
novel compounds. 
As discussed briefly in the earlier section, in silico screening techniques can be useful to 
detect complex structural and bioactivity relationships from the ligand-oriented 
information or the knowledge about protein structures. Ligand-based screening of new 
hits considers several methods such as techniques involving similarity principle, i.e. 
similar compounds have similar biological activity/profiles, in several forms such as 
classical similarity using descriptors or fingerprints, pharmacophore modeling, 
classification algorithms and self organizing maps. Structure-based approaches involve 
docking of large compound libraries into targeted protein structures and scoring and 
ranking of the poses/compounds, binding free energy calculations, molecular dynamic 
simulations and more accurate quantum and molecular mechanics methods. These 
methods suffer from high computational demands and manual intervention which put 
forward the need of high throughput computing environment for carrying out these tasks.  
1.1.3 Key Aspects and Challenges of in silico Drug Discovery 
Fundamental priorities of any pharmaceutical company are to reduce the research cost and 
time of the drug discovery process and to increase the reliability and confidence in 
discovered leads which will be processed through development stages. There are several 
challenges in the in silico drug discovery process which need to be addressed to accomplish 
these goals [20].  
- Management of huge amount of versatile scientific data – The in silico drug 
discovery process generates vast amount of data in terms of structures, sequences, 
compounds, models, databases and images. Interpretation and integration of such 
data is a challenging task which helps in enhancing knowledge discovery as well as 
simplification of complex workflow. This involves data manipulation, data format 
standardization, definition of dataflow in a distributed system, data storage and 
administration with respect to the infrastructure and software providers, database 
updates and registration of data and meta-data. 
- Management of different softwares – Integration of a variety of software poses 
another challenge which helps in the construction of efficient and complex 
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workflows and aids in data mining and data management. Creation of web servers 
which are available via internet is another effective way to provide software in a 
distributed environment. Man power is another important issue to use software 
where several experts are needed to keep a record of updates and maintenance of 
software, managing workflows and pipelines to project new methodology, utilize 
remote services, analyze and exploit the outputs and come to a conclusion about 
which compounds to be proposed for further screening. The main advantage of 
scientific workflows is that they assist researchers and decision makers in 
organizing the complicated tasks in a flexible way and to pass over the data, 
information and knowledge to the organization. 
- Deployment of intensive computing – Huge amount of computing resources and 
computing power is the main requirement of large bioinformatics calculations, e.g. 
docking hundreds of compounds in several targets retrieving thousands of poses or 
molecular dynamics simulations of even a small system require in the order of a 
few TFlops within one day. Several computational methods based on all-atom 
physics-based force fields comprising of implicit solvation and free-energy 
calculations also need large computational resources to represent accurate protein 
structure models. Generally, the computer centers’ clusters and small university-
wide servers are occupied with a large number of short tasks causing problems for 
such gigantic jobs [20].  
- Collaborations between public and private partners – When life sciences are 
combined with computational approaches for in silico drug discovery, strong 
remote collaborations involving sharing of resources (data, information, 
knowledge, tools, software and workflows) as well as infrastructures (computers, 
servers, storage devices and networks) is required and need to be maintained. Such 
comprehensive interfaces not only help to integrate outputs from in silico drug 
discovery but also from experimental processes reducing development time of new 
methods. 
- Security, firewalls and authentication - Important aspect of any academic 
organizations and pharmaceutical industries is to effectively protect critical data, 
information and intellectual properties to avoid mal-behavior. This includes – 
allowing access to the users from various institutions across firewall barriers and 
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their authentication, provision of flexible mechanisms and support to resource 
owners to manage user accounts, their privileges and privacy settings [20]. 
As discussed in this section, the in silico drug discovery process faces some vital challenges 
such as addressing huge amount of data, data and software integration, deployment of 
intensive computing, public-private remote collaboration, resources sharing and strong 
security and protection constraints. Thus, in house as well as remotely available tools, data, 
storage and computing infrastructure need to be shared and integrated in an influential 
and secured environment. 
1.2 Grid Technologies for in silico Drug Discovery 
Timely analysis and evaluation of incoming data in research and development is very 
important for the decision-making processes in this highly competitive world of industrial 
drug discovery. The degree of accuracy of these decision making processes is in turn 
dependent on the computational resources used to generate the precise hypotheses [21]. In 
the context of in silico screening and molecular modeling, the demand for computational 
power has increased drastically in recent years to perform rigorous calculations. 
Regardless of the present computing infrastructure, the emergence of various software, 
algorithms and programs in all scientific fields which require tremendous calculation time 
for their execution has demanded further enhancement. In particular, there is a need of 
investigating new innovative strategies for more efficient utilization of distributed 
computing resources by combining them in the form of clusters and computational grids 
with regards to the interdisciplinary research activities. Although availability of clusters 
and huge servers with thousands of processors eases the computational research, they are 
dedicated resources and their use is limited by their high costs, user complexity, 
permission issues, resource management, queueing mechanisms and preferences.  
Dramatic advancements in computing hardware with improved networking technology 
have enabled the coordination of distributed resources within or outside the enterprise 
domain, providing access to computing facilities at much faster rate with affordable cost. 
This resulted in diverting the focus of the scientific community from the supercomputers to 
the personal desktop workstations and PCs. Despite their slow speed and limited 
performance, these small computers prove beneficial and circumvent the shortcomings of 
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supercomputers when used in conjunction with many others. The environment of grid-
enabled distributed computing in the institution increases the computational power to a 
great extent with individual ownership to each of the PC owner.  
Grids render a new dimension to the emerging information technology paradigm 
providing and coordinating the resources such as various organizations, people, 
computing, storage and networking facilities as well as data, knowledge, software and 
workflows. In simple terms, a grid is the well organized combination of dispersed but 
networked computational resources and the intermediate middleware furnishing 
streamlined services to the users. Grid technology imparts an opportunity to combine 
different aspects of scientific disciplines such as life science research, pharmaceutical 
industries, healthcare systems, infrastructures and field work using the collaborative 
information technology environment. It provides a distinct possibility to collect and 
analyze the distributed information from a situation where all data are not localized at a 
single depository. The data can be stored and maintained at any place within a grid and 
still be accessed transparently by any authorized users. Similarly, the computational 
resources of a grid can also be shared and mobilized whenever needed on demand. The 
grids will be discussed further in details in chapter 2. 
1.2.1 Grids - Resource Sharing, Information Flow and Speed Acceleration 
The grids provide the multi-dimensional horizons to the in silico drug discovery in several 
forms. They present some unique and remarkable opportunities for sharing the resources 
and collaborations, expose interesting ideas and perspectives to deal with incoming 
information flows and supply the resources for speeding up the execution of time-
consuming software [22] . 
With respect to provision of the opportunities regarding resource sharing and 
collaborations, numerous distinct features imparted by grids need to be considered. Grids 
allow cross-organizational collaborative resource sharing among universities, academic 
research institutions and pharmaceutical industries, leading to increase in co-operation and 
communication between partners. This in turn helps in routine mobilization of information 
and resources or in an emergency situation. High performance computing and cycle-
stealing is another benefit of grids where they exploit otherwise-wasted CPU power to 
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maximize optimal usage of resources and take advantage of spare computation. Another 
interesting feature of grids includes networking and aggregating available hardware 
resources which assist in reduction of costs and manpower. Grids allow the use of large 
structural and chemical databases and time-consuming life-sciences software to take 
advantage of new information technology applications. Attainment of mutual benefits by 
collaborative exploration of distributed, large, diverse and complex information has been 
made possible with grids. 
Handling the information flows is another important aspect of grids. In this scenario, grids 
open exciting perspectives which allows permission to handle relevant data and regular 
updates of the databases and publications. Grids also allow secured and transparent access 
to the storage and retrieval of large amount of archived data in self-organized and 
automated manner. They help in compliance of the pre-defined rules to analyze, organize 
and co-ordinate the data and information in an understandable way. Formation of relevant 
databases and workflows has been made possible to understand the task under study and 
keeping the records of the respective steps. Implementation of the infrastructures and 
services to aggregate the information from various firms and research centers assist in 
enhancing interpretation of the problem in an efficient fashion.  
Execution of the time-consuming exercises is another major concern of the current in silico 
drug discovery processes and grids help to accelerate these tasks in efficient ways by 
allowing implementation of high performance computing to advanced areas of research for 
more rigorous and accurate calculations. They allow execution of stringent data analysis, 
mathematical modeling and in silico drug discovery tasks with the aid of large computing 
resources such as supercomputers, graphical processing units, servers and even desktop 
PCs. They assist in exchanging ideas, tasks, tools and workflows among the organizations 
and researchers. Creation of automated job scheduling and submission policies and 
distribution facilities to perform large compute-intensive tasks in effective way has become 
possible with grid technologies. With the successful application of grids, permission to the 
resources and services all time around the year (365x24) on heterogeneous platforms 
distributed across geographically diverse sites has become a reality. Thus, in total, grids 
are distinct implementations for information sharing and collection, taking proficient 
inputs and opinions from experts in networking, transfer and spreading of data and 
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knowledge resources among the partners after certain time intervals or in an emergency, 
which helps in creation of a suitable environment for development of in silico drug 
discovery processes [22]. 
1.2.2 Basic Characteristics of Grids 
Provision of different forms of resource sharing in terms of high-throughput (or 
distributed) computing for the life sciences applications has been one of the major goals of 
grid technologies in the past years. Although it mainly involves utilization of idle desktop 
workstation- or PC-cycles, exploiting various experimental equipments at the partner or 
collaborators’ sites in a flexible, reliable and secure way offers significant benefits. For 
example, secure remote coupling of the essential databases and computers/servers with 
expensive and specialized unique devices such as high performance NMR spectroscope, x-
ray-source beamline, etc. among the participating institutions assist in important data 
curation and analysis. This allows the scientists to access the data instantaneous across the 
enterprise boundaries rather than working locally [23]. 
Networking support in the forms of internet, corporate intranets or World Wide Web is 
considered to be a crucial aspect of grid computing environments which aids in 
maintaining heterogeneous sources together. Although internet is considered as the best 
option for this delivery system, its deployment on grids is strictly restricted by the 
connectivity and bandwidth sharing concerns along with the slow speed and inability to 
deal with large amount of data [24]. Another important issue to be considered about 
implementation of grids over internet is the cost of data transmission, where networking 
services which enable the fast communication at high capacity over less cost open 
promising opportunities for grid computing [25]. Several exciting techniques such as 
optical networking, optical burst switching (OBS) [26], Quality of Service enabled networks 
[27], wavelength division multiplexing (WDM) technology, micro-electro-mechanical 
systems (MEMS) technology, Transmission Control Protocol/Internet Protocol (TCP/IP), 
Novell Netware, fiber distributed data interface (FDDI) and various remote procedure call 
(RPC) systems are attractive propositions and hardware solutions help to reach global 
resources at affordable bandwidth for the better communication which are the 
requirements of the data-intensive grids [24, 28].  
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Regardless of the availability of high-performance networking capabilities and 
continuously decreasing costs of its maintenance, it has not really fostered inter- or intra- 
institutional collaborations. The virtual organizations (VOs) [29] formed by such sharing 
and co-ordination of resources within a group of people and/or organizations face more 
severe problems. Since internet is used as an underlying mechanism of communication for 
many VOs, the security concerns in terms of hazardous intrusion and sabotage need to be 
considered profoundly without hampering the accessibility to the resources. Drug 
discovery applications and related in vivo, in vitro and in silico data and information are 
strictly confidential and must also meet regulatory requirements, providing proper 
attention towards data protection, safety and reliability. The primary fundamentals of 
privacy and confidentiality have to be followed all the times. Authentication, identity and 
authorization levels of the users, firewall restrictions, different ownership and 
administrative complications with high-level security and access control policies are the 
important characteristics while constructing a grid. If these attributes are not addressed 
properly, the establishment of a grid environment becomes quite difficult. For such cases, 
various solutions have been put forward which include negotiation of the access to the 
computing facilities, configuration of the systems so that users can use them effectively 
without compromising the security of the resources. This becomes very much essential in 
parallel computations where multiple computational resources are spread across a wide 
range of administrative domains running thousands of processes simultaneously. The 
establishment of trustworthy relationships between these sites for execution of the 
applications is also hampered by the dynamic nature of the grids. Furthermore, the inter-
domain security negotiations should work hand-in-hand with diverse intra-domain access 
control technologies rather than replacing them. Several constraints are laid down into the 
grid environment to avoid non-secure intrusion such as initial authentication to acquire, 
use, manipulate and release resources, protection of user credentials (passphrases, secured 
keys, etc.), local and inter-domain security policies, easy encryption and decryption codes, 
multiple security implementation technologies, secure group communication, etc [30].  
In the early 1990s, before so called middlewares gained their popularity, different legacy 
applications such as distributed computing environment (DCE) [31] or Common Object 
Request Broker Architecture (CORBA) [32]have been put forward to address these 
networking and distributed computing issues. The distributed applications are exclusively 
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constructed with a purpose of sharing the resources and their execution on multiple 
platforms. Distributed Computing Environment (DCE) software was developed by the 
Open Software Foundation (OSF, Cambridge) to bring together more than 330 worldwide 
members of hardware and software vendors, end users and research institutions. It mainly 
focused on the heterogeneity of the operating systems, their security policies along with 
networking and cooperation among the members. DCE helped the users to develop, 
deploy, and manage applications that efficiently use a network’s scattered computing 
resources [33]. On the same stream, the Object Management Group (OMG) developed 
CORBA, which enables to merge a variety of software components written in different 
languages such as C, C++, Java, COBOL, python, etc., running on different computers to 
work with each other like a single application. It provides a flexible communication and 
acts as a catalyst for distributed heterogeneous object-oriented computing environments. 
The main characteristics of CORBA include its heterogeneity in terms of diverse 
programming and implementation on different computers and equipments; the ability to 
be used in a variety of environments, and  its object-oriented software development 
techniques [34]. In both of these applications, resources are not allocated and processes are 
not created explicitly by programs, but they connect to established ‚services‛ that 
encapsulate hardware resources or provide defined computational services. When the 
different environments do not have more information about each others, the 
communication is achieved using remote procedure call or remote method invocation 
models via standardized protocols (based on TCP/IP) that are devised for portability and 
not for high performance. There are a variety of problems related to these technologies 
such as failure to satisfy the portability and performance requirements, difficulties in their 
sophisticated implementation, inability to share resources or harness idle computers, and 
failure to address flexibility, performance issues, reliability and trust.  
Tremendous technical advances in the past few years helped to handle most of these 
concerns providing solutions to heterogeneous resource sharing, resource management, 
networking, security and speed of accession across administrative boundaries. 
Middlewares have emerged as the boosting technologies to solve these issues facilitating 
the access to the computational grids by coordination of heterogeneous computational and 
information technology resources across a network, allowing them to function in unison. 
In general terms, a middleware is the building block used to construct the grid. It can be 
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generally conceived as the layer of software sandwiched between the operating system and 
applications, providing a common programming abstraction across a distributed system 
and a variety of services required by an application to function correctly [35]. It is 
specifically designed to mask the heterogeneity incurred in distributed systems, networks, 
hardwares, operating systems and programming languages as well.  
The Globus Toolkit, a trademark of University of Chicago, is such a pioneer, open source 
middleware used for building grids [36]. It presents a software infrastructure that 
integrates diverse computing resources and users from different geographical locations to 
demonstrate them as a single entity. It provides basic functionalities and competencies 
required for building a computational grid. The toolkit contains various components for 
implementing elementary services required for grids such as authentication and 
communication, security, information services, data management, resource management 
and application development environments. It contributes in a variety of application-
oriented tasks having a major collaborative role to develop wide-spread grid-enabled 
applications. The Globus toolkit helps in designing and constructing large-scale testbeds, 
both for research and production in various scientific as well as engineering fields. Several 
such projects, which depend on the Globus toolkit, include European DataGrid project 
[37], Teragrid [38], GriPhyN (Grid Physics Network) [39], DOE Science Grid [40], etc. 
Several similar middlewares emerged after the success of Globus with different goals and 
specialties for effective utilization of unused computer power. These include Condor[41], 
Unicore [42], gLite [43], GEMSS [44], Legion [45], Nimrod [46] and many more to furnish 
object-based remote access systems for different studies. Companies such as Entropia [47], 
United Devices (now known as Univa UD) [48] or Oracle Corporation [49] also work on 
similar streams and provide softwares for different purposes such as harvesting idle cycles,  
cluster scheduling, load sharing facilities and portable batch systems within institutional 
PC grids. Data Grid technologies built on these and other technologies address issues 
related specifically to computations on data and its distributed management. 
Grid systems such as EU DataGrid [50]or NSF TeraGrid [51]give an impression that the 
current grid technologies have transformed from the experimental phase to the point 
where production capabilities are possible. Still there are many areas where this large scale 
resource sharing has not really prospered up to the expectations which may be attributed 
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to the absence of uniform applicable standards as well as heterogeneity and fragmentation 
of available grid services, tools and middlewares. Increasing use of service-oriented 
standards and commercial web service technologies influenced the development of grid-
oriented services such as middlewares and tools. Although these middleware toolkits are 
available for cluster and grid computing, they are very complex to implement, as prior 
knowledge about their underlying mechanisms and computational resources management 
is of prime importance. Thus, mapping life sciences applications and tools used for in silico 
drug discovery processes on a grid infrastructure is a non-trivial exercise. 
1.2.3 Grid Applications in Drug Discovery Projects 
There are numerous efforts for supporting scientific applications by utilizing grid 
environments and distributed computational resources. Grids have become an integral 
part of the current drug discovery and virtual screening processes. They are widely used 
from pharmaceutical research to bioinformatics, chemoinformatics, genomics, proteomics 
and other life science applications. Grid technologies proved to be very promising in terms 
of reducing time and increase efficiency [23, 52-60].  Several CPU cycle scavenging projects 
were accomplished by several organizations where worldwide network resources were 
utilized via internet. Different institutions and enterprises have also realized the 
importance of distributed computing and implemented ae grid infrastructure within the 
organization to effectively harness wasted computing power. A brief overview of these 
projects along with their basis is presented in the following section. 
1.2.3.1 Cycle Scavenging Screensaver projects 
FightAIDS@Home (FAAH) [61], a part of World Community Grid, is the first biomedical 
distributed computing project run by Olson laboratories at The Scripps Research Institute 
in La Jolla, California. It uses AutoDock to perform virtual screening of novel inhibitors 
available from the NCI (National Cancer Institute, Bethesda, MD, USA) against wild-type 
HIV protease. FAAH was installed on about 450 000 clients worldwide using a small 
software package (downloaded from world community grid) which runs in the 
background of the computer and was capable of screening around 10 000 ligands per day 
[62].  
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Folding@home[63] is recognized as the most powerful distributed computing project in the 
world designed to execute compute-intensive simulations of protein folding and other 
molecular dynamics for targets linked to various diseases such as Alzheimer’s, Mad Cow 
(BSE), Parkinson’s, Huntington’s, many cancers and cancer-related syndromes. The project 
recently accomplished simulated folding in the 1.5 millisecond range. Various molecular 
dynamics software packages are used in this project, which include – Gromacs, Amber, 
Protomol, Tinker and Desmond. The computing statistics are reviewed periodically and by 
august 2011, the peak speed of the project was 4 native PFLOPS (6.4 x86 PFLOPS) from 
430,000 individual PCs and PlayStation 3s.  
The cancer screensaver lifesaver project [64]is an initiative by the department of chemistry 
of the University of Oxford, which has accomplished screening of 3.5 billions of 
compounds in one year against twelve targets in a virtual screening experiment since its 
implementation in April 2001, by using more than 1.5 millions of computers from more 
than 200 countries. This has created a 65-teraflop machine that has provided more than 
100,000 years of CPU time [54]. The THINK software has been used for matching 
pharmacophores and full conformational searches. It ranks the hits using the ChemScore 
function, thus providing estimation about the free energy of binding for the conformation 
of each bound molecule. Subsequently, after the success of the initial in silico drug 
discovery and design on a grid in the form of the cancer screensaver project, the same 
institute launched the Anthrax research project [65] and the smallpox protection project 
[66]. During the Anthrax protection project, a clustering algorithm based robust method 
was invented to locate ligand-binding sites on proteins and 3.57 billion small molecules 
were screened on more than one million PCs to retrieve about 300,000 hits as  promising 
candidates for the treatment of cancer [67]. Similarly, in the Smallpox protection grid 
project, more than 2 million users in over 200 countries contributed their idle times to find 
drugs to combat the post-infection effects of smallpox virus. About 35 million compounds 
were screened against eight smallpox proteins to narrow down the number of drug-like 
molecules binding and ultimately inactivating smallpox proteins [66]. The virtual 
screening was performed using the LigandFit molecular docking software from Accelrys. 
The distributed computing aspect for all these projects was handled by United Devices 
(now Univa UD) [48], which distributes the work packages to individual PCs and collects 
and validates the returned results.  
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Docking@Home [68] is a small scale distributed computing project having more than 6000 
volunteers worldwide with the aim to create new and improved medicines against major 
disease targets such as P38 alpha, Trypsin and HIV proteases. The protein-ligand docking 
protocol is based on the CHARMM package and is run on BOINC (Berkeley Open 
Infrastructure for Network Computing), a free, open-source middleware system for 
volunteer computing.  
GPUGRID [69] is an innovative distributed supercomputing project designed for all-atom 
biomolecular simulations using NVIDIA’s CUDA-compatible graphical processing units 
with BOINC as the basic software platform. Several molecular dynamics simulation 
experiments have been carried out successfully for targets such as triose phosphate 
isomerase (TPI) enzymes, the D2 dopamine receptor, and HIV protease, along with free 
binding of benzamidine to trypsin.  
Rosetta@home [70] is another promising distributed computing project for predicting and 
designing 3-dimensional structures of proteins mainly of malaria, anthrax, HIV, Alzeimer’s 
disease, Spanish Flu (H1N1) Influenza and others based on the BOINC (Berkeley Open 
Infrastructure for Network Computing) infrastructure. With the help of more than one 
million volunteer PCs, it processed 58 teraFLOPS on average by June, 2011.  
In another distributed computing project called drug design and optimization lab (D2OL) 
[71] hosted by the Rothberg Institute, a platform was developed for the users from around 
the globe to dedicate their personal computers for computing the interactions of small 
molecule drug candidates with target molecules that likely play prominent roles in specific 
human disease pathways, including those involved in SARS, Avian Flu, Ebola and 
Smallpox and other potentially devastating infectious diseases. The parallel computing 
aspect was managed by Sengent Inc.'s CommunityOS framework [72]. This project was 
active for more than seven years (ended on April 15, 2009) and returned results for docking 
of over 150 million drug candidate into disease targets, utilizing over 3000 years worth of 
CPU time in the process. 
1.2.3.2 Drug Discovery on Computational Grids 
The Drug Discovery Grid (DDGrid) constructed by Zhang et al [73] demonstrates the use 
of Peer-to-Peer (P2P) environments and grid technologies based on BOINC middleware for 
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execution of molecular docking based virtual drug screening services on geographically 
distributed resources. Docking applications (in the form of Dock v4.0.1 and gsDock v2.0, 
which is a generic algorithm optimized form of Dock), preprocessing software and toolkits 
(such as autogrid/autodock, combimark, combilib) and chemical databases (e.g. ZINC, 
Specs, National Cancer Institute database, China Natural Product Database and Traditional 
Chinese Medicine Database) were used for screening against the farnesoid X receptor 
(FXR) to finally discover 5 compounds with high binding affinities. This system was also 
used in drug screening for anti-SARS, anti-diabetic and anti-arthritis drug research 
projects.  
Molecular docking was used as a virtual screening tool in the WISDOM (World-wide In 
Silico Docking On Malaria) project to identify novel hits and leads against malaria and 
other neglected diseases [74]. In this work, one million compounds obtained from the 
ChemBridge database were screened against 5 targets of the Plasmepsin family using 
FlexX and AutoDock. They reported that about 41 million dockings were performed within 
6 weeks, which is equivalent to 80 CPU years [75]. The Wisdom-II project [76, 77] was 
subsequently launched after the success of the initial WISDOM project to continue the in 
vitro screening after VS experiments. Several new targets were explored such as 
Glutathione-S-transferase and tubulin along with two previously well known proteins: 
dihydrofolate reductase (DHFR) from Plasmodium falciparum and from Plasmodium vivax. 
4.3 million compounds obtained from the ZINC database were docked against the crystal 
structures or homology models of the above mentioned targets. Technically, about 140 
million docking runs (equivalent to 413 CPU years), representing an average throughput of 
almost 80,000 dockings per hour, were performed in 90 days. Both WISDOM projects used 
mainly the EGEE (Enabling Grid for E-sciencE) grid infrastructure [78]. Other than EGEE, 
several other grid infrastructures such as: AuverGrid [79], EELA [80], EUChinaGrid [81] 
and EUMedGrid [82] provided significant contributions to this project.  
The BioinfoGRID project [83] promotes the bioinformatics grid applications, mainly in the 
fields of Genomics, Proteomics, Transcriptomics and Molecular Dynamics, reducing data 
calculation times by distributing the calculation on thousands of computers using the Grid 
infrastructure network created by the EGEE Project. Within the framework of this project, 
molecular dynamics simulations were performed on 5000, 5000 and 15,000 docked 
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conformations of Plasmepsin, Glutathione-S-transferase and P. falciparum DHFR, 
respectively, retrieved from WISDOM. 25 days were taken to simulate 25,000 compounds 
which otherwise would have taken 347 days on a single CPU. The WISDOM project is a 
good representation of the advanced biomedical research and its implementation on 
computational Grids for generation, storage and sharing of huge scientific data located at 
different research institutions throughout the world for drug discovery against malaria 
and other neglected diseases.  
BRIDGE (Bilateral Research and Industrial Development Enhancing and Integrating GRID 
Enabled Technologies)[84] is another WISDOM-type grid scenario based on the SIMDAT 
grid infrastructure for accessing the applicability on the data grids. It aims at performing 
malaria and birdflu docking experiments using various docking tools such as FlexX, 
AutoDOCK, DOCK, GasDock and AutoxX. Development of the interoperable grid-based 
virtual screening application using molecular docking for pharmaceutical R&D is a main 
focus of BRIDGE workflows.  
The OpenMolGRID (Open Computing GRID for Molecular Science and Engineering) 
project [85] was developed to implement the grid approach for dealing with large-scale 
drug design, pharmacy, chemistry and engineering related tasks. The basic grid services 
and functionalities were based on the UNICORE infrastructure. The OpenMolGRID system 
provided several features such as 1. Creation of data warehouse technology, MOLDW for 
retrieving chemical compound data from public resources and storage and integration of 
structural information for other processes; 2. Use of different data mining techniques such 
as multi-linear regression (MLR), principle component analysis (PCA), partial least squares 
(PLS), and artificial neural networks (ANN) to develop QSPR/QSAR models and 3. 
Prediction of biological activities or ADMETox properties. Several programs such as 
MOLGEO, MOPAC and CODESSA PRO were integrated in this grid system which was 
used for analyzing millions of structures in short time and screening promising hits.  
The SwissBioGrid (SBG) project [86] is a national Swiss Grid infrastructure, collaboration 
between academia and industrial organizations, developed for life sciences and 
computational biology research. ProtoGRID, a prototype of meta-scheduling system, was 
developed initially and then NorduGrid’s ARC middleware solution [87] was chosen to 
build their production grid middleware in the later phases. Performance of the grid was 
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measured by considering docking-based virtual screening experiments to identify potential 
candidates against dengue virus using Autodock 3.05.  
1.2.3.3 Enterprise Grid Computing 
High-throughput docking calculations were performed using the Dock 4.01 docking 
software package for the discovery of human casein kinase II (CK2) inhibitors at Novartis 
[88]. The corporate enterprise grid constructed was based on the grid computing 
architecture developed by United Devices (now Univa UD) [48]. Around 400,000 
compounds were docked in the binding site of a homology model of the protein to retrieve 
12 hits, one out of which was the most potent inhibitor for CK2 ever reported. A very 
efficient, hierarchical protocol comprising of rigid and semi-flexible docking along with 
molecular dynamics was presented by Ghemtio et al. [89] for high-throughput structure-
based virtual screening utilizing the Grid5000 [90] cluster grid computing infrastructure, 
which is geographically distributed at nine sites in France, featuring more than 3,200 
processors and 5,700 cores. A user-level middleware called a parameter sweep tool (APST) 
was used for the virtual screening manager for the grid computing (VSM-G) platform to 
build a multi-cluster environment. The ZINC database comprising of 13 million 
purchasable compounds was used as the starting point for virtual screening against the 3 
β-isoforms of liver X receptors, employing the Omega software for conformation 
generation, SHEF and GOLD docking programs for rigid and semi-flexible docking, and 
NAMD for molecular dynamics simulations.  
A streamlined version of the AMBER simulation package based MM-PBSA (molecular 
mechanics with Poisson-Boltzmann surface area) protocol was implemented by Brown and 
Muchmore  [21] of Abbott Laboratories for high-throughput calculations of protein-ligand 
binding affinities on an enterprise grid utilizing the distributed computing middleware 
Condor. Bullard et al. [91] from Anadys Pharmaceuticals established an enterprise grid, 
‚Hydra‛ for utilization of spare cycles from users’ desktop computers along with a set of 
dedicated computers inside the company. A homogeneous environment of Linux 
operating systems was created by use of coLinux as a service to run Linux in the 
background of Windows operating systems. Scientific applications such as Omega v2.1, 
ROCS v2.2, Fred, Szybki v1.4, and GOLD v3.3 were implemented with Sun Grid Engine 
(SGE) as basis grid technology. 
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1.3 Aim of the Thesis 
The primary scientific goal of this thesis was to develop a university wide applicable grid 
system for standard structure- and ligand-based drug discovery workflows using freely 
available academic software and to test its performance for classification of P-gp substrates 
and non substrates. Several open research questions should be addressed, such as: 
- The challenges and accomplishments related to the establishment of a distributed 
grid infrastructure, UVieCo (University of Vienna Condor pool). 
- The efficiency of the grid by performance measurement experiments using 
sequential and parallel tasks.  
- The relationship between ABC transporters and anticancer compounds by NCI 
(National Cancer Institute) data mining. 
- The identification of compounds exhibiting P-gp substrate like properties by using 
shape-similarity based virtual screening of the NCI database.  
- The identification of novel selective serotonin reuptake inhibitor (SSRI) like 
compounds for searching the mechanism of apoptosis using shape-similarity and 
unsupervised machine learning based virtual screening. 
- The development of predictive classification models for a dataset of P-gp substrates 
and non-substrates addressing the problem of imbalanced class distribution. 
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In the first chapter, we discussed various aspects of computational grids and their role in 
the in silico drug discovery process. Grid computing has been implemented in modern 
computational research to fulfill the increasing demands of the computer resources and to 
achieve better cost efficiency, thus effectively extracting the value from existing desktop 
computers. It in turn has enabled to tackle the scientific and high throughput computing 
challenges in terms of their implementation, resource sharing and management across 
several administrative domains, complex application formulation and development, 
networking and security issues.  
Several alternative systems were proposed to construct large scale computing 
infrastructure by utilization of different available hardware. One type consists of 
traditional clusters which refer to the feature-rich, highly efficient aggregation of 
multiprocessors, servers and clusters which provide efficient and fast interconnection 
between the nodes. Another type is desktop grids which combine the wasted computing 
power of the idle PCs from organizations to perform useful tasks. The most suitable 
applications for desktop grids are those which do not need to communicate among the 
tasks and can be executed independently (high computation to communication ratio). For 
the public volunteer projects, such desktop grids are designed to deal with large 
applications comprising millions of small tasks contrary to the institutional desktop grids, 
where the dimensionality of the applications is reduced because of the limited resources 
and only modestly-sized tasks are accomplished successfully. Another advantage of 
desktop grids is the mutual cost benefits provided by users (in terms of hardware, internet 
connection, power supply, etc.) and beneficiary (in terms of networking, server and 
management services) to each other to exchange massive and unaffordable computational 
power. Thus, desktop grids prove advantageous not only for the high throughput public 
computing projects, but also to the academia and industries for harnessing otherwise 
wasted CPU cycles and storage space from their local PCs. Increase in processor strengths 
and capacities along with improved networking and communication bandwidths of local 
desktop computers further strengthen the practical implementation of desktop grids and 
reduce the costs when compared with dedicated clusters and supercomputers.  
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In this chapter, we provide the basic introduction to grids and high-throughput computing 
environments. Then the concepts of our university-wide campus/desktop grid, UVieCo 
will be presented with more details about its architecture, security, firewall transversal and 
coLinux concepts. In the final section, the applications implemented on UVieCo are 
discussed along with their performance measurements experiments. 
2.1 Introduction 
Use of grids for the research purpose and the drastic improvement in its own development 
has been seen since the past few years. According to  Moore’s law, computer power 
doubles almost every 2 years whereas the price and size reduces in the same manner [92]. 
Now-a-days, size of the transistors on integrated circuits has reached to such an extent that 
thousands of them can be arranged near to each other, equal to the thickness of the human 
hair. Such advancements in computing hardware with improved networking technology 
have enabled access to computing facilities at much faster rate and at much more 
affordable cost, making implementation of grid infrastructures possible. 
The concept of ‚grid computing‛ was first coined by Ian Foster and Carl Kesselman in 
their book ‘The Grid: The Blueprint for a New Computing Infrastructure’ in 1998, where 
they defined a computational grid as “the hardware and software infrastructure that provides 
dependable, consistent, pervasive, and inexpensive access to high-end computational capabilities” 
[93]. This definition hints grid computing more likely as the high performance computing 
(HPC) in supercomputing facilities than collaborative resource sharing among the various 
organizations. Thus, after 2 years in 2000 the same authors with Steve Tuecke extended this 
definition to address social and policy issues, stating that grid computing is “concerned with 
coordinated resource sharing and problem solving in dynamic, multi-institutional virtual 
organizations (VOs)” where VO is a group of individuals and/or institutions which follow a 
certain set of resource sharing rules to perform a joint task [29]. They further elucidate that 
the nature of sharing is not essentially file exchange but more of a direct access to 
computers, software, data, and other resources such as scientific instruments, sensors, etc. 
In 2002, Ian Foster proposed a simple checklist to modify the earlier definition of a grid, 
according to which a grid is “a system which coordinates resources that are not subject to 
centralized control using standard, open, general purpose protocols and interfaces to deliver non-
trivial qualities of service” [94]. The coordinated resources represent the computing 
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infrastructure with identical or different administrative domains addressing security, 
sharing policy, costs and membership issues following the well set protocols to handle the 
fundamental aspects of grid computing such as authentication, authorization, locating and 
accessing available resources. The grid grants different qualities of service (QoS) associated 
with security, availability, throughput, response time and resource co-allocation to fulfill 
complex user demands, thus rendering a scenario where utility of a combined grid system 
is significantly greater than the sum of all the resources when used separately. 
The above definition was perceived as too restrictive or too vague by several scientists and 
proposed different and less technical definitions of grid computing [95-98]. For instance, a 
general definition is given by Wolfgang Gentzsch: “A grid is a hardware and software 
infrastructure that provides dependable, consistent, and pervasive access to resources to enable 
sharing of computational resources, utility computing, autonomic computing, collaboration among 
virtual organizations and distributed data processing, among others” [96]. On the other hand, 
Andrew Grimshaw proposes that “a grid enables users to collaborate securely by sharing 
processing, applications, work flows and processes, and data across heterogeneous systems and 
administrative domains for collaboration, faster application execution, and easier access to data” 
[97]. In a more general way, we can say that  grids are fundamentally heterogeneous, 
loosely coupled and dispersed systems, but can be viewed as a unique virtual environment 
by the user, providing uniform and remote access to resources and aggregating processing 
power. Although processors are the most apparent and basic components of the grid, it 
also encompasses middleware, networking devices, supercomputers, graphics processing 
units (GPUs), data-storage systems, applications, databases, software and scientific 
instruments owned and managed by various institutions.  
The original idea of a computational grid is analogous to electrical power grids. Several 
prime-energy resources are used to generate electricity which includes hydro, thermal, 
wind, solar, coal, gas, oil, nuclear energy and many others. An electric power grid is 
responsible for its pre-processing, storage, transmission and distribution so that it would 
be available easily to the end-users who aren’t aware of its complexity and reliability. 
Similarly, computational grids aggregate a variety of computational resources such as 
clusters, supercomputers, desktop PCs and workstations along with scientific databases, 
instruments, devices for storage and visualization. The users would not even know which 
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computer performs the computations in the same way that that users of power systems are 
not aware about the part providing them the electricity they use [99]. The goal of such 
heterogeneous grid technologies is to provide a transparent secure access to high-end 
resources irrespective of th location of their physical existence and the location of access. 
Although these two terminologies are equivalent to each other in many aspects, 
computational grids are still in their infancy and need a more sophisticated operational 
model, organized systems transmission to ensure network stability, global resource 
sharing policies, universalizing the resource properties and ease of use [100]. 
Although different researchers and groups use grids for various purposes, the main 
objectives of grid computing can be summarized as follows [101]: 
- Provision of consistent load-balancing by utilization of unused computational 
resources in terms of CPU cycles and storage capacity to employ existing 
application on different machines. 
- Exploitation of multiple processors for CPU intensive grid application using 
parallel applications via networking. 
- Reliable and uniform, inter- and intra- institutional access to remote resources for 
enhancing collaborations and research opportunities. 
- Virtualization of the existing distributed computing resources to enable 
participation of heterogeneous systems to form a larger grid having individualized 
policies and priorities for both resources and users. 
- Resource balancing in terms of sharing special equipments, software, licenses, and 
other services. It also includes temporary suspension or even cancellation of low 
priority tasks to execute the higher priority tasks when the grid is fully used.  
 
 
 
 
Grid Development and UVieCo – University of Vienna Condor Pool                  Chapter 2 
27 
 
2.1.1 Grid Components 
While the individual grid projects differ in their architecture, a general collection of 
components necessary for constructing any grid remains the same and individual projects 
implement their own version of components accordingly. It ensures the interoperability, 
code sharing and portability among the participants of virtual organization to distribute 
heterogeneous resources in dynamic manner. As shown in Figure 2.1, the components 
required to form basic grid architecture are arranged in distinct layers having their own 
functionality [102]. 
The fabric layer consists of heterogeneous, geographically distributed resources such as 
multi-processor computers, physical storage systems and their local resource management 
systems. Computational power is generated by individual desktops or workstations 
running a variety of operating systems, or clusters having their own operating systems or 
resource management systems such as LSF, Condor or PBS. This layer also includes data 
storage facilities such as databases or file systems as well as different software and 
scientific instruments such as x-ray crystallography beamer or radio telescope. A grid 
middleware is required for unhindered interactions within them as all these resources are 
controlled by different local resource operators with variety of monitoring mechanisms.  
 
Figure 2.1: The components required to construct a Grid, split into layers containing Applications, 
Grid Tools, Grid Middleware and Fabric. Modified from [102]. 
Grid Development and UVieCo – University of Vienna Condor Pool                  Chapter 2 
28 
 
The core middleware layer renders important communication and security protocols to grid 
infrastructure for abstracting complexity and the heterogeneity of the fabric layer. The 
information services help to overcome the dynamic nature of the grid, i.e. they provide 
means to register and retrieve information about grid resources, services and their status in 
a more sophisticated way as their location and availability are constantly changing. Both 
resource providers and users benefit from resource trading which assists them to formulate 
strategies, while in turn maximizing their objectives. Security services also play a crucial 
role in dealing authorization, authentication, privacy, integrity and accountability issues to 
access cross-boundary, autonomously administered diverse systems. 
The user-level middleware layer imparts programming frameworks and tools for different 
types of applications, and resource brokers to chose specific required resources for 
particular programs. These high level services support standard programming languages, 
a variety of programming paradigms (e.g. message parsing interfaces (MPIs) or distributed 
shared memory), compilers, parallelization tools and libraries that allow applications to be 
developed which can run on the grid. Resource management and scheduling should be 
user-friendly, self-explanatory and provide opportunity to utilize and manage processor 
time, memory, network, storage and other resources effectively and proficiently using 
middlewares. 
The applications layer is the final and important component of grid architecture. It is 
developed using grid-enabled programming environments and interfaces that lets end-
users to utilize grid services to solve large scale scientific and engineering problems. These 
grid applications should be easy-to-use for naïve users and should also run on several 
platforms and operating systems. It also includes software and tools to support application 
workflow and composition. Web portals are thus emerging as excellent solutions in 
providing unconditional remote access to the resources and databases to users for their 
application execution.  
This is a simple architectural model of the grid system. A large number of components are 
required to construct the grid and there exist many complex interactions among them. An 
agreed set of standards needs to be adopted for developing grids so as to achieve 
interoperability and acceptance from a wide user community. 
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2.1.2 Types of Grids 
Grids are categorized into various types based on different criteria perceived by computer 
scientists, research analysts and IT vendors. These are classified based on the types of 
resources, services, geographic locations, functionality, architecture and built-in-
components. Depending on the geographical dispersions of the computers, grids are 
classified into three categories such as cluster grids, campus grids and global grids [101, 
103].  
Cluster Grids – These are the localized grids, for example within a department or a research 
group, possessed and operated by a small number of people. Cluster grids consist of 
several systems functioning together to allow a single point of access to users. Both high-
throughput and high-performance jobs are supported where resources can focus 
particularly on a smaller set of repetitive tasks, or complex jobs can be executed in a 
parallel manner. 
Campus Grids – These are the localized grids within a department or a research group (e.g. 
Pharmacoinformatics research group) possessed and operated by a small number of 
people. Cluster grids consist of several systems functioning together to allow a single point 
of access to users. Both high-throughput and high-performance jobs are supported where 
resources can focus particularly on a smaller set of repetitive tasks, or complex jobs can be 
executed in a parallel manner. 
Campus Grids – Campus grids are formed when cluster grids within different departments 
of an organization or university are merged together to fulfill the demands of larger 
computation. For example, UVieCo Condor pool of University of Vienna as shown in 
figure 2.2. Various computing resources along with networking solutions, middleware, 
software and utilities are shared in a co-operative way within a particular domain to 
handle multiple tasks and projects.  
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Figure 2.2 : Types of grids based on geographical distribution. Modified from [103] 
The three classes of grids are represented in Figure 2.2. In the cluster grid, small groups or 
organizations own their cluster where user’s tasks are performed at a particular site. On 
the broad spectrum, several such cluster grids come together forming more complex 
campus grids to perform bigger tasks. Both of them can be a part of a global grid to extend 
their network worldwide, where jobs can be executed on multiple sites.  
With a widespread demand of computational power, most of the research institutions are 
using shared computing grids which have quite different characteristics than those of 
traditional supercomputers, clusters, or commercial clouds. The wasted CPU cycles from 
the idle computers, e.g. when the users are away during the breaks or in the evenings, can 
be harnessed for doing some fruitful calculations. In other words, campus grid computing 
is emerging as an innovative strategy to make use of personal computers and disparate 
clusters, connected by different middlewares for massive amount of calculations. 
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2.2 UVieCo and High Throughput Computing using Condor 
Large numbers of scientific and data intensive calculations require weeks or even months 
of computation to solve the problem. Establishment of the computational environment to 
fulfill the massive requirement of computational power is desired to tackle this situation. 
Concurrent execution of the scientific tasks with available resources serves a faster mean of 
computing than a single server. This led to emergence of new terminology called as ‘high 
throughput computing (HTC)’, where a variety of computing resources are used (in serial 
as well as in parallel mode) for a longer period of time to complete compute-intensive tasks 
[104, 105]. The main advantage of HTC is that the costs are kept very low as new 
computers need not to be acquired and the processing is performed when the available 
computers would normally be idle. 
We developed a university-wide campus grid, UVieCo (University of Vienna Condor 
pool), composed of the resources from the ‘Research Lab Computational Technologies and 
Applications’ of the Faculty of Computer Science and the ‘Pharmacoinformatics Research 
Group’ of the Faculty of Life Sciences to develop an infrastructure for large scale 
distributed computing. The basic idea originated after analyzing the scenario where many 
computational resources within the university are underutilized by the computer owners. 
By exploiting the wasted CPU cycles when these computers would normally be idle, high 
throughput computing can be accomplished while maintaining the very low costs without 
much investment on the hardware. It is referred to as a Condor pool because several life 
sciences related applications are executed on different machines within the university 
network using a public domain middleware, Condor [41], which acts as an interface to the 
grid. It renders different computation and data storage resources to the university-wide 
user, thus they can accomplish compute intensive tasks over the high throughput network.  
With the implementation of a graphical user interface (GUI) and easy registration policies, 
this system promotes the users to become a part of our Condor pool. Self extracting 
executables including Condor and other necessary auxiliary packages were prepared for 
Linux and Windows platforms which can be downloaded from the portal. These single 
click installable packages were prepared in such a way that the user machine becomes a 
part of the pool immediately after its installation and in further runs, as soon as the 
machine is turned on. The co-operative virtual machine concept (CoLinux) was 
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implemented in a way that Linux-executable jobs can be run inside Windows. Firewall and 
security issues have been resolved using a virtual private networks setup to guarantee the 
accessibility of the participating machines among various departments. 
In this section, first we briefly describe the basic components of Condor. The detailed 
information about Condor can also be found in the manual [106]. Then the architecture of 
the UVieCo and issues related to the firewall transversal, openVPN gateway and CoLinux 
concept are presented.  The applications implemented on the grid are subsequently 
elaborated along with concluding remarks and future directions. 
2.2.1 Condor 
Condor is a widely used high throughput grid computing software which was developed 
with an aim to take full advantage of the available computing resources within the 
organizational network through distributed ownership [41].  It is a distributed batch 
system providing some interesting features such as job management mechanisms, queuing 
and scheduling policies, priority schemes, resource monitoring and resource management 
[107]. The Condor system comprises a pool of idle workstations, servers, clusters, with 
each processor of them working as a compute node for submission and execution of the 
computation jobs. In this way, it performs computer intensive calculations within short 
times by efficiently exploiting wasted computational power from idle machines. It creates 
the workflows and helps to organize the scientific tasks in such a manner that huge 
amounts of computation are performed without much intervention from users. It assists in 
submitting a large number of jobs based on the policies specified by the users, tracks their 
progress, gives error notification if there is any and finally intimates the users after 
completion and returns the results [108]. The main advantage of Condor is that it does not 
require modifying the source code of the program to be implemented into the Condor 
system. Several interesting features such as checkpointing and remote system calls are 
provided by Condor in relation to re-link the codes with its libraries. These aspects along 
with several important functionalities will be discussed in the following section. 
2.2.1.1 Condor Components and Daemons 
Condor facilitates the users to run batch jobs on a centrally organized network of 
computers. This network bears the responsibility of the jobs, searches and schedules the 
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resources, transfers the necessary files and performs rescheduling if the jobs are stopped 
abruptly on certain machines. The coordinated groups of schedulers and execute machines 
with condor installations are called as ‚condor pools‛ (Figure 2.3) [41].  
The central manager (CM), considered as the ‘heart’ of a Condor pool is a single important 
machine. It acts as the centralized repository of information which periodically assesses the 
current status of the pool and attempts to complete the pending tasks by rescheduling 
them to appropriate resources. As this machine performs the matchmaking process 
(discussed in next section) in the Condor system, it should be chosen in a way that it 
should be reliable and likely to be online all the time or at least will be quickly rebooted. 
Also, in an ideal scenario, it should have a good network connection to the rest of the 
machines in the pool to achieve better communication. It collects the periodic updates and 
information from an arbitrary number of other machines joining the pool and negotiates 
between resources (machines) and resource requests (jobs). These two roles are performed 
by separate daemons called condor_collector and condor_negotiator and are considered as the 
central components/core of the Condor pool.  
Besides the CM, there are two additional machine roles that are important for using the 
Condor system, submit/scheduler and execute roles. The ‘submit machine’ allows 
submission of the Condor jobs. It requires large swap space and/or real memory as it 
generates another process and retains the memory image of the job submitted to the 
remote execute machine. Additionally, the checkpoint files and the binaries of the 
submitted jobs are also stored on the local disk of the submit machine. On the other hand, 
‘execute machines’ are configured to execute the Condor jobs. They have a simple 
configuration and don’t need many resources. The Condor pool will not be functional 
without their service and the more resources (CPU speed, real memory, swap space, etc.) 
these machines have, the more efficiently the resource requests will be served by them.  
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Figure 2.3 Overview of Condor Architecture 
The central manager collects the periodic updates and information from an arbitrary 
number of other machines joining the pool and negotiates between resources (machines) 
and resource requests (jobs). These two roles are performed by separate daemons called 
condor_collector and condor_negotiator respectively and are considered as the central 
components/core of the Condor pool. The collector daemon monitors the status of all the 
rest of the machines within a Condor pool in the form of classads. Thus, the users as well 
as all other daemons can query the collector to obtain the specific information about the 
different parts of the Condor pool. The negotiator daemon is responsible for match-making 
process which is initiated by a negotiation cycle where the status of a pool is determined 
by querying collector, each schedd having awaited resource requests are contacted in 
priority order and finally meeting the requests with the available resources.  
The ‘submit’ and ‘execute’ machines are comprised of the condor_schedd and condor_startd 
daemons respectively. The schedd daemon represents the resource requests. It allows the 
user to submit the jobs (using condor_submit command) and manages them by viewing 
(condor_q), monitoring (condor_status) and manipulating (condor_rm) the job queue. It 
publicizes the information about the jobs in a queue and seizes the available resources to 
accomplish those tasks. Once the matching resource is found for the particular task, schedd 
gives rise to condor_shadow daemon which acts as a resource manager and allows the 
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transfer of a given request to the remote execute machine. The startd daemon on the other 
hand corresponds to the resource offerings and advertises the properties of the resources 
that might prove useful to meet the awaiting resource requests. It comprehends the 
resource owner’s policies and controls the circumstances to start, suspend, resume, vacate 
or kill the jobs on any remote execute machine. When it is ready to execute a job, it 
commences a child process in the form of condor_starter daemon which actually runs the 
job on a remote machine. It configures the requisite execution environment, monitors the 
status of the job and returns the information to the submit machines after the completion. 
2.2.1.2 Prominent Characteristics of Condor 
ClassAds  
A classad (classified advertisements) is a set of unique expressions comprising of specific 
characteristics and requirements of the machines using Condor to specify the policies 
required for matching the resource offerings (e.g. machines) or resource requests (e.g. jobs) 
[109]. This concept was originated from the brief advertisements in the morning 
newspapers where sellers advertise the details about their products to attract the 
customers whereas buyers may also publish the features about their proposed necessities. 
In this way, the constraints from both buyers and sellers are listed and satisfied [108-110].  
Classad plays an important role in Condor’s matchmaking process where it acts as a 
schema-free resource allocation mechanism to fulfill requirements from the users about job 
requirements and job desires. For example, a user would want his job to be run on a 
machine with at least 128Mbytes of RAM with Linux operating system and specified CPU 
type and speed or virtual memory size, whereas workstation owner can state his 
preferences about running jobs from particular department or a set of users. Such job 
requirements/preferences along with resource availability are described as powerful 
expressions using classads which help in adapting any form of working policy. They are 
used for scheduling the jobs, maintained in log files for future statistical and debugging 
purposes as well as for knowing the current status of the Condor pool. The simple 
examples of classads describing a submitted job and that of a machine are as follows 
(Figure 2.4): 
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Job Classad 
[ 
MyType = "Job" 
TargetType = "Machine" 
Requirements = ((other.Arch =="INTEL" 
&& other.OpSys =="LINUX") 
&& other.Disk >="10000") 
Owner = "griduser" 
NumUsers = 0 
MaxJobsRunning = 200 
StartLocalUniverse = TRUE 
TotalIdleJobs = 0 
TotalRunningJobs = 0 
] 
 
Machine Classad 
[ 
MyType = "Machine" 
TargetType = "Job" 
Activity = "Idle" 
LoadAvg <= 0.034252  
KeyboardIdle > 900 //seconds 
Disk = 332542 //Kbytes 
State = "Unclaimed" 
Arch = "INTEL" 
OpSys = "LINUX" 
Name = "10-8-1-13.unigrid" 
Rank = other. Deptt==self. Deptt 
] 
Figure 2.4: Examples of job classad and machine classad from Condor 
Signed Classads  
Security with the classads sometimes becomes a prime issue as these are sent in plain text 
by default and thus may be read and modified by any intruder. The altered policies in the 
classads which are provided to the central manager from the machines can cause rejection 
of the services, illegal access of the resources for their own benefits or misuse of the results 
before returning to the submitter. Condor provides an excellent solution for this problem 
in the form of ‚signed classads‛, where digital signatures are created for executables, 
arguments, and input data by the submit machine prior contacting to the central manager 
[111]. The signatures are verified by the central manager, the job is executed with other 
machine and results are returned to the submitter who checks the signatures on the results 
and confirms whether the central manager has been consistent with the policy. The 
signatures are made and checked using X.509 keys and certificates and any alteration in 
them can be easily detected. Signed classads can play a role in authentication and 
authorization and keep away intruders from intercepting Condor’s communication and 
harmful modifications in classads. 
Job Checkpoint and Migration 
The checkpointing is a process in which the information of the program’s current state is 
saved and can be reused for resuming its execution on another machine. This is very much 
important for long-lasting jobs which take weeks or months for their completion. If the 
machine running a Condor job becomes unavailable, a checkpoint is created to preserve 
the already completed computation. This is then used for continuation of the job on other 
machine after migration, thus enabling Condor’s preemptive-resume scheduling policy. 
Periodic checkpointing is essential when the jobs are executing on machines which become 
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unavailable after every short time. It provides an efficient mechanism of fault tolerance and 
act as a precautionary measure to save the accumulated computation time in case of 
system failure such as shutdown or crash of executing machine [108, 112, 113].  
Remote System Calls 
When a job is submitted to a Condor pool, it is often executed on the remote machine. 
Despite this external demand, the security and internal local execution environment of the 
remote machine is preserved by Condor’s mechanism called ‘remote system calls’. It helps 
to bypass the needless requirements such as transferring data files or creating a login 
account on the remote machine before execution of user’s programs. The job related 
input/output files are maintained on the submit machine, thus avoiding their imposition 
on remote machine [113].  
User’s Source Code Unchanged 
Prior programming knowledge is not necessary for using Condor. Condor can run non-
interactive programs efficiently with above mentioned transparent and automatic 
functionalities. User only needs to re-link the programs with Condor libraries without its 
modification or recompiling. 
Flocking of Condor Pools 
Several Condor pools located at different places can be hooked together which allows 
submission of a job in one pool and its execution in another. This mechanism is very much 
flexible and after submitting the jobs, another subset of machines within second pool can 
set the policies stating which jobs to be executed and which users to allow doing the same.  
Priority to Machine Owners 
Condor gives prime importance to the machine owner and he has complete priority for 
using his own resources. The owner allows others to use his machine when it is idle and as 
soon as he returns, Condor automatically facilitate to regain the control back without any 
special efforts. 
Ordering the Dependencies 
Condor considers the dependencies among the jobs and facilitates their execution in 
sequential manner. DAGMan (Directed Acyclic Graph Manager), a meta-scheduler is used 
to specify the set of inter-dependent executions of one or more jobs [114]. Here, each node 
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in this graph represents individual job and edges recognizes the dependencies. It presents 
the programs to Condor in order depicted in DAG and processes the results. Prior to 
submission of a job, an input file describing DAG is specified alongwith a Condor submit 
description file for each sub-job in DAF file. A simple DAG containing 4 nodes and its 
corresponding DAG input file is presented in Figure 2.5. 
# File name: dagman.dag 
JOB A A.condor 
JOB B B.condor 
JOB C C.condor 
JOB D D.condor 
PARENT A B CHILD C 
PARENT C CHILD D 
Figure 2.5: Dagman DAG dependancies 
DAGMan monitors the log files after submitting the jobs to execute programs in order as 
stated in DAG. It is also responsible for scheduling of tasks, recovery of the results and 
reporting about the set of programs presented to Condor. We used this scheduling 
mechanism for sequential execution of DOCK sub-programs as presented in section 2.2.6.1. 
 
2.2.2 UVieCo Architecture 
The very basic architecture of UVieCo is shown in Figure 2.6. This example shows how the 
resources between the faculties of computer science and life sciences are shared in a single 
Condor pool. The various components are shown in Figure 2.6, namely the connection 
manager, the execute machines and the network and firewall setup. Administration and 
implementation information is provided as appendices 1 and 2. 
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Figure 2.6: Basic Architecture of UVieCo 
Central Manager 
The central manager is intended to actually have three additional roles apart from being 
the condor central manager (Condor 7.0.1) [41]: a web interface (Apache Tomcat 6.0) [115], 
a database server (PostgreSQL 7.4) [116] and a VPN gateway (OpenVPN 2.0.9) [117]. 
Figure 2.6 shows how these applications work together. This machine is currently running 
Suse Linux Enterprise Server 10 and owns four dual core AMD Opteron processors with 
2GHz each and 24GB of RAM.  
Execute Machines 
As can be anticipated from Figure 2.7, the execute machines are a collection of 
heterogeneous computers which can be roughly divided into two categories. 1. Dedicated 
machines which are intended to be used for the campus grid only or at least to a great 
extent. Most of them will be running on Linux, while all others run on Windows. 2. 
Workstations, which on the other hand are pre-existent machines intended for lab work 
which will be utilized in times of low usage by the owner. Concerning the condor software, 
an execute machine will be running the startd daemon which will be configured to only 
accept jobs from the central manager's negotiator and schedd daemons.  
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Figure 2.7: Collaboration between central manager components 
2.2.3 Firewall Transversal 
One of the biggest problems for a condor deployment is to guarantee the accessibility of 
the execute machines behind firewalls. Usually, the potential client machines on the 
campus do not possess a global IP address and are hidden behind network address 
translation (NAT) boxes. Several solutions have been mentioned in the related work 
section.  
2.2.3.1 Firewall within Condor 
It has been stated that initially condor was designed to run in a network environment 
which is both ‘symmetric’ (i.e. one in which any machine can initiate a connection to any 
other machine), and in which there are no restrictions on types of network traffic (e.g. 
firewalls blocking UDP). Now-a-days, in the modern computing environment such an 
‘open’ network environment is increasingly rare. It is thus the case that it can be quite 
difficult to deploy condor in many current network environments due to the presence of 
firewalls, private networks (i.e. networks of machines with IP addresses in a specified 
range) and other circumstances that break the symmetry of the network [118]. Firewall 
issues related to condor system have been intensively studied by O’Donnell [119],  Son et. 
al [120, 121], Lodygensky et al. [122], Beckles et al. [118], Calleja et al. [123] and Scherp et al. 
[124].  
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There are currently two main mechanisms for dealing with firewalls within Condor [125]: 
1. Restrict condor to use a specific range of port numbers, and allow connections through 
the firewall that use any port within the range, and 2. Use Condor Connection Brokering 
(CCB) or Generic Connection Brokering (GCB). Condor Connection Brokering or CCB 
allows condor components to communicate with each other when one side is in a private 
network or behind a firewall. Currently, the functionality of GCB is being replaced by CCB 
because GCB provides communication between two different private networks whereas 
CCB only supports communication between nodes with one-directional connectivity. The 
main reasons why CCB is preferable are: support for all platforms (including Windows), 
easier configuration and troubleshooting, and ability to restart and reconfigure on the fly. 
Generic Connection Brokering, or GCB, is a system for managing network connections 
across private network and firewall boundaries. Although GCB provides numerous 
advantages over restricting condor to use a range of ports which are then opened on the 
firewall, it has to be noted that it’s also a very complicated system, with major implications 
for condor’s networking and security functionality. 
O’Donnell addressed the problem of condor’s lack of ability to function through a firewall 
for the first time in the Wisconsin Computer Science network (cs.wisc.edu) [119]. He 
considered two approaches: writing a custom proxy server and using an existing standard 
proxy system, considering the fact that the best solution should not negate the original 
purpose of a firewall, i.e. security. He finally came up with the SOCKS proxy system which 
was equipped with security, auditing, management, fault tolerance, and alarm notification 
at that time. 
Son and Livny [120] observed that in grid computing, the pools of hundreds or thousands 
machines are not necessarily having world-addressable IP addresses and the 
administrators of those pools would prefer private network configuration as it helped 
them to manage their clusters easily and also reduced the cost by paying for only several 
public IP addresses for head nodes instead of hundreds or thousands ones. According to 
them, these private networks and firewalls damaged internet connectivity, making it 
asymmetric and difficult or even impossible for peer-to-peer computing. They then 
correlated this problem with the condor system and came up with two different 
approaches, DPF (Dynamic Port Forwarding) and GCB (Generic Connection Brokering) 
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which have different characteristics in terms of clusters supported, security, and 
performance and suggested that the users should choose the better one depending on their 
policies and situations. 
In an another approach, Son et al. [121] presented a middleware firewall traversal system 
called CODO (Cooperative On-Demand Opening), which provides applications end-to-end 
connectivity over firewalls/NATs in a secure way along with allowing applications 
authorized through strong security mechanisms to traverse firewalls/NATs so that 
authorized applications can communicate through it , while blocking unauthorized 
applications. 
Lodygensky et al. came up with a lightweight grid solution for the deployment of multi-
parameters applications  by using XtremWeb coordinator to solve problems related to 
domain administrations and firewalls when connecting different condor pools [122].They 
demonstrated the usefulness of this approach measuring the performances of a multi-
parameters bio-chemistry application deployed on two sites: University of 
Wisconsin/Madison and Paris South University. 
Beckles et al. [118] raised several issue related to condor’s pattern of network 
communication such as machine’s role, direction of network communication, network 
protocols and port usage, administrative overhead, private firewalls, inadequate 
documentation, unresolved bugs relating to network communication, etc. Then explaining 
why these are unfriendly to the firewalls and private networks and finally coming up with 
the solutions / techniques which have been developed to address or mitigate these 
problems. These solutions include - mitigating the effects of firewalls, altering the pattern 
of network communication e.g. reducing it to ‘few-to-many ‘or even to ‘one-to-many’, 
firewall/NAT traversal, i.e. traversing the security boundary along with generic connection 
brokering (GCB) and dynamic port forwarding (DPF). 
A grid infrastructure, WISENT has been created using Globus Toolkit and Condor by 
Scherp et al. [124] to handle large heterogeneous datasets generated in energy meteorology 
research. Because of the 6 different locations of the partner sites, the construction of the 
grid infrastructure is hindered by blocking firewalls due to strong firewall policies and the 
use of network address translation (NAT). To tackle with this problem, after considering 
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possible solutions such as an extra grid-zone, a tunnel via virtual private network (VPN) 
established with each external project partner and application level gateway (ALG), they 
came with an approach of using a connection broker which can be used for hole punching 
to traverse firewalls and NAT systems. 
Similarly, Calleja et al. [123] implemented an experimental solution by constructing a 
dedicated Virtual Private Network (VPN) and flocking the small condor pools across this 
VPN. They further claimed that VPN enabled to tunnel through departmental firewalls 
and encrypted traffic across interdepartmental links, allowing nodes with private IP 
addresses which could join a grid that crosses institutional boundaries. Jobs migrated 
seamlessly across the flocked Condor pools and there was no noticeable degradation in 
performance due to the overhead of running across the VPN. 
2.2.3.2 Firewall Solution in UVieCo 
For these issues, we settled for a different solution, the openVPN package. Calleja et. al 
[123] have similar implementation of the condor setup as we have in our pool. Their setup 
differs from ours as they used the VPN to flock their Condor pools whereas we intended to 
use it to connect the execute machines to the central manager. OpenVPN supports a wide 
variety of operating systems including Windows 2000/XP/Vista/7, Linux and Mac OS X. 
Considering a more detailed look at the connection between the central manager and the 
execute machines, the setup actually looks like it is shown in Figure 2.8. 
2.2.4 Security  
The detailed description of security implementation in Condor can be found at [126]. We 
describe here the security solutions implemented with UVieCo. 
VPN Tunnel 
The VPN software is configured to lease private IP addresses to all authorized clients. 
Authorization is done via client certificates. The establishment of the VPN tunnel is 
initiated via UDP from the client-side. The firewall protecting the execute machine 
therefore has to allow outgoing UDP connections. A brief overview of the execute machine 
startup is shown in Figure 2.9. 
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Figure 2.8: Network Setup: 1. VPN tunnel traversing firewalls; 2. Central manager's firewall; 3. VPN 
client-to-client connections are not possible 
 
 
Figure 2.9: Execute machine startup sequence 
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Central manager's firewall 
The central manager is a central point in this network setup as it is able to communicate 
with all the connected clients through firewalls which were put in place to protect them. 
We therefore intend to restrict incoming as well as outgoing IP traffic on the central 
manager to the ports or port ranges used by condor. This has been done via the Linux tool 
‚iptables‛. 
VPN Client-to-client connections 
As an additional security measure, the VPN server will be configured to disallow 
communication between the VPN clients (the execute machines).  
The openVPN software offers to fine-tune a wide range of parameters for the tunnel. We 
have set the most important ones so far, as outlined in the following list. 
1. Authentication is done by setting up a public key infrastructure (PKI). The 
openVPN server as well as each client owns a private and a public key (or ‚certificate"). 
Additionally there is a Certificate Authority (CA) public/private key pair which is used to 
sign the client and server certificates. OpenVPN will be configured to require each client to 
present a valid CA-signed certificate and allow only one client to connect with the same 
certificate which may also be revoked manually. Concerning the cipher used to encrypt the 
condor traffic, the default value ‛Blowfish" is considered to be enough for our uses. 
Although there are some recommendations against the use of this cipher, the payload in 
our case is not precious enough to research more secure possibilities of encryption. 
2. IP addresses - Each client connecting to the VPN gateway receives an IP address for 
its virtual device. In order to prevent conflicts due to the VPN subnet overlapping with the 
client's other networks we intend to use an unpopular address space such as 10.8.1.0 
3. Server port - In order to expose as few potential targets as possible to the outside 
world, the UDP server port which is responsible for accepting VPN clients will be set to a 
random number far away from the default value. The same is intended for the SSH port, 
which, together with the openVPN server port will be the only two ports available to the 
public world. 
As can be seen in the list above, setting up a basic openVPN server is fairly simple and a 
matter of adjusting a few configuration parameters.  
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2.2.5 Virtualization and CoLinux Package 
Enormous advancements have also been observed in the field of virtualization of computer 
hardware which allows users to run multiple virtual machines in a single computer, each 
of which acts as a separate section with a unique instance of an operating system. Several 
open-source [127-130] as well as commercial [131, 132] packages are available for 
virtualization. 
Use of this concept has also already been demonstrated for establishing condor pools 
where the implementation of linux-based condor has been carried out in windows 
computers using coLinux, utilizing different methodologies by  several groups pioneered 
by Sumanth at the University of Nebraska Lincoln [133] and adopted later by Neeman 
et.al. [134], Severini et al. [135], Santosa et al. [136] and Alexander et al. [137]. For 
networking, they used the winPcap tool [133, 137], which requires real IP addresses of the 
machines, resulting in having the same local IP for all coLinux installs. So the suggestion of 
changing mac-address of the new TAP-Win32 device has been proposed to have real host's 
IP. Another observation is that these pools have only windows machines as a part of the 
grid whereas we plan to have a grid comprising of different machines with linux as well as 
windows operating systems. There are several similar approaches emerging, such as 
making use of virtual machines as an attractive tool for building campus grids,  Pools of 
Virtual Boxes (POVB) [138], or exploring Virtual Workspace Concepts [139] or the use of 
virtual network, ViNe [140]. 
The coLinux installer basically contains a Debian 4.0 root image with all the necessary 
auxiliary packages and the client .deb package installed. The scripts are therefore 
essentially the same. One difference, however, when running under windows is for condor 
to determine if the machine is idle or busy. Under a native Linux, condor may access the 
CPU status and the keyboard and mouse activity. When running inside coLinux, however, 
the virtual machine has no access to the windows keyboard and mouse usage. The same 
applies to the CPU. This problem was solved with a small VBScript running as a windows 
service (‚colinux_monitor‛) which reports the current performance data to a directory 
shared by windows and the coLinux virtual machine. Inside coLinux, the script 
unigrid_monitor.sh, which is periodically called by condor, reads out the windows 
performance data and acts accordingly.  
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2.2.6 Applications and Performance Efficiency Measurement 
Several molecular modeling software packages have been running on the grid 
environment using different methodologies [91, 141]. For our implications, we decided to 
target DOCK, OMEGA, ROCS, NAMD and WEKA.  These are free for academics and we 
did not need to modify their source code for Condor. 
2.2.6.1 DOCK 
DOCK is developed at the University of California in San Francisco (UCSF) and evaluates 
chemical and geometric complementarities between a small molecule and a 
macromolecular binding site [142]. It examines the fitting pattern of the small molecules 
such as a drug into macromolecules like an enzyme or protein receptor. Compounds that 
might bind tightly to the target receptor must have complementary chemical and spatial 
natures. Thus, docking can be seen as a 3D puzzle searching for pieces that will fit into the 
receptor site [141]. It is important to be able to identify small molecules (compounds), 
which may bind to a target macromolecule [15]. This is because a compound, which binds 
to a biological macromolecule, may modulate its function and with further development 
eventually become a drug candidate. 
The sequential connections between the sub-programs in the DOCK suite are depicted in 
Figure 2.10. The user initially has to prepare some preliminary files using the freely 
available chimera software [143]. Although a new update of chimera allows the user to 
build the molecular surface file from the non-hydrogenated pdb file, we used the open 
source C code of the DMS [144] program from the UCSF Computer Graphics Laboratory 
for this task. The program sphgen [145] generates spheres from these molecular surfaces 
which are used to create a negative image of the surface invaginations of the target. A 
subset of spheres which represents the binding site is chosen using a sphere-select program 
considering the defined radius around the ligand or the binding pocket residues. Then an 
interactive program, showbox, is used to visualize and define the location and size of the 
grid of sphere centers that reflects the actual shape of the active site which is then 
calculated using the grid program[146, 147]. The spheres (generated by sphgen) are 
matched with ligand atoms using the dock program and uses scoring (from the software 
GRID) to evaluate ligand orientations [145, 147]. 
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Figure 2.10: The sequential connection between sub-programs in the dock suite 
The focus of our work was to create a workflow using condor’s DAGMan [114] meta-
scheduler and measuring the performance of the docking task when compared with single 
processor runs. Single compound docking using DOCK is expected to take up to 5 hours of 
execution time on a desktop computer. We docked 4 compounds with 100 conformations 
each into 60 homology models of P-glycoprotein using our grid, considering the mixed 
pool of linux and windows machines.  
Two different cases were considered to determine the effect of inter-node communication 
speed in terms of cpu-time between the departments of computer-science and life-science. 
The 28 computers chosen are from the informatics labs from both departments, which are 
accessible to all users. 
Case 1 – pool of 50 processors only from life-science department comprising of 22 dual-
core linux machines and 6 windows machines with coLinux. 
Case 2 – pool of 50 mixed processors where 6 windows machines with colinux nodes were 
from computer-science department and 22 dual-core linux machines from life-sciences 
department. 
 
Grid Development and UVieCo – University of Vienna Condor Pool                  Chapter 2 
49 
 
Table 2.1: The statistics of the 60 docking experiments 
Parameter Case 1 Case 2 
Average time to complete a job 209.6 min 181.7 min 
For 60 jobs on a single machine (209.6*60) = 12576 min (181.7*60) = 10902min 
Time taken by grid for 60 jobs 366 min 322 min 
Average speed-up value of grid 12576/366 = 34.36 10902/322 = 33.86 
Average Efficiency 34.36/50 = 0.6872 (68.72%) 33.86/50 =0.6772 (67.72%) 
 
Both pools perform in a similar way for the sequential tasks if we consider speedup values 
and efficiency. The ‘time taken by the grid for 60 jobs’ is more when compared to regular 
docking job as condor’s queuing mechanism allows the calculations of the first 50 jobs on 
50 processors, keeping 10 jobs idle which will be started after the completion of first 10 jobs 
in the queue. Also the delays in completion for case 1 might be because of the inter-
departmental communication time as our central manager is located at the computer-
science department. Similarly, if some users intervene during this measurement then this 
particular machine becomes unavailable, leading to transfer of the job to another computer, 
which adds a further delay in completion.  
Web server implementation 
We also implemented a web based docking job submission portal for DOCK with 
normalized parameters. To facilitate the docking for new users who are not aware about 
working with DOCK, we implemented an automated pipeline of our sequential docking 
method and developed a web server interface. Tomcat/Apache served as a J2EE container 
for Java Servlet and JSP. A iptables mechanism of Linux was used to store the user account 
information, uploaded data and docking results. The web server runs on the central 
manager mentioned earlier and works with both the Microsoft Internet Explorer and 
Mozilla Firefox browsers. It can be visited at https://goedel.ani.univie.ac.at/unigrid/. 
2.2.6.2 NAMD 
Molecular dynamics simulations play an important role in modern molecular biology and 
can be used for different purposes starting from studying the natural dynamics of 
biomolecules on different timescales with or without solutions or simulating a single 
molecule with its surroundings for a period of time [148]. It can also be used to determine 
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the bulk properties of fluids and the free energy differences for chemical processes such as 
ligand binding and to explore the conformational space of a molecule or a complex [149]. 
These are very computer time-intensive tasks, which limits the physical time and the size 
of the systems that can be studied. A promising means of overcoming these limitations is 
through the use of parallel computers.  
NAMD is a parallel, object-oriented molecular dynamics program designed for high 
performance simulation of large biomolecular systems [150-152]. It uses a spatial 
decomposition scheme to partition the domain in a way that provides maximum scalability 
coupled with a multithreaded, message-driven design which is shown to scale efficiently 
to multiple processors. Based on Charm++ parallel objects, NAMD scales to hundreds of 
processors on high-end parallel platforms. NAMD binaries were compiled for the parallel 
execution on our condor pool. Version 2.6 of NAMD was used, compiled with the mpi 
compiler and OpenMPI was used for parallelism. 
We used the default files of Ubiquitin protein provided with NAMD installation for our 
performance measurement studies (running for 100 & 2000 steps). Following three 
instances were considered and CPU time in seconds was compared as shown in Table 2.2 
and Figure 2.11. 
1. In the first instance, only the Open-MPI setup was used to make the time-evaluation. 
This is very fast and takes only a short time to complete the job. 
2. The second instance was establishing a local condor pool (using 20 PCs in the 
informatics lab of the life-science department), taking their real hostname & IP-
addresses, establishing one of the PCs as central-manager and remaining 19 as 
execute PCs to perform the time-evaluation. This works similar to the first instance. 
3. The third attempt of performance check has been done using the UVieCo grid using 
20 PCs in the informatics lab of the life-science department considering virtual 
private IPs and a central manager which is in the computer-science department. In 
this case, the performance until 8 nodes/processors is almost similar to the 2nd 
instance, but onwards decreases drastically. The reason for this drop in 
performance might be because of the openVPN, the ethernet connection and inter-
node communication time lag. 
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Table 2.2: The difference in calculation time for the mentioned 3 instances  
No. of 
Processors 
Time for 100 steps (sec) Time for 2000 steps (sec) 
Instance 1 Instance 2 Instance 3 Instance 1 Instance 2 Instance 3 
2 66.4 61.3 125.28 1644 693.45 1625.2 
4 46.3 45.5 54.32 706.7 388.76 729.5 
8 40.67 36.76 47.6 329.62 242.42 678 
12 43.08 39.87 56.6 245.18 228.76 795.4 
16 39.24 36.5 54.2 212.48 186.53 994.3 
20 37.4 34.54 52.06 230.54 222.68 1098.4 
24 36.44 35.42 56.5 225.43 209.54 1064.9 
28 35.13 35.2 64.2 224.51 213.4 1315 
32 34.2 31.9 231.8 265.39 238.5 1683.6 
36 32.48 31.59 268.8 248.07 242.68 1967.7 
40 32.11 31.62 446.8 266.56 254.3 2458.8 
Figure 2.11: CPU time comparison for 3 instances considering 100 steps and 2000 steps of MD 
simulations using NAMD 
2.2.6.3 OMEGA and ROCS 
We implemented the shape-based similarity searching approach on our pool using 
OMEGA and ROCS from OpenEye Inc [153, 154]. We can process these tasks in a 
sequential manner using condor. But another hurdle came across for this implication, i.e. 
Execution of similarity-based screening requires huge amount of time on a single 
processor. Unfortunately, Condor stopped the support for PVM universe, which is needed 
for openeye’s parallelization approach. So, we installed these programs in parallel using 
the PVM environment, independent of the Condor pool, thus making them efficient. 
Performance measurement was carried out with both OMEGA and ROCS (using 20 PCs in 
the informatics lab). For OMEGA analysis, we used 1395 compounds giving finally 100,811 
conformers. For ROCS calculations, we screened a small dataset of 130 compounds (with 
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max. 3 conformers of each) against 1395 compounds (with max. 10 conformers of each). 
Rest of the parameters was kept default for both OMEGA and ROCS. The statistics for 
different number of processors is shown below in Figure 2.12. 
 
 
 
 
 
 
Figure 2.12 CPU time comparisons OMEGA and ROCS 
2.2.6.4 WEKA 
WEKA is developed at the University of Waikato, New Zealand and is a collection of state-
of-the-art machine learning algorithms for data mining tasks [155, 156]. It contains tools for 
data pre-processing, classification, regression, clustering, association rules, attribute 
selection and visualization. It is designed to quickly trying out existing methods on new 
datasets in flexible ways as well as well-suited for developing new machine learning 
schemes. 
Weka was extensively used with our Condor pool to carry out several tasks. For our 
classification problem, initially we used Weka’s support vector machine (SVM) module via 
libsvm [157]. In this program, the values of the gamma and cost parameters are needed to 
be chosen using grid search in such a way so as to get the maximum accuracy. We 
performed the grid search changing both the values of gamma and cost parameters from 2-
15 till 215 for various experiments with several feature-selection methodologies. We also 
tried other classification algorithms, changing several parameters similar to a grid search 
approach. The jobs were submitted as sequential tasks and accomplished on 20 linux-
operated computers. The application of Weka for classification of P-gp substrates and non-
substrates is discussed in details in the section 3.3. 
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2.2.7 Conclusions and Future Tasks 
Computational grids facilitated to tackle the data-intensive, large-scale problems efficiently 
with sharing and aggregation of distributed resources. With UVieCo, we tried to address 
the computational drug discovery problems via effectively handling the firewall and 
coLinux issues alongwith implementation of several molecular modeling techniques using 
the middleware Condor. The use of coLinux to create a homogeneous grid of linux-based 
computers has proven to be very efficient. The VPN was enabled to tunnel through 
university-wide firewalls and to encrypt traffic across interdepartmental links, allowing 
nodes with private IP addresses to join UVieCo that crosses institutional boundaries. The 
DAGMan workflow manager was employed to automatize the execution of docking jobs. 
Virtual screening of thousands of compounds was enabled with fast shape similarity 
methods such as OMEGA and ROCS. Parallel execution of NAMD program was also 
tested using openMPI in UVieCo to measure the efficiency of grid for parallel tasks. It 
needed more detailed investigation to minimize the inter-node communication delays. 
Subsequently, a collection of machine learning algorithms using WEKA program was 
implemented for data mining and ligand-based QSAR. Web based monitoring is also 
possible with a separate portal for submission of docking jobs. Finally, other users are also 
need to be convinced to become part of UVieCo to keep it in use and continuously 
growing. 
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In the second chapter, the basic architecture, underlying technology and novel concepts 
implemented in our grid environment, UVieCo were discussed. The important drug 
discovery techniques in the form of molecular docking, molecular dynamic simulations, 
shape-base similarity analysis and ligand-based QSAR techniques in the form of 
classification algorithms are also successfully implemented and reviewed.  
In this chapter, we describe the real-life applications and scientific experiments carried out 
using these implementations. The data used in these studies was the raw data collected 
from the rich repository of National Cancer Institute. 
3.1 NCI-60 Data Mining 
Over the last 5 decades, the National Cancer Institute (NCI) has played a crucial role in the 
development of drugs for the cancer treatment which is evident from the fact that 
approximately half of the chemotherapeutic agents currently used were discovered and/or 
developed at NCI [158]. It was established way back in 1937 when it started to screen 
experimental cancer drugs. The transformation into an official organization (called as 
Cancer Chemotherapy National Service Center) took place in 1955 to incorporate 
laboratory resources with clinical facilities. In the early era, leukemic mice were used to 
test various compounds, but later in 1975, an initiative to screen new compounds with 
mice bearing murine leukemia P388 cells was introduced. This strategy satisfactorily 
identified compounds active against leukemias, but could not distinguish those which 
were effective against solid tumours such as carcinomas. 
Thus, NCI developed a replacement approach for this method in terms of a new in vitro 
primary screen based upon a diverse panel of 60 human cancer cell lines (the NCI-60) 
[159]. The NCI-60 panel represents nine distinct tumour types such as leukemias (6 cell 
lines), melanomas (8), lung (9), colon (7), kidney (8), breast (8), prostate (2), ovary (6) and 
central nervous system (6). Since 1990, this panel of 60 human tumor cell lines was used by 
NCI’s Developmental Therapeutics Program (DTP) to screen potential anticancer drugs 
from more than 70,000 chemical compounds with a defined range of concentrations to 
determine the relative degree of growth inhibition or cytotoxicity [160-162]. Each 
compound is tested in individual cell line and a sulforhodamine B assay is performed to 
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assess the growth inhibition from the changes in total cellular protein after 48h of drug 
treatment. A characteristic profile or a ‚fingerprint‛ is generated using a vector of 60 
growth inhibition values (50 percent growth inhibitory concentration, GI50), one for each 
cell line, representing the activity pattern of a compound. The patterns of such 60 GI50 
values across NCI-60 open a whole broad spectrum of unexpectedly rich, discriminative 
information about mechanisms of drug action, resistance and modulation [163-165]. Each 
compound’s pattern is essentially unique among many billions of distinguishable 
possibilities. The usefulness of this information can be further improved by the correlation 
of these activity patterns with molecular characteristics (e.g. MDR1 levels and p53 status) 
of genes/tissue types [165-168] or structural descriptors of the tested compounds [169]. All 
these experiments and assay procedures led to generation of various information-rich 
anticancer drug databases which include protein and mRNA expression profiles of 
molecular targets (genes) in the NCI-60, in vitro cell line screening and growth inhibitory 
profiles of small molecules along with their 2D and 3D structures collected and stored in 
the NCI repository since its establishment. To make better use of these information-rich 
databases, this project has also encouraged to develop, utilize and validate important data 
mining tools, like COMPARE [163, 170]. It analyzes correlations between protein/mRNA 
expression profiles of molecular targets (genes) and activity patterns of anticancer 
compounds using Pearson correlation coefficients to understand the possible mechanism 
of action of a drug and/or to discover potential novel lead compounds. Using COMPARE, 
promising lead compounds have been successfully identified for numerous molecular 
targets [171, 172]. 
Several remarkable characteristics of the cancer cell line data are presented by Wang et al. 
[173] who emphasize the integrated use of chemical, biological and genomic information 
from NCI-60 screen and relevance in finding biomarkers from variety of data relating to 
current research. By provision of a well curated set of tumor-related cellular assay 
screening results for thousands of compounds, it substitutes the use of high-throughput 
screening data. The screening program is progressing regularly as the information about 
the cancer cell line is continuously growing while maintaining the number of cell lines 
constant (in terms of numbers, assay procedures and comparability of results). The most 
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important thing about this data is that it is provided freely from the DTP Web server which 
can be used for further research and publications. 
3.1.1 Gene expression profiles and drug activity patterns 
In the past, assessment of cell characteristics was performed on the basis of one gene, gene 
product or molecular pathway at a time. Scherf et al. [174] imparted a broad perspective to 
this work and performed more extensive microarray expression analysis of many 
thousands of genes simultaneously in the 60 cancer cell lines to generate protein and 
mRNA expression database [175-177]. These databases are applied for cancer diagnosis, 
prognosis, prevention and therapy and can been included as useful information to the data 
mining activity of the NCI compound screening [178].  
It has been observed to a large extend that NCI-60 cells lines show common behavior in the 
gene expression patterns and clustered in the same way as they cluster based on their 
phenotypic properties (in this case, histological tissue of origin). According to Ross et al. 
[177], the gene expression profiles illustrate the patterns of phenotypic variation in the 
NCI-60 cancer cell lines. This approach of analyzing gene expression patterns was 
extended by Scherf et al. to pharmacologically characterize the drug sensitivity [174]. They 
correlated the activity patterns of more than 70,000 compounds tested in NCI-60 against 
mRNA expression levels of 9,703 cDNAs (~8,000 unique genes) in NCI-60 for the 
interpretation of drug-gene expression profiles. It is well represented in figure 3.1. A subset 
of 1,376 genes was selected from the initial 9,703 genes based on selective filters of strong 
patterns of variations and clustering in cell lines. Similarly, from the database of 70,000 
compounds, 1,400 compounds tested at least 4 times on all or most of the cell lines were 
selected for detailed analysis. Cluster analysis was performed using both subsets to 
organize NCI-60 cell lines on the basis of gene expression patterns and the growth 
inhibitory activities (GI50). It has been demonstrated that the 60 cell lines clustered well by 
organ of origin on the basis of gene expression patterns rather than on the basis of the 
patterns of drug sensitivity. The reason for this difference in clustering was attributed to 
the ability of certain cell lines (NCI-ADR-RES, ACHN, UO-31 and HCT15) to express the 
multi-drug resistance gene ABCB1 [179]. 
NCI-60 Data Mining and Grid Applications                    Chapter 3 
58 
 
 
Figure 3.1: Simplified representation of NCI’s drug discovery and development program. Each row 
of the activity database represents the pattern of activity of a particular compound across the 60 cell 
lines, and each column represents the pattern of sensitivities of a particular cell line to the 
compounds tested. The gene-expression database contains cDNA microarray measurements on the 
60 cell lines. The small gene expression database of 48 ABC transporters was performed by Szakács 
et al.  Modified from Figure 1 of Reference [174]. 
3.1.2 Expression profiling of ABC transporters in NCI-60 
Szakács et al. [179] extended the above mentioned approach and hypothesized that 
measuring the expression of ABC transporters in NCI-60 will allow to correlate ABC 
transport function with the structural, molecular, physiological and pharmacological 
features of the cells. Similarly, analysis of resistance or sensitivity of particular transporter 
to several classes of anti-cancer agents can be assessed based on relationship between ABC 
expression levels and sensitivity to drugs. Earlier studies about expression profiling of 
NCI-60 cell lines from Scherf et al. [174] and Staunton et al. [180] involved only 15 and 11 
of 48 ABC transporters using cDNA arrays and affy-metrix Hu6800 oligonucleotide chips, 
respectively. This led Szakács et al. [179] to perform the transcript expression measurement 
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experiments using the superior method, quantitative real-time RT-PCR, rather than the less 
sensitive, less specific microarray technology. Improved quantitative correlations were 
observed between expression and sensitivity which demonstrated the important role of 
ABC transporters in the drug resistance of cancer cells. The complete RT-PCR results on 
the 48 ABC transporters were presented by Szakács et al. [179] and we used them to 
calculate the person correlation coefficients for a larger set of compounds. They showed 
that the cancer with specific tissue of origin cluster together leading to common pattern of 
expression profiles. 
3.1.3 Correlation of mRNA expression of ABC transporters and drug sensitivity 
Since ABCB1 (P-gp/ MDR1) expels the chemicals from the cell, it has been demonstrated 
that the compounds showing negative correlation between their sensitivity/cytotoxicity 
and the transporter expression across the NCI-60 are expected to be transported by the 
transporter and termed as ‘substrates’ [179, 181, 182]. Weinstein et al. [164] plotted the 
correlations of a set of 118 compounds with known mechanism of action to confirm this 
hypothesis. They found that substrates showed prominent inverse correlations, whereas 
non-substrates were noncorrelated or positively correlated. In this study, they also found 
that two drugs were inversely correlated *(NSC 355644, r = −0.36) and Baker's soluble 
antifol (NSC 139105, r = −0.3)+, despite no proof of being as ABCB1 substrates. However, 
Gupta et al. showed that Verapamil, a potent ABCB1 inhibitor reverses the resistance of 
Baker’s antifol, indicating it as an ABCB1 substrate [183].  
To identify which ABC transporters and substrates might play roles in drug resistance of 
cancer cells, Szakács et al. [179] extended the analysis to a larger data set of 1,429 
compounds and calculated Pearson's correlation coefficients for a total of 68,592 
relationships (48 genes × 1429 compounds). They emphasize that the real-time RT-PCR 
database and analytical approaches used by them provided an unbiased method for 
discovering the substrate specificities of known, as well as yet uncharacterized, members 
of the ABC superfamily. 
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3.1.4 Calculation of Pearson correlation coefficients for available compounds 
In the present work, we performed the comprehensive analysis of NCI-60 drug activity 
data using RT-PCR expression results of the 48 ABC transporters from Szakács et al. [179] 
to compute Pearson correlation coefficients for all available compounds. Here, we were 
interested in 50% growth inhibition (GI50) which will give a good indication about drug 
sensitivity, resistance and toxicity and was also used by Szakács et al. [179]. The screening 
results of the drugs which were screened against NCI-60 for cancer are updated 
periodically. The GI50 metafile updated in October 2009 (‚gi50_oct09.bin‛) was 
downloaded in the form of compressed ASCII file from the NCI’s Developmental 
Therapeutics Program (DTP) server (http://dtpws4.ncifcrf.gov). Each row describes eleven 
different dose response parameters to express the screened drugs alongwith the log 
activity values for 159 cell lines representing cancers of different origin. They are as follows 
[184]:  
1. NSC number - the NCI’s internal ID number (NSC) 
2. Concentration unit – either molar, volumentric or μg/mL 
(CONCUNIT) 
3. Log of highest concentration tested (LCONC) 
4. Panel name for the cell line (PANEL) 
5. Cell line name (CELL) 
6. Panel number of the cell line (PANELBR) 
7. Cell number of the cell line (CELLBR) 
8. Log of the result (NLOGGI50) 
9. Number of tests for NSC and cell line (INDN) 
10. Maximum number of tests for this NSC (TOTN) 
11. Standard deviation for the log10 of the results average across all tests 
for this NSC and cell line (STDDEV) 
 
The handling and preprocessing of this file was very complicated and time consuming as 
the word handling programs were unable to process such a huge file of size 185MB with 
2.7 million rows. Thus, we spited the big metafile into small sub-files.  Several compounds 
were having more than one concentration (LCONC) values (i.e. the highest concentration 
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tested of the cell-line to achieve 50% growth inhibition). The concentration units are also 
represented in terms of Molar, µg/ml and volumetric units which are finally presented as 
LOGGI50 values. Since the developed perl script (Appendix 3) was unable to handle 
compounds with same NSC but tested at different concentrations, they were renamed 
based on the concentrations and represented uniquely. The same script was used to 
process each of the sub-files. The code of which can be represented as follows: 
- Read the sub-file 
- Present the data about expression of particular ABC transporter under study in the 60 cell 
lines (taken from Szakács et al. [179]) 
- Split the rows based on comma as delimiter 
- Read the lines specified for each unique NSC 
- Check if the cell line is from the 60 cell lines we are interested in. 
- Consider the NLOGGI50 activity values for these cell lines 
- Calculate the sum, mean, standard deviation for each NSC based on available NLOGGI50. 
- Compute covariance between expression values of particular transporter and retrieved 
NLOGGI50 activity values 
- Finally compute the Pearson correlation coefficient (PCC) 
- Iterate the process for all compounds till the end 
The Pearson correlation coefficient (PCC) between the activity of the ith compound and the 
expression level of the ABC gene was calculated based on standard deviation and 
covariance using following formula: 
       
    
     
 
Where, 
        = Pearson correlation coefficient of ith compound for particular transporter 
    and     = Standard deviation of the activity of the ith compound and the expression 
of transporter, calculated from the available GI50 data out of 60 cell-lines. 
       = Covariance between the two variables, viz – activity and expression 
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The process mentioned in the perl script was iterated several times, searching the new NSC 
from the top of the file again and again after finishing the calculation of PCC for each NSC. 
Thus, having bigger file consumes huge amount of computing power and time for 
processing. It was avoided by splitting the metafile into sub-files providing great 
advantage. 
With this process, 48,758 Pearson correlation coefficients were calculated for 47,622 
compounds considering gene expression patterns of each of the 48 ABC transporters in the 
60 cell lines and GI50 data. Only 40,935 compounds have valid PCCs i.e. 6687 compounds 
had same GI50 activity across all available NCI-60 cell lines, leading to standard-deviation 
to zero. So, we decided to consider only these compounds which have valid growth-
inhibitory information. The updated 2D-structure file (‚jan2010_2d.zip‛) was downloaded 
from the same DTP server mentioned earlier. It contains structures for 40,375 compounds 
out of 40,935 compounds in sdf format. The remaining 560 compounds were manually 
searched on the PubChem Substance database [185]. Out of 560 compounds, structures of 
only 220 compounds were retrieved as the rest of the compounds were representing 
proteins, extracts, glycosides, interleukins and polymers and therefore not considered in 
our study. These were added to earlier dataset containing 40,375 compounds. Thus, finally 
we have a dataset of 40,595 compounds with valid PCCs for all available 48 transporters.  
This dataset was used as a starting point for shape similarity measurements and QSAR 
analysis in the form of classification studies. In the next sections, we will discuss the 
utilization of NCI’s data mining approach in separation of substrates and non-substrates of 
ABCB1/ P-gp transporter using 3D-shape similarity approach and classification approach 
for handling imbalanced data. 
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3.2 Shape Similarity Approach  
Molecular similarity approaches are widely used in the computational drug development 
studies for various purposes such as virtual screening, chemical property and activity 
prediction, data mining and selection of potential hits. In these methods, the structural 
characteristics of the compounds under investigation are examined to measure 
similarity/dissimilarity among them [186]. Even with the pharmacophore modeling or 
quantitative structure–activity relationships (QSARs), similarity among the local 
determinants of activity such as stereochemistry, orientation and conformations of the 
compounds, bonding patterns, functional groups and related physicochemical properties is 
considered. According to the ‘Molecular similarity principle’, structurally similar 
compounds behave in the same manner having similar physicochemical as well as 
biological properties than dissimilar ones [187]. Thus, medicinal chemists tend to have 
measures for precise prediction of similarity or dissimilarity among the molecules to get 
better insight into the underlying SAR.  
Different methods are proposed to assess similarity, ranging from two- /three- 
dimensional, quantum chemical, molecular field approaches to supervised/unsupervised 
machine learning methods. The chemical compounds are represented quantitatively using 
topological, spatial, physicochemical, electronic, quantum chemical descriptors; molecular 
fingerprints and holograms as well as molecular shape analysis in terms of steric and 
electronic overlays [188]. Comparison of these numeric values (binary or nonbinary) and 
their patterns provide an important mean to evaluate structural similarity among the 
molecules. Similarity coefficients strongly influence the degree of similarity between these 
properties, thus exhibiting similarity among the compounds themselves. Several forms of 
these coefficients are proposed and categorized in three types such as association 
coefficients (for binary data), correlation coefficients (assess degree of correlation among 
numerical descriptors) and distance coefficients (measure degree of dissimilarity) [189, 
190]. 
Among all these coefficients, tanimoto coefficient based on binary fingerprints is widely 
used for determination of chemical similarity. It can be represented by following Tanimoto 
equation 
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Tanimoto coefficient = nAB / (nA + nB -nAB) 
Where nA and nB are the number of structural fragments/features in compound A and B 
respectively and nAB is the number of common features between them.  
Fingerprints are the set of commonly used fragment substructures. Presence or absence of 
structural fragments is expressed as 1s and 0s (bit string) representing a unique binary 
pattern for individual molecule. Collection of predefined structural features, such as 
MACCS keys are used to identify fragments contained in a molecule. Comparison of these 
topological identities proves to be an effective tool in screening large chemical libraries. 
Despite their fast and efficient processing, the 2D similarity methods incline towards 
searching compounds of resembling scaffolds to that of reference molecule. Thus, to 
identify structurally diverse compounds taking into account the stereochemical aspects 
and geometric constraints, 3D shape similarity techniques are extensively used now-a-
days. But the complexity in generation, selection and comparison of 3D representations of 
chemical compounds make such methods computationally expensive and time consuming. 
Grid computing and fast hardware/ networking resources prove to be an efficient way to 
increase the available computational power which has enabled to use fast 3D structural 
overlay programs, such as ROCS [191] for large database screening.  
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3.2.1 Identification of P-gp Substrates 
In this section, we present a distinct approach of identification and separation of P-gp 
substrates from non-substrates using three-dimensional shape similarity technique. Two 
NCI databases (containing 35,692 and 1,429 compounds respectively) with Pearson 
correlation coefficient (PCC) information were used. 3D shape similarity calculations were 
performed using the substrates from the small database to screen the large database. 
Results were analyzed using area under the ROC curve to understand whether this 
approach was able to identify P-gp substrates. 
Materials and Methods  
The database containing 3D-strucutres of 42,247 compounds (‚cans03sd.bin‛) which was 
ready to download from NCI’s DTP server was used in this study. From this database, 
35,692 compounds with available PCC values were extracted and used for further studies 
(‘NCI_big’ in short). The distribution of the PCC values in NCI_big is presented in figure 
3.2. A smaller NCI database (‘NCI_small’ in short) containing 1429 compounds with PCC 
information for 48 ABC transporters is available as supplementary information from 
Szakács et al.[179]. For the present study, we considered compounds with PCC values only 
related to P-gp. In both databases, compounds with PCC less than -0.30 were subsequently 
annotated as ‘substrates’ and rest of the compounds as ‘non-substrates’. This resulted in 
885 and 104 substrates for NCI_big and NCI_small respectively.  
ROCS 2.4.2 (Rapid Overlays of Chemical Structures) superposition program was chosen to 
determine similar compounds based on 3D configurations [153, 191]. It distinguishes 
compounds with similar 3D shape using atom-centered Gaussians as a measure to 
compute geometric overlap. Along with the shape based measure of molecular volume 
overlap (shapeTanimoto score), chemical complementarity of the functional groups (donor, 
acceptor, hydrophobe, cation, anion, and ring) is critical for biological activity and is 
considered using color force-field (color score). The combination of both these scores, so-
called as ‚combo score‛ provides an improved estimate of shape similarity. 3D shape 
similarity studies often require the reference/query compounds to search related similar 
compounds from large databases. Computation of conformational space based on the 
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molecular flexibility is also important for both such types of compounds and is taken into 
account using the OMEGA 2.3.2 program [192]. 
Conformer databases were created for both these data sets using OMEGA 2.3.2. For each of 
the 104 substrates from NCI_small, a single low-energy conformation was generated (by 
setting the parameter maxconfs = 1) which were then used as query molecules. Similarly, 
maximum 400 conformations were generated for the NCI_big database. Rest of the 
parameters was kept as defaults. ROCS 2.4.2 has a built-in ImplicitMillsDean color 
forcefield which includes pKa model based on pH=7 and is used in this work (with the –
chemff ImplicitMillsDean flag). All overlays were optimized to maximize color (chemical) 
overlap after the best shape overlay was located (using the -optchem flag). The hits were 
ranked on the basis of the sum of their shapeTanimoto and the normalized color score in 
this optimized overlay (using the -rankby combo flag). Also the combo cutoff was set to 0.3 
to cover the whole chemical space of NCI_big (using flag -cutoff = 0.3). 
 
Figure 3.2 Pearson correlation coefficients of the compounds present in NCI-big database 
 Several quantitative techniques such as calculation of enrichment factor or hit rate were 
proposed to assess the performance of a particular tool in virtual screening. These metrics 
solely depend on the ranking-based cutoffs at different intervals, thus minor changes in 
ranking lead to large variations in the final results. This sensitivity to the small changes in 
ranking can be avoided to a great extend by screening entire databases and measure the 
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performance using area under the receiver operator characteristic, or ROC [193]. The ROC 
curve is derived by plotting sensitivity (fraction of false positives) on the x-axis versus 1-
specificity (fraction of true positives) on the y-axis. It provides an accurate estimate of 
given tool’s performance by pruning the whole database, unlike enrichment factor or hit 
rate which examine just specified, initial points of the database. The value of area under a 
ROC curve is 1.0 (maximum) when virtual screening tool perform perfectly whereas value 
of 0.5 suggests random performance. In this study, we used all the 3 scores viz 
shapeTanimoto, color and combo.  Area under the ROC curve (AUROC) was calculated, 
compared, and the performance of virtual screening experiments was assessed. 
Results and Discussion 
104 substrates from NCI_small were used as queries for ‘shape and chemical similarity 
based screening’ of 35692 compounds from NCI_big using ROCS. Each query was 
processed against each compound from NCI_big database, thus giving ~40,00,000 different 
of scores. Combo score was used to sort results from highest to lowest. The numbers of 
unique hits were separated based on multiple thresholds which is the requirement for 
calculating area under the ROC curve (Table 3.1). Similar separation was performed using 
shapeTanimoto and color scores (Table 3.2 and 3.3).  If the hit is annotated as ‘substrate’ in 
NCI_big, it is considered as true positive. Similarly number of false negative, false positive 
and true negative compounds was determined. Subsequently, pairs of sensitivity and 1-
speficity derived for each of these thresholds were used to plot ROC curve (Figure 3.3). 
Finally, the AUC is manually calculated in Microsoft Excel using Trapezoidal rule which is 
the sum of the areas of the rectangles below the ROC curve [193]:  
      
                  
 
 
 
 
Where Se and Sp denote sensitivity and specificity respectively. 
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Table 3.1: Cumulative number of hits retrieved per threshold using combo score 
Threshold Hits 
NCI_big 
Substrates (TP) 
FN FP TN 
Sensitivity 
TP/(TP+FN) 
(1-Specificity) 
FP/(FP+TN) 
Combo = 2.0 111 90 795 21 34786 0.10 0.00 
Combo = 1.95 194 109 776 85 34722 0.12 0.00 
Combo = 1.9 302 127 758 175 34632 0.14 0.01 
Combo = 1.85 428 141 744 287 34520 0.16 0.01 
Combo = 1.8 570 152 733 418 34389 0.17 0.01 
Combo = 1.75 709 162 723 547 34260 0.18 0.02 
Combo = 1.7 940 173 712 767 34040 0.20 0.02 
Combo = 1.65 1401 179 706 1222 33585 0.20 0.04 
Combo = 1.6 2163 196 689 1967 32840 0.22 0.06 
Combo = 1.55 3107 214 671 2893 31914 0.24 0.08 
Combo = 1.5 4279 231 654 4048 30759 0.26 0.12 
Combo = 1.45 5682 250 635 5432 29375 0.28 0.16 
Combo = 1.4 7380 278 607 7102 27705 0.31 0.20 
Combo = 1.35 9456 308 577 9148 25659 0.35 0.26 
Combo = 1.3 12368 344 541 12024 22783 0.39 0.35 
Combo = 1.25 16021 392 493 15629 19178 0.44 0.45 
Combo = 1.2 19671 439 446 19232 15575 0.50 0.55 
Combo = 1.15 22799 494 391 22305 12502 0.56 0.64 
Combo = 1.1 25506 565 320 24941 9866 0.64 0.72 
Combo = 1.05 27749 639 246 27110 7697 0.72 0.78 
Combo = 1.0 29605 693 192 28912 5895 0.78 0.83 
Combo = 0.95 30955 734 151 30221 4586 0.83 0.87 
Combo = 0.9 31942 762 123 31180 3627 0.86 0.90 
Combo = 0.85 32663 785 100 31878 2929 0.89 0.92 
Combo= 0.8 33163 807 78 32356 2451 0.91 0.93 
Combo = 0.75 33521 818 67 32703 2104 0.92 0.94 
Combo = 0.7 33762 828 57 32934 1873 0.94 0.95 
Combo = 0.65 33893 838 47 33055 1752 0.95 0.95 
Combo = 0.6 33974 841 44 33133 1674 0.95 0.95 
Combo = 0.55 34019 842 43 33177 1630 0.95 0.95 
Combo = 0.5 34054 843 42 33211 1596 0.95 0.95 
Combo = 0.4 34090 845 40 33245 1562 0.95 0.96 
Combo = 0.3 34095 845 40 33250 1557 0.95 0.96 
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Table 3.2: Cumulative number of hits retrieved per threshold using color score 
Threshold Hits 
NCI_big 
Substrates (TP) 
FN FP TN 
Sensitivity 
TP/(TP+FN) 
(1-Specificity) 
FP/(FP+TN) 
Color = 1.0 250 126 759 124 34683 0.14 0.00 
Color = 0.95 764 152 733 612 34195 0.17 0.02 
Color = 0.9 1145 166 719 979 33828 0.19 0.03 
Color = 0.85 1595 178 707 1417 33390 0.20 0.04 
Color= 0.8 2324 206 679 2118 32689 0.23 0.06 
Color = 0.75 4212 259 626 3953 30854 0.29 0.11 
Color = 0.7 8523 345 540 8178 26629 0.39 0.23 
Color = 0.65 10623 391 494 10232 24575 0.44 0.29 
Color = 0.6 13212 447 438 12765 22042 0.51 0.37 
Color = 0.55 18846 572 313 18274 16533 0.65 0.53 
Color = 0.5 23959 665 220 23294 11513 0.75 0.67 
Color = 0.45 27817 732 153 27085 7722 0.83 0.78 
Color = 0.4 29752 766 119 28986 5821 0.87 0.83 
Color = 0.35 31313 801 84 30512 4295 0.91 0.88 
Color = 0.3 32255 819 66 31436 3371 0.93 0.90 
Color = 0.25 33393 836 49 32557 2250 0.94 0.94 
Color = 0.2 33722 840 45 32882 1925 0.95 0.94 
Color = 0.1 34025 845 40 33180 1627 0.95 0.95 
Color = 0.0 34095 845 40 33250 1557 0.95 0.96 
 
Table 3.3: Cumulative number of hits retrieved per threshold using shapeTanimoto score 
Threshold Hits 
NCI_big 
Substrates (TP) 
FN FP TN 
Sensitivity 
TP/(TP+FN) 
(1-Specificity) 
FP/(FP+TN) 
ST = 1.0 114 90 795 24 34783 0.10 0.00 
ST = 0.95 267 119 766 148 34659 0.13 0.00 
ST = 0.9 968 155 730 813 33994 0.18 0.02 
ST = 0.85 3093 198 687 2895 31912 0.22 0.08 
ST= 0.8 8401 269 616 8132 26675 0.30 0.23 
ST = 0.75 16569 370 515 16199 18608 0.42 0.47 
ST = 0.7 24117 453 432 23664 11143 0.51 0.68 
ST = 0.65 28713 574 311 28139 6668 0.65 0.81 
ST = 0.6 31358 663 222 30695 4112 0.75 0.88 
ST = 0.55 32713 733 152 31980 2827 0.83 0.92 
ST = 0.5 33322 780 105 32542 2265 0.88 0.93 
ST = 0.45 33746 823 62 32923 1884 0.93 0.95 
ST = 0.4 33977 839 46 33138 1669 0.95 0.95 
ST = 0.3 34095 845 40 33250 1557 0.95 0.96 
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Figure 3.3 Area under the ROC curves obtained using 3 different scores (combo score, color score 
and shapeTanimoto score) from the ROCS results of NCI_big database using substrates from 
NCI_small 
Various structure-based (e.g. docking) as well as ligand-based methods (e.g. shape-
similarity based) are extensively used in identification of hits from vast chemical space. 
Similarly, they have been proven efficient in distinguishing binders from non-binders, in 
our case substrates from non-substrates. Generally, most of these methods require the 
knowledge of bioactive conformation of reference compounds for superior performance. 
The ligand-oriented method used in this study, ROCS bypasses this prerequisite and uses 
similarity based on shape, pharmacophoric features and their combination to rank the 
compounds [194]. In our study, equal weight to the alignment of Gaussian volumes (shape 
similarity) and chemical complementarity (functional group similarity) in combo score 
failed to provide superior performance in virtual screening. Rather, the overlap of chemical 
groups performs better than rest of two similarity measures. 
Shape-similarity methods frequently endure a contradictory problem of false positives and 
false negatives. As both shape and functional group similarity of unknown compounds is 
considered and matched with that of the query molecules, there are higher chances of false 
positives. Similarly, compounds with different shape than query compounds could simply 
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escape the screening. In our case, 104 substrates from NCI_small which are used as queries 
and the compounds in NCI_big are diverse in nature. ROCS algorithm initially overlaps 
the centers of mass of query and database compounds and then their principal moments of 
inertia are aligned. Thus, when two diverse compounds having same functional groups are 
aligned based on moments of inertia, these functional groups are misaligned. This results 
in low combo score for the compounds. This might be the reason for low AUC values 
when shapeTanimoto and combo score are used for plotting ROC curves. 
Conclusions 
In conclusion, three different types of scores viz shapeTanimoto, color and combo, are used 
to assess the performance of the ROCS program in identifying compounds of interest, here 
P-gp substrates. Even though the scoring approach based on pharmacophoric features 
demonstrate superiority over the other two scores, the results could not be considered 
significant as the area under the ROC curve values are just around random. This suggests 
that the 3D shape similarity approach using ROCS is insufficient to identify and separate 
substrates from non-substrates. 
  
NCI-60 Data Mining and Grid Applications                    Chapter 3 
72 
 
3.2.2 Identification of SSRI-like compounds using shape similarity approach 
Some selective serotonin reuptake inhibitors (SSRIs) have been described to be responsible 
for programmed cell death in B-lymphoid originated malignant cells, i.e. cells extracted 
from Burkitt lymphoma [195]. Current cytotoxic treatment is very expensive to the people 
where this disease is endemic, i.e. sub-Saharan Africa, Papua New Guinea and 
northeastern Brazil [196]. Thus, SSRIs can prove as an alternative, less expensive modality 
for treating Burkitt lymphoma. However, low selectivity is a prime concern for SSRIs since 
at μM concentration range, they interact with other ubiquitously expressed targets 
inhibiting proliferation of and killing variety of mammalian cells [197]. In such 
concentrations, they also act as effective spermicides and can kill protozoa such as 
Trichomonas vaginalis [198]. These higher concentrations needed for exerting toxic action 
can also cause potentially severe serotonin syndrome.  On the other hand, our 
collaboration partners Freissmuth and co-workers ascertained the relation between affinity 
to the obvious SSRI target, serotonin transporter (SERT) and extent of apoptosis using 
[3H]thymidine incorporation assay. The acetylated versions of SSRIs (N-acetyl-fluvoxamine 
and N-acetyl-paroxetine) kill the experimental tumor cells in comparable concentrations as 
those of their original non-acetylated counterparts, demonstrating SERT is not necessary 
for cell killing [197]. This led us to devise all the virtual screening experiments in search of 
potent SSRI-like compounds exclusively using ligand-based virtual screening approaches.  
Initially, the in-house library of synthesized compounds and later the chemical library 
from Enamine Ltd. were used as the screening databases to identify novel chemotypes 
similar to SSRIs. The program ROCS v3.1.2 [191] was used to assess the similarity between 
the reference compounds (sertraline and paroxetine) and the compounds from the 
datasets. In the preliminary screening (round 1) of the in-house data, where top-ranked 
compounds were tested using [3H]thymidine incorporation assay for their ability to induce 
apoptosis in  HEK293 cells, we found a molecule (REM25, 8.81μM) which was more potent 
than the most active SSRIs. Subsequently, for screening of a large chemical library (round 
2), an unsupervised machine learning method, self organizing maps (SOM) [199] was used 
in order to narrow down the number of hits retrieved from ROCS screening. Out of 8 
commercial compounds selected and purchased for biological evaluation, 2 were 
confirmed as potential hits in vitro (25% hit rate). These hits possess chemical scaffolds 
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different from those of the reference compounds. The scaffold-based follow-up screening 
of the novel chemotypes yielded several additional hits in micromolar range, out of which  
one  compound  will be chosen as lead compound for preliminary structure-activity 
relationship studies.  Still there is much room for improvement in the compound potency 
by modifying the flexible backbone and substituted phenyl moiety. The results 
demonstrate the effectiveness of in silico techniques such as shape similarity approach and 
unsupervised machine learning methods in identification of new chemotypes. 
Materials and Methods 
Datasets 
The in-house database contained 412 unique compounds either synthesized in our lab or 
provided by collaboration partners. The other chemical library containing 1,286,460 
compounds was obtained from Enamine (Enamine Ltd., version Aug-2009, Kiev, Ukraine, 
http://www.enamine.net). Counterions, salts and metal containing fragments were 
removed in MOE v2009.10 [200] before generating the conformations in OMEGA v2.4.6 
[192]. 3394 compounds were excluded further during the processing since OMEGA does 
not consider compounds with unparameterized atoms like Se, Pt, Mn, As, etc. as well as 
compounds with inappropriate geometry. 1,283,066 compounds in 365,836,769 
conformations were finally scored by ROCS. After the preliminary screening, thirteen 
compounds (REM14 [201], REM25 [201], GE68 [202], REC2219 [203], GPV0389 [204], 
GPV0385 [205], GPV0865 [206], GPV0189 [203], GPV0186 [203], GPV0825 [207], GPV0896 
[207], GPV0442 [208], and GPV0512 [209]) were selected for pharmacological experiments.  
In the second round of screening, 18 permanently charged compounds were removed out 
of 400 ROCS hits (200 each for sertraline and paroxetine). Additionally, a small subset of 
five known actives (SSRIs such as paroxetine, fluoxetine and hits retrieved from in-house 
database screening: REM25, REM14 and GPV896) was used for the self-organizing maps 
based screening. Thus, for the dataset of 387 compounds, the lowest energy conformer of 
each molecule was retrieved from OMEGA and the energy minimized in MOE using 
MMFFx94 forcefield.  
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Shape-based similarity screening 
OMEGA v2.4.6 was used to generate the 10 conformers of the reference compounds 
(sertraline and paroxetine) and upto 400 conformers of each compound from the in-house 
as well as enamine databases. Rest of the parameters was kept default. The three-
dimensional shape-based similarity screening was performed with the program ROCS 
v3.1.2. The ComboScore, the sum of ShapeTanimoto score and ScaledColor score, was 
employed to rank the database compounds. The cutoff value of ComboScore was set to the 
value 1.  
HN
Cl
Cl
H
N
F
O
O
O
Sertraline Paroxetine  
Structures of the chemical compounds used as reference in ROCS screening round 1. 
Self-Organizing Map (SOM)  
Self-organizing maps (or Kohonen neural networks) [199], a specialized type of artificial 
neural network, implemented in SONNIA v4.20 software package [210] was used in this 
study. In this method, higher dimensional objects are visualized into a space of lower 
dimensionality such as two-dimensional arrangement in a plane. The class labels are not 
considered while training the maps and thus the self-organizing maps are called as an 
unsupervised learning method. To begin with the training process, the weights are 
randomly assigned to each neuron and the number of weights corresponds to the 
dimensions of the structural representations, i.e. number of descriptors. During training 
molecules are arbitrarily presented to the network several times. For each molecule, the 
most similar neuron, so called winning neuron is identified based on the lowest Euclidean 
distance between its structural descriptors and the neuron weights. The response of the 
neural network is further improved by adjusting the weights of winning neuron 
accordingly to the training data. As the training progresses, the degree of weight 
adjustment and the number of neighborhood neurons is decreased. When the training is 
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finished, overall network response is computed and the molecules are projected from high 
dimensional space into 2D plane. This leads to map similar compounds in adjacent or even 
in the same neurons. It depends on mainly the size of the network, the heterogeneity in the 
data set and the number of compounds.  
Seven types of descriptors, two network topologies (rectangular and toroidal) and 3 
different network sizes (15x15, 19x12 and 20x20) were used to train the models of SOMs 
and later utilized for identifying co-localization of the Enamine compounds with known 
actives. Descriptors (Topological (2D), VSA, VSURF, MACCS, Physicochemical properties, 
Topological (2D) autocorrelation and Spatial (3D) autocorrelation vectors [211]) were 
calculated using the software packages such as MOE v2009.10 and ADRIANA.code v2.0 
[210]. For using in SONNIA, the descriptors were first autoscaled (mean centered and 
scaled to unit variance) to yield the final set.  
Hit selection was performed as outlined in the Results and Discussion section. The sizes of 
the maps were chosen in a way to prevent over-crowding of the neurons with high number 
of co-localizations. Table 3.4 gives the number of Enamine compounds co-localizing with 5 
actives obtained with the seven models and three different network sizes.  
Table 3.4: SOM Models and number of co-localizations 
SOM Model 
Type of 
Descriptors 
No. of 
Descriptors 
Dimension Topology 
No. co-
localizations 
model 1a MOE 2D 146 15 x 15 Rectangular 0 
model 1b MOE 2D 146 19 x 12 Rectangular 0 
model 1c MOE 2D 146 20 x 20 Rectangular 0 
model 1d MOE 2D 146 15 x 15 Toroidal 5 
model 1e MOE 2D 146 19 x 12 Toroidal 0 
model 1f MOE 2D 146 20 x 20 Toroidal 0 
model 2a 2D-autocorrelation 88 15 x 15 Rectangular 7 
model 2b 2D-autocorrelation 88 19 x 12 Rectangular 4 
model 2c 2D-autocorrelation 88 20 x 20 Rectangular 9 
model 2d 2D-autocorrelation 88 15 x 15 Toroidal 14 
model 2e 2D-autocorrelation 88 19 x 12 Toroidal 7 
model 2f 2D-autocorrelation 88 20 x 20 Toroidal 2 
model 3a 3D-autocorrelation 96 15 x 15 Rectangular 1 
model 3b 3D-autocorrelation 96 19 x 12 Rectangular 3 
model 3c 3D-autocorrelation 96 20 x 20 Rectangular 5 
model 3d 3D-autocorrelation 96 15 x 15 Toroidal 0 
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model 3e 3D-autocorrelation 96 19 x 12 Toroidal 7 
model 3f 3D-autocorrelation 96 20 x 20 Toroidal 6 
model 4a VSURF 75 15 x 15 Rectangular 4 
model 4b VSURF 75 19 x 12 Rectangular 6 
model 4c VSURF 75 20 x 20 Rectangular 17 
model 4d VSURF 75 15 x 15 Toroidal 3 
model 4e VSURF 75 19 x 12 Toroidal 12 
model 4f VSURF 75 20 x 20 Toroidal 10 
model 5a VSA 32 15 x 15 Rectangular 10 
model 5b VSA 32 19 x 12 Rectangular 12 
model 5c VSA 32 20 x 20 Rectangular 5 
model 5d VSA 32 15 x 15 Toroidal 4 
model 5e VSA 32 19 x 12 Toroidal 6 
model 5f VSA 32 20 x 20 Toroidal 10 
model 6a MACCS 166 15 x 15 Rectangular 13 
model 6b MACCS 166 19 x 12 Rectangular 19 
model 6c MACCS 166 20 x 20 Rectangular 10 
model 6d MACCS 166 15 x 15 Toroidal 1 
model 6e MACCS 166 19 x 12 Toroidal 8 
model 6f MACCS 166 20 x 20 Toroidal 9 
model 7a Physicochemical 11 15 x 15 Rectangular 14 
model 7b Physicochemical 11 19 x 12 Rectangular 3 
model 7c Physicochemical 11 20 x 20 Rectangular 4 
model 7d Physicochemical 11 15 x 15 Toroidal 2 
model 7e Physicochemical 11 19 x 12 Toroidal 10 
model 7f Physicochemical 11 20 x 20 Toroidal 1 
 
Results and Discussion 
Ligand-based virtual screening was performed in two cycles based on the ‚similarity 
principle‛ and unsupervised machine learning methodology. The most active SSRIs from 
the earlier apoptosis experiments, sertraline and paroxetine were used as the starting point 
for both the screenings. The whole screening process is illustrated in Figure 3.4. 
1. In a first cycle of virtual screening, the database of in-house compounds was virtually 
screened by the ROCS v3.1.2 program, a fast 3D shape comparison program using 
sertraline and paroxetine as reference compounds. The ComboScore, sum of 
ShapeTanimoto score and ScaledColor score representing shape and chemical feature 
overlay respectively, was employed to rank the database compounds. The top 10 database 
compounds with high ComboScore were selected for each reference compounds. Four hits 
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from each of the hit-list of reference compounds (compound 1-4 for sertraline and 
compound 5-8 for paroxetine, Table 3.5) were selected. These retrieved 8 compounds were 
tested using 3H-Thymidine incorporation assay for HEK293 cells killing (apoptosis) and 
EC50 values were determined. All the compounds exhibit the phenomenon of programmed 
cell death at various concentrations. The best hits (REM25 and REM14) have different 
scaffold architecture than their corresponding reference compound, sertraline indicating 
successful scaffold-hops using ROCS. REM25 found to be more potent (EC50= 8.81μM) than 
the reference compounds (Sertraline EC50 = 9μM and paroxetine EC50 = 11μM). Furthermore, 
qualitative structure-activity relationship was performed to assess importance of sulfur, 
hydroxyl, propyl substituents and size of the linkage within the same series. Additional 5 
compounds (9-13, Table 3.5) were selected and screened using 3H-Thymidine 
incorporation assay.  
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Figure 3.4: Overall workflow of the screening process
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Table 3.5: Compounds used in screening round 1 
R1
O
O
R2
X OH
R3
R1
R5
R4
R3
 
Compound 
Scaffol
d 
Position R1 R4 R5 
R2 =Scaffold A 
X = Scaffold B 
R3 
EC50 
(μM) 
1 (REM25) A - Me - - S NH(i-Pr) 8.81 
2 (REM14) A - H - - S NH(i-Pr) 15.23 
3 (REC2219) B ortho CH2CH2Ph H H H NH(CH3) 129.5 
4 (GPV0442) B meta Ph H -CH3 -OH NH(n-Pr) 120.4 
5 (GPV0865) B para Et H H -OH N
 
260.3 
6 (GPV0512) B meta R1-R4 = -CH2-CH2 H -OH N
 
281.5 
7(GPV0389) B meta Me H H -OH N
 
306.8 
8 (GPV0385) B para Me H H -OH N
 
335.2 
9 (GE68) A - H - - O NH(n-Pr) 25.18 
10 (GPV0896) B meta Ph H H -OH 
N N
 
36.31 
11 (GPV0825) B meta Ph H H -OH 
N N
S
HN
 
55.07 
12 (GPV0189) B meta CH2CH2Ph H H H N
 
65.47 
A B 
 80 
 
13 (GPV0186) B meta CH2CH2Ph H H H N
 
70.54 
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2. In the second cycle, the same two reference compounds (sertraline and paroxetine) were 
used in ROCS to screen Enamine database. The same virtual screening approach as 
implemented in step 1 was used except that the top ranked 200 compounds were selected 
from each query. 18 hits out of 400 hits contained permanent charges and were thus 
removed from further studies. For identification of new lead compounds, 382 hits were 
merged with a small subset of actives (SSRIs such as paroxetine, fluoxetine and hits 
retrieved from in-house database screening: REM25, REM14 and GPV896) and subjected to 
the processing with self-organizing maps (SOM). The idea behind this approach was to 
analyze the hits co-localizing with active compounds leading to identification of highly 
active hits [212]. The characteristic phenomenon demonstrated by SOM is its ability to 
depict a multidimensional space into 2D form by agglomerating compounds with similar 
properties. Hits from the 42 models were collected and those with co-localization 
frequency ≥ 3 were retrieved giving rise to a set of 26 compounds (Table 3.6). Finally, eight 
of out of 26 compounds were cherry-picked based on the frequency of co-localization, 
corresponding actives, types of descriptors and scaffold resemblance (figure 3.5). When 
pharmacologically tested, two out of these eight compounds, T5771924 (EC50=49μM) and 
T5572953 (EC50=132μM) were shown to be active in [3H]thymidine incorporation assay 
(Figure 3.6a and Figure 3.6b). 
Table 3.6:  Hits found at least 3 times in all 42 SOMs  
Compound Corresponding co-localized 
actives 
Descriptor 
types 
Frequency 
T5771924_S Flu(8) m, 11 8 
T5380000_S Flu(5), Par(1) vu, v, m, 11 6 
T5984498_S Flu(5) 2a,3a,m 5 
T6451571_P Par(5) vu, v, m 5 
T5259781_P GPV(3), Rem14-25 2a, 2m, v, 11 5 
T5379981_S Flu(5) m, 11 5 
T5380001_S Flu(5) m, 11 5 
T5380002_S Flu(5) m, 11 5 
T5532533_P Par(4), Rem14 2a, v 4 
T5546523_P GPV(4) 3a 4 
T5833735_P Par(4) 2a, m 4 
T6412799_S Flu(4) vu, m 4 
T0502-1769_P Par(3), GPV v, m, 11 4 
T6386646_P Par(2), Rem14-25 2a, v 4 
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T0502-1034_P Par(2), GPV v, m, 11 3 
T0502-1719_P Flu, Par, GPV vu, v, m 3 
T0502-1749_P Par(2), GPV v, m 3 
T0511-5763_P GPV(3) vu 3 
T5247275_P Flu, GPV, Rem25 2a, v, 11 3 
T5438183_P Par(2), Flu 2a, 3a, m 3 
T5548387_P Par, GPV, Rem14-25 3a, vu, m 3 
T5572953_S Flu, Rem14-25 m 3 
T5822995_S Flu(3) vu 3 
T5984503_S Flu(3) 2a, m 3 
T6174731_S Flu(3) m 3 
T6486556_P Par, GPV, Rem25 2a, 2m, m 3 
Note: _S, _P: in Compound column represent the corresponding reference compound (sertraline or 
paroxetine) from which this hit was identified. Corresponding co-localized actives: Flu- fluoxetine, 
Par- paroxetine, GPV – GPV896, Rem14-25 – both Rem14 and Rem25. Descriptor types: m- 
MACCS fingerprints, 11 – 11 Physicochemical properties, vu- VSURF descriptors, v- VSA 
descriptors, 2m- 2DMOE descriptors, 2a- 2D autocorrelation descriptors, 3a- 3D autocorrelation 
descriptors. The compounds highlighted with grey color were ordered from Enamine Ltd. for 
pharmacological screening. 
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Figure 3.5: Structures of the 8 compounds ordered and pharmacologically tested using 
[3H]thymidine incorporation assay 
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Figure 3.6a: Population of live HEK293 cells analyzed by flow cytometry after treatment with 8 
compounds ordered from Enamine Ltd. Paroxetine was used as standard compound. Compounds, 
T5771924 and T5572953 show good activity  
 
Figure 3.6b: Effect of paroxetine and two hits from Enamine on viability of HEK293 cells 24 h after 
exposure to drug. 
As a follow-up study, small subsets of structural analogs for the two hits T5771924 
(compounds 1-6 in Table 3.7) and T5572953 (compounds 7-10 in Table 3.7) were selected 
from the Enamine database and biologically tested (Figure 3.7). In the case of the quite 
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active T5771924, two out of six compounds tested showed pharmacological activity below 
100μM (Table 3.7). In case of the weak active T5572953, none of the four compounds tested 
showed significant pharmacological activity. These results confirmed that indeed new 
scaffolds can be identified by this approach  
H
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Figure 3.7: 10 compounds (follow-up) ordered and tested using [3H]thymidine incorporation assay 
Table 3.7: Compounds ordered in follow-up study  
# Compound EC50 (μM) 
1. T5793031  19 
2. T5806609  64 
3. T5774460  106 
4. T5792972  161 
5. T5409985  215 
6. T5785540  289 
7. T7132649  109 
8. T5574208  170 
9. T5386402  253 
10. T7117489  267 
A multi-step ligand-based virtual screening approach was implemented to discover seven 
and three novel hits (EC50 ≤ 100μM) both from our in-house chemical library and from the 
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Enamine database, respectively. The preliminary Enamine database screening yielded two 
hits (T5771924 and T5572953) from a total of eight tested compounds, implying a hit rate of 
25%. Both these hits were imparting vacuole formation in the cells revealing their role in 
apoptosis. Subsequent hit follow-up process considered the structural analogues of both 
hits and six and four compounds respectively (Figure 3.7) were ordered and 
pharmacologically tested. This study provided very potent hit (T5793031) which will be 
used for further lead optimization studies.  
Conclusions 
A virtual screening protocol for identification of novel SSRI like compounds has been 
presented. The two-step strategy consisting of shape and pharmacophore based similarity 
screening followed by self-organizing maps was employed. By utilizing this methodology, 
several active compounds were identified which represented novel scaffolds than SSRIs. 
The discovery of REM25 and REM14 is a proof-of-concept for the directed inclusion of 
benzothiophene scaffolds to mimic programmed cell death activity in the search of 
potential candidates. 
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3.3 Imbalanced Data Classification Problem 
Now-a-days, tremendous amount of data regarding the effect of small molecules on the 
biological systems is becoming available via public archives such as PubChem, ChEMBL, 
DrugBank, NCI, etc. General drawbacks with such pharmaceutical, biological and medical 
data are small number of observations/data points, incomplete and missing data, or most 
importantly, unbalanced class distribution [213]. A small example is provided in Table 3.8 
where the imbalanced ratio of actives and inactives for several important targets from 
PubChem is presented. Also in our case, the data set used is extremely imbalanced with 
e.g. 776 substrates of P-gp and 36,064 non-substrates. The highly skewed class distribution 
usually creates difficulties in the binary data analysis where the data with non-desired 
property (majority class or negatives samples) always exceed the data with desired 
property (minority class or positive samples) by a significant amount. Most of the machine 
learning methods and standard classifiers do not take this data distribution into 
consideration and focus either on minimizing global quantities such as error rate or 
increasing accuracy, thus maximizing overall performance of the resulting models [214]. In 
other words, they are inclined towards the majority class and thus usually showing 
substandard performance on the minority class (lack of generality). If we consider a simple 
example where the majority class contains 99% of the data and the remaining 1% belongs 
to the minority class, any conventional classifier predicting all entities as belonging to the 
majority class still gives 99% accuracy, thus producing quite misleading results. 
A number of solutions have been proposed to deal with the class-imbalance problems, 
mainly comprising sampling and cost-sensitive learning approaches [215, 216]. The 
sampling techniques handle only the training data related issues whereas cost-sensitive 
methods look up into the algorithms and their modifications to tackle the imbalance. 
Random oversampling and undersampling are the non-heuristic methods that aim to 
balance class distribution so as to equalize the composition of the dataset without any 
specified rules. Random removal of majority class examples during undersampling lead to 
loss of valuable information from the data whereas replicating the minority class data 
randomly in oversampling might lead to overfitting as multiple instances of certain 
examples become tied to each other [215].  
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Table 3.8: Class imbalance of actives and inactives for some important targets in PubChem 
# 
PubChem
AID 
  Target 
Number of Compounds 
Active             Inactive 
Active : Inactive  
(Imbalance Ratio) 
% Actives in  
whole dataset 
1 602 ABCB1 35 85,167 1 : 2433.34 0.04 
2 1326 ABCB1 130 193,674 1 : 1489.80 0.07 
3 1325 ABCG2 200 194,393 1 : 971.97 0.10 
4 807 ABCC1 10 9522 1 : 952.20 0.10 
5 601 ABCB1 12 9977 1 : 831.42 0.12 
6 2676 RXFP1 1084 357,384 1 : 329.69 0.30 
7 2648 hERG 1083 304,532 1 : 281.19 0.35 
8 2247 TRPC4 1189 302,815 1 : 254.68 0.39 
9 1511 hERG 1552 304,061 1 : 195.92 0.51 
10 567 5HT1a 366 64,541 1 : 176.34 0.56 
11 799 ABCC1 843 137,879 1 : 163.56 0.61 
12 612 5HT1a 416 61,189 1 : 147.09 0.68 
13 1024 CYP2C9 1368 95,860 1 : 70.07 1.41 
14 844 ABCC1 42 761 1 : 18.12 5.23 
15 1451 ABCB1 18 255 1 : 14.17 6.59 
16 741 ABCB1 29 267 1 : 9.21 9.80 
17 397743 hERG 15 113 1 : 7.53 11.72 
18 778 CYP2C19 20295 95,899 1 : 4.73 17.47 
19 434978 TRPC4 541 1726 1 : 3.19 23.86 
20 1835 hERG 749 1656 1 : 2.21 31.14 
 
In case of directed/informed sampling, no new examples are created but the choice of 
samples to be replaced or eliminated is informed rather than random. It also includes 
synthetic sampling with data generation, sampling with data cleaning, editing or 
clustering techniques, and combinations of the above techniques [217].  
Synthetic minority oversampling technique (SMOTE) is a very effective method for 
handling imbalanced data in various applications [218]. The SMOTE algorithm creates new 
artificial instances rather than merely replicating the existing ones of the minority class (as 
in random oversampling). For each positive instance, its nearest positive neighbors were 
identified based on Euclidean distance and new positive instances were created and placed 
randomly in between the instance and its neighbors.  
Cost sensitive learning methods [219] consider the misclassification costs and target the 
imbalanced learning problem by using different cost matrices describing costs of 
misclassifying particular data examples. A strong connection between cost sensitive 
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learning and imbalanced data has been shown [220] and also proved its superiority over 
sampling methods in some specific imbalanced learning application domains [221, 222]. 
Thus, cost-sensitive techniques are seen as an important alternative to sampling methods 
for imbalanced learning domains.  
Kernel-based learning is centered on the theories of statistical learning and Vapnik-
Chervonekis dimensions [223]. Support Vector Machines (SVMs) are representative of it 
and give good classification results with imbalanced data [224] when combined with 
general sampling and ensemble techniques [225, 226]. It has been used for 
chemoinformatics data mining problem, suggesting that the assay data should be carefully 
selected from PubChem to avoid problems when using imbalanced data [227]. SVM also 
has been combined with maximum entropy methods for cost sensitive classification of 
highly imbalanced CYP450 data of drugs [228].  
Although there are a lot of efforts focused on two-class imbalanced problems, multiclass 
imbalanced learning problems also exist and are of equal importance. Several approaches 
based on cost-sensitive boosting algorithm [229], min-max modular network to decompose 
multiclass imbalanced problem into series of small two-class subproblems [230], the 
ensemble knowledge for imbalance sample sets (eKISS) method [231] are some of the few 
to tackle the multiclass imbalanced learning problems. 
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3.3.1 Prediction of P-Glycoprotein Substrates and Non-Substrates from Highly 
Imbalanced Dataset using Cost-Sensitive Machine Learning Methods  
Introduction 
P-glycoprotein (P-gp/ABCB1) is encoded by the highly conserved multidrug resistant 
(MDR) type 1 genes [232, 233]. It plays an important physiological role in the protection of 
cells and tissues from harmful xenobiotics (including drugs and chemicals) by extruding 
them out of cells. However, in the context of the cancer cells, this protective mechanism 
becomes destructive, leading to the expulsion of a wide variety of structurally and 
functionally diverse cytotoxic drugs from tumor cells and this phenomenon called as 
‚Multi Drug Resistance‛ (MDR), which is one of the major reason for failure of 
chemotherapy to the cancer treatment [234]. Several strategies including development of P-
gp inhibitors have emerged initially to tackle the problem of MDR in the cancer treatment 
[235]. However, because of the regulatory role of ABCB1 transporters in pharmacokinetics, 
toxicity and drug-drug interactions, it is more advised to identify and characterize the 
substrates in early phase of drug discovery and development process [236-240].  
For this reason, various in vivo and in vitro screening assays have been developed to 
classify P-glycoprotein substrates [241]. However, these assay procedures are expensive, 
laborious and time consuming, which results in use of smaller datasets by them. This leads 
to the need of in silico methods, which can handle large amount of data and provide rapid 
and efficient screening for P-gp substrates and inhibitors [242]. For this purposes, several 
QSARs [243, 244], rule-based models [245] and pharmacophore models [203, 246, 247] have 
developed. Very recently various machine learning methods have also been successfully 
applied for early prediction of ADMET properties in particular prediction of P-gp 
substrates and inhibitors [248-250]. 
 
 
 
* - This section should be seen as a manuscript to be submitted in ‘Journal of Chemical Information 
and Modeling’. 
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In the present study, we have used about 7000 compounds to build models for P-gp 
substrates and non-substrates using various machine learning methods such as support 
vector machine, random forest, kappa nearest neighbor, decision tree and naïve bayes for a 
test set containing about 29500 compounds. Predictive classification models were 
developed from highly imbalanced dataset (2% of substrates and 98% of non-substrates) 
which often gives poor or biased results when conventional machine learning methods 
were used. Several feature selection techniques were implemented and analyzed. In order 
to further validate our models, all the developed models were applied to an additional 
external dataset of 322 drug compounds. In addition, an applicability domain experiment 
was performed using a descriptor range approach. All these rigorous and time-consuming 
calculations were performed on our grid-platform. This is to our knowledge the first time 
that the information from such a highly imbalanced dataset is used to generate and 
validate in silico models to predict P-gp substrates and non-substrates. 
Computational Methods  
Dataset Preprocess and Curation  
As shown in the Figure 3.8, a set of 47622 compounds was retrieved from the NCI’s DTP 
tumor cell line data [251]. We found that 6687 compounds have same GI50 values across 
available NCI-60 cell lines, which leads to standard-deviation zero, thus giving invalid 
PCC. Chemical structures were searched for the remaining 40935 compounds in drug 
information system of DTP, which resulted in retrieval of a set of 40375 compounds and 
the remaining 560 compounds were manually searched in PubChem [185]. Out of 560 
compounds, only 220 compounds structure were obtained as the remaining 340 
compounds could not been represented by structural features, i.e. they were proteins, 
polymers, extracts or interleukins. From the 40595 remaining compounds, the counter ions, 
salts, mixtures and racemates were removed by using MOE software (Molecular Operating 
Environment) [200]. Filter program [252] from Openeye software Inc. was then used to 
remove compounds having other than H, C, N, O, F, P, S, Cl, Br, I elements. Subsequently, 
structures were preprocessed in Standardizer module from ChemAxon Ltd. [253] to have 
uniform representations. In this step, stereochemistry was cleared alongwith neutralizing 
and mesomerizing the structures leading to final dataset of 36840 compounds.  
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Since P-gp extrudes the molecules from the cell, it has been shown [179, 181, 182] that the 
compounds showing negative correlation between transporter expression and their 
activity/cytotoxicity across the 60 tumor cell lines are expected to be transported by the 
transporter. Compounds with PCC less than -0.3 (≤ -0.3) were assigned as substrates 
whereas compounds with >-0.3 were assigned as non-substrates. From the dataset of 36840 
compounds, 776 compounds were assigned as substrates and the remaining 36064 
compounds as non-substrates. In addition to this, other activity thresholds were also 
explored. 
 
Figure 3.8: Flowchart of Dataset Preprocess 
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Molecular Descriptors  
In this study, three different classes of molecular descriptors were computed from the 2D 
structures of the compounds in MOE software [200]. A set of 152 2-dimensional (‘2DMOE’, 
in short) descriptors was calculated. These numerical molecular features were derived 
from the connection table representing a molecule which includes the physical properties, 
atom and bond counts, adjacency and distance matrix descriptors containing BCUT and 
GCUT descriptors, Kier & Hall connectivity, kappa shape indices, subdivided surface 
areas, partial charges and pharmacophoric features. In addition, a set of 32 VSA (Van der 
Waals Surface Area) descriptors was calculated. VSA descriptors focus on incremental 
surface area for logP, molar refractivity and partial charge properties. A set of 166 MACCS 
structural keys [254] was computed from MOE. Each "key" represents a small substructure 
consisting of about one to ten non-hydrogen atoms and enumerates very simple features, 
but when used in combination can prove to be very specific and useful in distinguishing 
the characteristics among the small molecules. 
Selection of Training and Test set  
All the computed descriptors and fingerprints were merged with binary biological activity 
(1 for substrates, 0 for non-substrates) of 36840 compounds. As mentioned in the previous 
section, final dataset has an imbalance ratio of 1/45 (substrate/non-substrate) i.e. 2 % 
substrates and 98% of non-substrates. To avoid the overfitting and to improve 
generalization of the models, the dataset was divided into a training (n=7368; 155 
substrates and 7213 non-substrates) and a test set (n=29472; 621 substrates and 28851 non-
substrates) using MOE’s diverse subset selection approach. This process starts with 
selection of reference compound and then the compounds most structurally different from 
each other are identified using generally MACCS/Tanimoto similarity till the desired 
number of diverse compounds is chosen. 
Machine Learning Methods and Feature Selection  
Various commonly used machine-learning methods such as support vector machine 
(SVM), decision tree (DT), kappa nearest neighbor (kNN), random forest (RF) and Naïve 
bayes (NB) were applied. A detailed account of the theory behind these methods can be 
found elsewhere [156, 255]. These methods are based on the different concept and 
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representative of most of classification methods. All the classification models were 
constructed using Weka data mining software [256], which provides a set of classification 
and regression methods, variable selection methods. For the high-dimensional imbalanced 
datasets, it is very important to select features, which distinguish between the two classes 
and can capture the high skewness in the class distribution. In the present study, various 
automatic feature selection procedures were applied such as CfsSubsetEval (correlation-
based feature subset selection evaluator) with BestFirst search method and feature ranking 
methods viz Chisquared, InfoGain, ReliefF and GainRatio methods with Ranker search 
method. All feature selection was performed in Weka data mining software [256]. 
Cost-Sensitive Bagging Approach (CSB)  
Most classifiers assume that the active and inactive compounds are evenly distributed in 
the dataset with equal misclassification costs. They are designed with the goal to maximize 
the accuracy (or to minimize the error rate). This in turn led to classification of all instances 
as negative (Minority class or positive class predicted as negative class) in a highly 
imbalanced dataset. In order to solve this imbalanced problem, many approaches have 
been proposed [215], which includes sampling techniques and cost-sensitive learning 
approaches (CS). Cost-sensitive learning considers misclassification error and assigns high 
cost to the misclassification of the minority class. It has recently being used in machine 
learning classification problem, where the class distributions in the dataset are highly 
imbalanced [228].  
 CS learning was first introduced by Elkan [219] and Zadrozny [257] and later it was 
simplified by Ling et al [258]. In brief, CS demonstrates the importance of misclassification 
cost in the different cost-sensitive algorithms. For example, a simple binary cost matrix can 
be represented as shown in Table 3.9. Misclassification of actual positive instance into 
negative instance is much more expensive than an actual negative instance classified into 
positive instance, i.e. value of C (0,1) or FN > value of C(1,0) or FP. For example, from the 
pharmaceutical point of view, P-gp substrate is the positive class (minority) and non-
substrate is the negative (majority) class. Failing to correctly predict substrates is a more 
serious problem than predicting non-substrates as substrates (FP). P-gp substrates being 
predicted as non-substrates would cause serious problem later in the drug development 
process.  
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Table 3.9: Cost matrix for two-class classification 
 
Actual Positive Actual Negative 
Predicted Positive C (1,1) or TP C (1,0) or FP 
Predicted Negative C (0,1) or FN C (0,0) or TN 
Note: C (i, j) represents the cost of incorrectly labeling an instance from its actual class j into a 
predicted class I. Here 1 and 0 denote Positive and negative classes respectively. 
Assume that x is the compound under investigation and this compound is classified either 
as active or inactive by probability. In the cost matrix, this compound is classified to a class 
having low expected cost and this can be expressed as follows 
                           (Eqn. 1) 
 
where R(i|x) is the expected cost of compound x classified into class i (predicted), P(j|x) is 
the probability of compound x to be classified into class j (actual). Compound x is classified 
as active by classifier, if expected cost of compound x classified into active is smaller than 
expected cost of compound x into inactive class. i.e. P(0|x)C(1,0)+P(1|x)C(0,0) ≤ 
P(0|x)C(0,0) +P(1|x)C(0,1).  
Probability of compound x classified as inactive can be written as P(0|x)=1-P(1|x). 
Compound x is classified as active by the classifier, if P(1|x) is equal or greater than the 
threshold p*. Threshold p*can be calculated from the misclassification of active (FN) and 
inactive (FP) as shown in Eqn. 3.  
   
      
              
  
  
     
     (Eqn. 2) 
In addition to the cost-sensitive learning method, we used the bagging algorithm as an 
ensemble classifier [259, 260], as it is implemented in the Weka data mining tool [256]. 
Bagging (bootstrap aggregating) [260] creates an ensemble of classifiers where the same 
size of new training sets are created (called as ‚bags‛) by sampling with replacement from 
the original training data either by deletion or by replication of compounds. This sampling 
procedure is repeated several times and bagging chooses those prediction class where the 
majority of classifiers having most votes.  
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Model Evaluation and Performance Measurement  
All the constructed models were evaluated in terms of predictability of test set and n-fold 
cross validation, for clarity only 5-fold cross validation and test set predictions are 
provided. Most often model performance is measured using overall accuracy and error 
rate of the model, however, these measurement perform poorly when learning from 
imbalanced datasets. In order to overcome this problem, we used performance measures 
which effectively address the imbalanced learning problems, such as sensitivity (true 
positive rate), specificity (true negative rate), G-mean, precision,  recall, accuracy and 
Matthews correlation coefficient (MCC).  
Sensitivity (TPR) or Recall = 
  
     
                  (Eqn. 3) 
Specificity (TNR) = 
  
     
                   (Eqn. 4) 
Geometric-mean (G-mean) =                                        (Eqn. 5) 
Precision =  
  
     
                    (Eqn. 6) 
Accuracy = 
     
            
                   (Eqn. 7) 
Matthews correlation coefficient = 
           –          
                                
              (Eqn. 8) 
 Considering a basic two-class problem, all these parameters are calculated from true 
positive (TP), true negative (TN), false positive (FP) and false negative (FN). The geometric 
mean (G-mean) evaluates the degree of inductive bias in terms of a ratio of positive 
accuracy and negative accuracy. Precision can be seen as a measure of exactness or fidelity 
(i.e. correctly labeled positive examples among all positives) whereas recall (sensitivity) is a 
measure of completeness (i.e. correctly labeled positive examples among all positive class). 
Matthews’s correlation coefficient (MCC) indicates the degree of the correlation between 
the actual and predicted classes. It ranges from -1 to +1 and is generally regarded as a good 
measure of the quality of the binary classification. In the machine learning classification 
study, MCC values above 0.4 are considered to be predictive [261]. 
NCI-60 Data Mining and P-gp Substrate Prediction                   Chapter 3 
96 
 
In this study, we explored several feature selection approaches considering different base 
classifiers in combination with wide range of costs for cost-sensitive experiments. As our 
dataset is quite large and classification with weka requires much more time, large 
computational power was needed to tackle this situation. This led us to implement weka 
within our distributed computing grid environment, UVieCo [262].  
Results and Discussion  
Dataset Characterization and Physicochemical Properties of P-gp Substrates  
The drug-likeness of a dataset compounds was accessed by calculating the Lipinski’s 
‚Rule-of-Five‛ descriptors. The result shows that 69% compounds in the dataset did not 
violate any of the four rules. Approximately 27.4% of the compounds in the dataset violate 
one or two rules and 120 compounds violate all four rules. Inspecting of these compounds 
revealed that there was no structural similarity among them which indicates that p-
glycoprotein substrates are structurally diverse as mentioned in the introduction.  
The dataset was divided into training and test set according to diverse subset selection 
method. This resulted in a training set of 7368 compounds and a test of 29472 compounds. 
A principal component analysis (PCA) was performed to check possible presence of 
clusters, outliers, similarities or dissimilarities. First two principal components explain 79% 
of variance in the data set. The score plot from PCA shows (Figure 3.9) that the diversity of 
the dataset is satisfactorily reflected in the training set and there are no distinct clusters in 
the dataset.  
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Figure 3.9: Score plot from principal component analysis of NCI dataset (first two principal 
components are shown). Compounds are colored as follows, Blue dot: Training active, Red dot: Test 
active; Black circle: Test inactive and yellow dot: Training inactive. 
It was observed from the loading plot that most of the substrates are highly influenced by 
the topological polar surface area, molecular weight, hydrophobic parameters such as 
LogP(o/w), number of aromatic atoms and number of rings. This reveals that non-
substrates generally seem less hydrophobic than substrates. This is also in good agreement 
with the general idea of P-glycoprotein substrates, which first penetrate into the 
hydrophobic membrane and then bind to P-gp. In addition to PCA, we analyzed the 
chemical space of substrates and non-substrates from a set of 36840 compounds using 
simple molecular properties such as molecular bulkiness (molecular weight, molar 
refractivity, number of rings, number of rotatable bonds and van der Waals volume), 
hydrogen bonding ability (total number of nitrogen and oxygen atoms), polarity 
(topological polar surface area) and hydrophobicity (logP(o/w)). It was observed that most 
of the chemical properties have relative impact in discriminating substrates from non-
substrates (Figure 3.10). For instance, majority of the substrates have large TPSA, molecular 
weight, more hydrogen bonds and high molecular reflectivity.  
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Figure 3.10: Properties distribution of P-gp substrates and non-substrates. 
Construction of Classification Models by Machine Learning Methods  
Various machine learning classification models for P-gp substrates and non-substrates 
were developed using 9 set of descriptors to check which combination of descriptors might 
lead to a good classification model. The model’s performance was compared in terms of 
various statistical parameters of 5-fold cross-validation runs and a test set (Table 3.10), (for 
clarity only Matthew’s correlation coefficient (MCC), geometric-mean and overall accuracy 
are given). In general, all 9 set of descriptors perform well except ReliefF descriptors. The 
overall accuracy for the test set ranges from 55-73%. Notably, the quality of the models was 
good when using all 350 descriptors and 152 2D-MOE descriptors compared to other set of 
descriptors. From the feature selection methods, Chisquared method performs better than 
other methods and provides comparable statistics to initial 2 descriptor sets. These three 
models have reasonably high sensitivity (75-88 %) and specificity (60-69%) and these 
models have the ability to correctly predict both substrates and non-substrates, which is 
reflected in MCC (0.44-0.50) and G-Mean (72-73).  
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Table 3.10: Comparison of model performance using various feature selection methods 
Descriptors  
5-fold CV Test Set 
N MCC Accuracy G-Mean MCC Accuracy G-Mean 
ALL 350 0.34 0.67 0.67 0.50 0.74 0.73 
2D-MOE 152 0.32 0.66 0.66 0.49 0.74 0.73 
MACCS 166 0.06 0.53 0.53 0.29 0.62 0.55 
VSA 32 0.31 0.66 0.66 0.41 0.70 0.70 
CfsSubsetEval 12 0.28 0.64 0.64 0.43 0.71 0.70 
Chisquared 12 0.31 0.66 0.66 0.44 0.72 0.72 
GainRatio 12 0.31 0.65 0.65 0.42 0.71 0.71 
Infogain 12 0.27 0.63 0.63 0.41 0.70 0.69 
ReliefF 12 0.08 0.54 0.54 0.11 0.55 0.55 
Note: N: Total number of descriptors used for model building; 5-fold CV: Five-fold cross validation; 
MCC: Matthew’s correlation coefficient. 
Although models developed using all 350 descriptors and 152 2D-MOE descriptors 
perform better than other models, the number of descriptors used in Chisquared models 
were several folds less than these two giving almost similar predictions. Therefore we 
considered 13 Chisquared descriptors as starting point for our classification model 
building and model optimization. List of 12 Chisquared descriptors is given in Table 3.11. 
These mainly constitute the simple descriptors such as count of hydrophobic atoms, carbon 
atoms, and heavy atoms. Similarly, the bond information between heavy atoms is also 
considered important in this study. Number of hydrogen donating atoms and relative 
positive partial charges along with descriptors representing van der Waals surface areas 
based on octanol/water distribution coefficient, partial charge and hydrophobic atoms 
show significant contribution. The importance of these properties towards P-gp specificity 
has been reported in previous observations [263, 264].  
 
 
 
 
NCI-60 Data Mining and P-gp Substrate Prediction                   Chapter 3 
100 
 
Table 3.11: List of 12 Chisquared descriptors used in present classification analysis 
Chisquared Des. Definition 
a_heavy Number of heavy atoms 
a_hyd Number of hydrophobic atoms 
a_nC Number of carbon atoms 
b_heavy Number of bonds between heavy atoms. 
Kier1 First kappa shape index 
lip_don The number of OH and NH atoms 
PEOE_RPC+ 
Relative positive partial charge: the largest positive partial charge divided by the 
sum of the positive partial charges (PEOE partial charges) 
VAdjEq 
Vertex adjacency information (equality): -(1-f)log2(1-f) - f log2f (where f = (n2-
m)/n2, n is the number of heavy atoms and m is the number of heavy-heavy 
bonds) 
VAdjMa Vertex adjacency information (magnitude): 1 + log2 m   
vsa_hyd Approximation to the sum of VDW surface areas of hydrophobic atoms (Å2) 
PEOE_VSA-1 
Sum of  van der Waals surface area where partial charge is in the range [-0.10,-
0.05) 
SlogP_VSA0 
Sum of  van der Waals surface area such that the contribution to logP(o/w) is <= -
0.40 
Chisquared descriptors were used for machine learning classification using support vector 
machine (SVM), kappa nearest neighbor (kNN), naïve bayes (NB), random forest (RF) and 
decision tree (DT).  
Table 3.12: Classification models for P-gp substrates and non-substrates using machine 
learning methods 
Method 
Prediction (%) 
Sensitivity Specificity 
G-
mean 
Precision MCC Accuracy 
TP FP TN FN 
RFa 1 0 100 99 0.01 1.00 0.11 0.95 0.07 0.51 
DTa 0 0 100 100 0.00 1.00 0.00 0.00 -0.02 0.50 
NBa 26 8 92 74 0.26 0.92 0.49 0.75 0.23 0.59 
kNNa 6 2 98 94 0.06 0.98 0.25 0.74 0.10 0.52 
SVMa 0 0 100 100 0.00 1.00 0.00 - - 0.50 
RFb 0 0 100 100 0.00 1.00 0.00 0.00 -0.01 0.50 
DTb 0 0 100 100 0.00 1.00 0.00 - - 0.50 
NBb 51 29 71 49 0.51 0.71 0.60 0.64 0.22 0.61 
kNNb 8 2 98 92 0.08 0.98 0.28 0.80 0.14 0.53 
SVMb 0 0 100 100 0.00 1.00 0.00 - - 0.50 
Note: a) 5-fold cross validation prediction, b) Test set prediction, RF: Random forest, DT: Decision tree, NB: 
Naïve bayes, kNN: kappa nearest neighbor, SVM: Support vector machine, TP: True positive, TN: True 
negative, FP: False positive, FN: False negative, MCC: Matthews correlation coefficient. 
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Overall the quality of the models was poor, overall accuracy and MCC were below 65% 
and 0.25 (Table 3.12) respectively. However, correct prediction of non-substrates was quite 
high (specificity is >90%), which might be due to the fact that the dataset exhibits a high 
number of non-substrates, which dominate the classification model to a great extent. Here, 
the classifiers assume that the substrates and the non-substrates are distributed equally in 
the dataset, which leads to high substrate (minor class) misclassification rate and low non-
substrate (major class) misclassification rate. All classification models poorly predicted the 
substrates in the test set, with an overall prediction of the best model (NB) of 61% and a 
sensitivity of 51%. This imbalanced prediction is also reflected with the poor value of G-
mean (60%) and MCC (<0.40). All these observations argue us to develop cost-sensitive 
machine learning models, which consider misclassification error. 
Cost-Sensitive Bagging Models  
Cost-sensitive bagging (CSB) based machine learning classification methods were 
investigated. Costs (weights) for each method were optimized and selected a best 
classification model based on the MCC, G-Mean and overall accuracy. Overall, the 
different methods provide models of similar quality. From the 29472 compounds in the test 
set, 18034 to 21306 (64–74%) are correctly predicted in which 394 to 505 (63-81%) substrates 
and 17539 to 20832 (61-72%) non-substrates were predicted correctly. More importantly, 
sensitivity and specificity are 61-81% and MCC is >0.4 (Table 3.13). Support vector 
machine, random forest and naïve bayes methods give best models while other methods 
show reasonable performance. These methods significantly perform well in classifying 
substrates, 76%, 81% and 75% respectively. However, for non-substrates, SVM model 
achieves better prediction (72%) compared to other classifiers. Overall, RF and SVM 
correctly predict more than 72% of the test set and their performance is also reflected in 
high G-Mean (0.72-0.74), precision (0.71-0.73) and MCC (0.44-0.49). Five-fold cross-
validation of the training set shows slightly less prediction compared to test set prediction. 
Here, NB and RF models perform significantly higher. The sensitivity (63-72%) and 
specificity (63-68%) are well in balance with overall accuracy is >65%.  
 
 
NCI-60 Data Mining and P-gp Substrate Prediction                   Chapter 3 
102 
 
Table 3.13: Cost-sensitive bagging-machine learning classification models  
Method Cost 
Prediction (%) Sensiti-
vity 
Specifi- 
city 
G-
mean 
Precision MCC Accuracy 
TP FP TN FN 
RFa 110 63 32 68 37 0.63 0.68 0.66 0.66 0.31 0.66 
DTa 75 56 26 74 44 0.56 0.74 0.64 0.68 0.30 0.65 
NBa 1000 72 37 63 28 0.72 0.63 0.67 0.66 0.35 0.67 
kNNa 110 54 35 65 46 0.54 0.65 0.59 0.61 0.19 0.60 
SVMa 48 52 24 76 48 0.52 0.76 0.63 0.68 0.29 0.64 
RFb 110 75 31 69 25 0.75 0.69 0.72 0.71 0.44 0.72 
DTb 75 70 33 67 30 0.70 0.67 0.68 0.68 0.37 0.68 
NBb 1000 81 44 68 19 0.81 0.61 0. 70 0.67 0.43 0.71 
kNNb 110 63 40 72 37 0.63 0.64 0.64 0.64 0.28 0.64 
SVMb 48 76 31 81 24 0.76 0.72 0.74 0.73 0.49 0.74 
The models for the test set were also compared using area under the receiver operating 
characteristic curve (ROC). As seen from Figure 3.11, SVM, RF and NB have highest 
enrichment values around 0.80.  
 
Figure 3.11: Area under the Receiver Operating Characteristic Curve (AUC) for test set  
Furthermore, cost sensitive bagging models (CSB) were compared with non-cost-sensitive 
bagging models (Figure 3.12) and performance is evaluated in terms of G-Mean, MCC and 
overall accuracy. It is noted that cost-sensitive bagging models performs significantly 
higher than non-CSB model. Therefore, it can be suggested that cost-sensitive machine 
learning methods are suitable for highly imbalanced large dataset. 
AUC 
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Figure 3.12: Comparison of cost-sensitive bagging (CSB) models with non-CSB model 
Construction of Classification Models from Different Activity Thresholds  
As mentioned in the method section, the classification was performed based on the PCC 
value, which correlates transporter mRNA expression and compound activity or 
cytotoxicity across the 60 cancer cell lines. The problem was to set the right PCC for 
substrates and non-substrates. According to Szakács et al. we assigned compounds with 
PCC ≤ -0.3 as substrates (negative correlation) and compounds with PCC >-0.3 were 
classified as non-substrates. An additional experiment was performed using different 
activity thresholds to check how the model changes. In order to do this, the whole data set 
was used for classification and 5- and 10- fold cross validations were performed. In total, 
six models were developed using CSB-RF (Results of three-activity thresholds of 5-fold and 
10-fold cross validation are provided in Table 3.14). As seen from the table 3.14, predictions 
significantly improve when tightening the activity threshold for substrates i.e. from -0.25 to 
-0.40. Substrate prediction is substantially improved at threshold -0.40 (Model-3). 
Sensitivity and specificity are equally good (85%), which is also reflected in high MCC 
(0.70).  
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Table 3.14: Comparison of Random forest models (n-fold cross validation) with different 
activity threshold for P-gp substrates and non-substrates  
Models  
Prediction (%) Sensiti-
vity 
Specifi
city 
G-mean 
Precis
ion 
MCC Accuracy 
Cost TP FN TN FP 
Model-1a) 62 72 27 73 28 0.72 0.73 0.73 0.45 0.73 0.73 
Model-2a) 140 78 23 77 22 0.78 0.77 0.77 0.54 0.77 0.77 
Model-3a) 580 83 19 81 17 0.83 0.81 0.82 0.64 0.82 0.82 
Model-1b) 62 72 72 28 72 28 0.72 0.72 0.72 0.44 0.72 
Model-2b) 140 78 76 24 76 24 0.76 0.76 0.76 0.53 0.76 
Model-3b) 580 86 82 19 81 18 0.82 0.81 0.81 0.63 0.81 
Note: Model 1a) & 1b) 10-fold and 5-fold cross validation with threshold ≤-0.25 (Substrate)/ >-0.25 (Non-
substrate), Model 2a) & 2b) 10-fold and 5-fold cross validation with threshold ≤-0.30 (Substrate)/ >-0.30 
(Non-substrate), Model 3a) & 3b) 10-fold cross validation with threshold ≤-0.40 (Substrate)/ >-0.40 
(Nonsubstrate). TP: True positive, TN: True negative, FP: False positive, FN: False negative, BCR: Balanced 
classification rate, MCC: Matthews correlation coefficient 
Applicability Domain Investigation  
Applicability domain (AD) analysis has emerged as a hot-topic in recent ligand-based 
modeling such as quantitative structure activity/property relationships (QSARs/QSPRs), 
machine learning classification studies [265, 266]. AD is primarily used to check whether a 
given compound can be reliably predicted or not based on the chemical space of training 
set and this provides a first structural alert. Many theories have been proposed and each 
has their own pros and cons [265]. One of the well-known AD approach is 
‚physicochemical descriptor ranges‛ which is estimated from the descriptors range of 
training compounds (preferably, descriptors from final model). These ranges will be used 
for applicability checking of the test set. In the present study, AD was estimated using 
Ambit Discovery v0.04 software [267]. Ambit Discovery preprocesses the given dataset by 
principal component analysis in order to eliminate co-linearities among the descriptors. 
Subsequently, AD is estimated based on a physicochemical descriptor range approach. The 
applicability domain for the test set is provided in Figure 3.13. As can be seen, the majority 
of the test set compounds (99.65%) are within the chemical space of the training set 
compounds and only a small fraction were out of domain (0.35%).  
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Figure 3.13: Applicability domain analysis of true and false predictions from SVM model for test set 
using 12 Chisquared descriptors 
Analyzing these compounds, 5/474 true substrates (TP) and 98/8019 false substrates (FP) 
were out of the chemical space and only 0.11% of true non-substrates (32/20882) were out 
of the domain. To extent this experiment, we analyzed a set of 1252 FDA approved drugs 
from DrugBank and to check whether our CSB models can reliably predict also drug 
compounds. Surprisingly, more than 98% (1229/1252) of the drugs are within the chemical 
space of our training set. This investigation suggests that our classification model could be 
applicable to very diverse compounds. 
Comparison with Available Models  
It is not appropriate to directly compare our models with previously reported models, 
which have been developed with different datasets (size of training and test set) and assay 
protocol. All the developed models were compared with previously reported P-gp 
substrate and non-substrate classification models [243, 248, 268-271], which have overall 
accuracies of 63-90% and correctly predict substrate (sensitivity 53-96%) and non-substrate 
(specificity 67-89%) (Figure 3.14).  
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Figure 3.14: Comparison of our CSB models with previously published models for P-gp substrate-
nonsubstrate classification (Upper row represents the number of compounds used in the test set) 
Our models were trained using a highly imbalanced dataset with about 7000 compounds 
in training test and about 29000 compounds in test set. We achieved best models with 
support vector machine (overall accuracy is 74%, sensitivity: 76%, specificity: 72%) and 
random forest (overall accuracy is 72%, sensitivity: 75%, specificity: 69%) using only 12 2D 
descriptors from MOE using Chisquared feature selection method. Compared to previous 
models, our models correctly predict about 74% of the test set, which is slightly lower than 
the reported values. However, it can be emphasized that our dataset is two hundred times 
larger than previously reported datasets (n=25-120).  
During the preparation of this manuscript, a similar study has been published by Wang et 
al. [272] where they developed support vector machine models for P-gp substrates and 
non-substrate using a set of 332 compounds, which include drugs. Wang et al. showed that 
a support vector machine correctly classify 96% of substrates and 73% of non-substrates, 
with an overall accuracy of 88% in the test set using 23 ADRIANA-Code and MOE 
descriptors. In order to validate our classification models further, we used datasets from 
Wang et al. as additional external validation datasets. Before investigation, applicability 
domain for these compounds was checked with our training set, which revealed only 4 
compounds being out of our training set chemical space. Furthermore, we found 3 
duplicate entries in Wang et al. dataset and were skipped from our studies. Validation was 
performed in two scenarios: a whole dataset (n=325) was used as external test set in 
scenario 1 and only test compounds (n=119) were used for validation in scenario 2. CSB 
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classification models were developed using Chisquared descriptors and the result is 
provided in Table 3.6. In general, majority of the models perform good and the overall 
accuracy is 63-68%. In scenario 1, random forest (RF) and support vector machine (SVM) 
performs significantly better than other classifiers, both methods correctly predict >70% of 
substrates. Naïve bayes is good for predicting substrates (93%) but poorly predicts non-
substrates (39%), thus low overall predictive ability (G-mean 57% and accuracy 62%). 
Random forest moderately predicts the non-substrates (63%). Overall RF performs 
significantly better than other methods, which is also reflected in G-mean (0.68) and MCC 
(0.36). In the second scenario, we used Wang et al.’s test set as a validation set. Similar 
quality of models was obtained as scenario 1 and again RF and SVM perform better than 
other classifiers with good MCC values (>30). Both show balanced classification 
predictions for substrates (70-78 %) and non-substrate (53-67%). Similar to Zhi Wang et al. 
SVM model, our SVM model also performs significantly better for substrate prediction 
(78%) but it predicts only 53% of non-substrates correctly (overall accuracy  66%). The 
moderate prediction of our best models (CSB-RF and CSB-SVM) to model from Wang et al. 
dataset might be due to the fact that the annotation of substrates/non substrates is based on 
different experimental procedures.  
Table 3.6: External dataset prediction of P-gp substrates and non-substrates 
Methods Cost 
Prediction (%) Sensiti 
vity 
Specifi 
city 
G-
mean 
Precision MCC Accuracy 
TP FP TN FN 
RFa) 110 73 37 63 27 0.73 0.63 0.68 0.66 0.36 0.68 
DT a) 75 76 51 49 24 0.76 0.49 0.61 0.60 0.26 0.62 
NB a) 1000 93 69 31 7 0.93 0.31 0.54 0.57 0.30 0.62 
kNN a) 110 66 53 47 34 0.66 0.47 0.56 0.55 0.13 0.56 
SVM a) 48 83 52 48 17 0.83 0.48 0.63 0.61 0.32 0.65 
RF b) 110 70 33 67 30 0.70 0.67 0.68 0.68 0.37 0.68 
DT b) 75 74 49 51 26 0.74 0.51 0.62 0.60 0.26 0.63 
NB b) 1000 88 62 38 12 0.88 0.38 0.58 0.59 0.30 0.63 
kNN b) 110 68 40 60 32 0.68 0.60 0.64 0.63 0.28 0.64 
SVM b) 48 78 47 53 22 0.78 0.53 0.65 0.63 0.33 0.66 
SVM c) - 
 
- - - 0.96 0.73 - - 0.73 0.88 
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3.4.4 Conclusions  
In the present study, we reported the application of machine learning methods to predict 
P-gp substrate and non-substrates from highly imbalanced dataset consisting of 36840 
compounds. Models obtained from CSB-Random forest and support vector machine 
perform significantly better than the other CSB-classifiers. CSB models show better 
performance when compared to models obtained from conventional machine learning 
classifiers. The CSB-SVM model correctly predicts 74% of the overall compounds in test 
set. Most importantly, a balanced prediction model was obtained, which is able to correctly 
predict 76% of P-gp substrates and 72% of non-substrates. In addition to this, the 
classification models were further validated with a set of 325 drug compounds. An 
additional applicability domain experiment was performed and reveals that our model not 
only predicts NCI compounds, but it can also be applied to drug-like molecules. Models 
developed in this study are relatively simple and precise enough to be applicable for 
virtual screening of large chemical libraries for early identification of compounds, which 
are being transported by P-glycoprotein. An early identification of P-gp substrates can be 
potentially useful to remove compounds of poor ADMET properties. 
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APPENDICES 
 
Appendix 1 (UVieCo Administration) 
 
In this section, the main administration tasks of central manager goedel.ani.univie.ac.at for 
the UVieCo pool are such as user management, starting and stopping the various 
applications, and activating the firewall rules. 
1. Directory Structure 
All the necessary files are located under the directory /usr/local/unigrid which is owned by 
the user gridadmin. There are several subdirectories: 
bin contains various scripts for starting and stopping the various needed server 
applications 
condor contains the Condor application in its version 7.0.1 
keys the RSA keys necessary for accessing the VPN are generated and stored in this 
directory 
logs contains the generated logfiles 
openvpn contains OpenVPN version 2.0.9 built from source 
pkg_factory contains all the necessary files and scripts needed for creating client packages 
(including user-specific RSA keys) on-the-fly 
postgresql contains PostgreSQL version 7.4 built from source 
tomcat6 contains Apache Tomcat version 6.0 built from source 
2. User Management 
User data is stored in the PostgreSQL database running on goedel. The database may be 
modified by logging into goedel as user gridadmin, starting the command line client, and 
issueing SQL statements directly. The command line client for the PostgreSQL DBMS is 
called psql and its usage is shown in the following lines: 
gridadmin@goedel:~> psql -U gridadmin mydb 
Password: 
Welcome to psql 7.4.19, the PostgreSQL interactive terminal. 
Type: \copyright for distribution terms 
\h for help with SQL commands 
\? for help on internal slash commands 
\g or terminate with semicolon to execute query 
\q to quit 
mydb=> select * from users; 
user_name | user_pass | role_name | submit_privilege | department | 
----------------+---------------+---------------+------------------------+-----------------+- 
Yogesh       | *** | member | t | Pharma | yogesh.aher 
PhI_seminar  | *** | member | f | Pharma  | yogesh.aher 
test   | *** | member | f | TEST  | test 
Gerald  | *** | member | t | RLCTA | gerald.stam 
(4 rows) 
Techincal implementation of UVieCo was performed by Gerald Stampfel, Deptt. of Computer 
Sciences. 
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As can be seen in the listing above, the PostgreSQL database is called mydb. See the SQL 
documentation1 for details on the available commands. 
A more user-friendly way, however, is to use a graphical client. The procedures 
throughout this document are explained for the Windows client pgAdmin2 which is freely 
available. Other clients, although, should work very similar. 
As PostgreSQL is (for security reasons) configured to only accept connections stemming 
from the local host, it is not possible to connect to the DB without taking additional 
measures. Therefore, a SSH tunnel is (easily) set up using the Windows SSH client Putty3  
(see Figure A1.1). TCP port 5432 is the one used by PostgreSQL. 
After setting up the tunnel, the database can be access using the address localhost:5432 in 
pgAdmin (see Figure 2). 
 
 
 
 
Figure A1.1: SSH tunnel using Putty    Figure A1.2: pgAdmin setup 
 
 
 
 
 
1 http://www.postgresql.org/docs/7.4/interactive/sql.html 
2 http://www.pgadmin.org 
3 http://www.chiark.greenend.org.uk/ sgtatham/putty/download.html 
 
The important table for user management in the database is ‚Users‛ table (figure A1.3). 
The details of this table are as follows: 
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3.1 Create  
 
In order to create a new user, a new row has to be created for the user table. This is simply 
done by filling the last line in the ‚Edit Data‛ dialog (see Figure A1.4). In the table, values 
for the following columns have to be specified: 
OID: left empty, PostgreSQL internal data 
User_name: name of the user (as he will be displayed on the status web site) 
User pass: clear-text password 
Role_name: always has to be ‚member‛, this is for the basic authentication in Tomcat 
which checks every access to restricted web sites against this table  
Submit privilege: is the user allowed to submit jobs to the condor pool?  
Department: university department the user is part of 
Email: e-mail address 
 
Note: Changing a user's name will also lock this user out of the VPN. OpenVPN checks the 
keys presented by the user against this database and if the supplied user name does not 
exist, access is denied. Therefore, changing the name requires the user to fetch new keys. 
Also note that changing submit_privilege for a specific user also requires this user to fetch 
new keys. 
 
3.2 Delete 
Deleting a user is as simple as deleting the corresponding row in the ‚EditData" dialog (see 
Figure 4). 
 
    
 
     Figure A1.3: Users Table     Figure A1.4: Edit Data 
 
4 Server Daemon Control 
The machine goedel acts (in the context of UVieCo) as a Condor central manager, VPN 
gateway, database server, web server, and firewall is constantly running the following 
applications: Condor, OpenVPN, PostgreSQL, and Apache Tomcat. 
The applications have to be stopped in the right order: Tomcat and Condor first, then 
OpenVPN, and PostgreSQL last. Consequently, this order has to be reversed when starting 
the applications. 
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For controlling the applications, one has to login as gridadmin and use the start/stop 
scripts located in /usr/local/unigrid/bin: startTC.sh, stopTC-.sh for Tomcat; startCONDOR.sh, 
stopCONDOR.sh for Condor; startPSQL.sh, stopPSQL.sh for PostgreSQL; startOVPN.sh, 
stopOVPN.sh for OpenVPN. startTC.sh and stopTC.sh ask for the root password, this is 
necessary for Tomcat to be able to bind to TCP port 443. Once started, Tomcat drops the 
root privileges and proceeds as user gridadmin. 
 
5 Firewall 
A bash script called fwProtect.sh which sets up the necessary iptables rules is located in 
/usr/local/unigrid/bin. This script identifies three types of pool participants: the central 
manager, submit machines (in the 10.8.1.0/24 subnet), and execute-only machines 
(10.8.0.0/24 subnet). The iptables rules basically enable communication between the central 
manager and the other two parties. Furthermore, all submit machines are able to ping each 
other and the execute machines, but execute machines are disallowed to ‚see‛ each other in 
the VPN. 
All the denied packets are recorded in /var/log/firewall. 
All allowed communication paths (except for ICMP naturally) are restricted regarding 
their source and destination ports. 
 
6 Crontab 
 
The crontab of user gridadmin should look like this: 
gridadmin@goedel:~> crontab -l 
* * * * * /usr/local/unigrid/bin/update_status_db.sh 
&> /dev/null 
0 4 * * * 
/usr/local/unigrid/pkg_factory/deletePkgTempDir.sh &> /dev/null 
 
update_status db.sh pastes the output of condor status into the PostgreSQL database. These 
lines are then parsed by the JSP pages and displayed accordingly. 
deletePkgTempDir.sh deletes the client packages which were prepared for downloading in 
/usr/local/unigrid/tomcat6/webapps/unigrid/download/tmp.*. As soon as a user logs on to the 
web interface's download site, his personal keys are packaged together with the UVieCo 
client scripts. These package file are useless once a user has downloaded them, therefore, 
this cron task deletes these temporary directories. 
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Appendix 2 (UVieCo Implementation) 
 
This section describes the software setup of the central manager and the client machines. The 
detailed configuration of the applications Condor, OpenVPN, Apache Tomcat, and 
PostgreSQL are explained. Additionally, the bash scripts on the client and server side are 
shortly described. 
 
A2.1. Central Manager 
Before going into the details of configuration, a few more words on the VPN and 
authentication follow: For a machine to participate in the VPN, authentication has to be 
conducted. This is done via public/private key pairs. Consequently, a client machine has to 
show the OpenVPN server that it holds a valid keypair before being allowed access to the 
VPN. Moreover, this client-specific key pair has to be somehow brought to the client in a 
secure fashion. 
 
The approach chosen here is to create and store the RSA keys on a password-protected SSL 
web server (Figure A2.1). This method is sufficiently secure and user-friendly.  
 
 
 
Figure A2.1: Successful connect sequence for UVieCo. 
As can be seen in Figure A2.1, the client also receives a ‚local config‛. This refers to a small 
file which specifies additional Condor configuration rules specific for that user. 
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A2.1.1 Directory Structure 
All the necessary files are located under the directory /usr/local/unigrid which is owned by 
the user gridadmin. There are several subdirectories: 
bin : Contains various scripts for starting and stopping the server applications 
condor: Contains the Condor application in its version 7.0.1 
keys: The RSA keys necessary for accessing the VPN are generated and stored in this 
directory 
logs: Contains the generated log files 
openvpn: Contains OpenVPN 
pkg_factory: Contains all the necessary files and scripts needed for creating the client 
packages (including user-specific RSA keys) on-the-fly 
postgresql: Contains PostgreSQL version 7.4 
tomcat6: Contains Apache Tomcat version 6.0 
 
A2.1.2 OpenVPN 
We are using OpenVPN version 2.0.9 which was built from source. 
# openvpn --help 
OpenVPN 2.0.9 x86_64-suse-linux [SSL] [LZO] [EPOLL] 
built on Apr 20 2008 
(more) 
 
A2.1.2.1 Setup 
For the setup of the PKI infrastructure as described in the OpenVPN documentation 
(http://openvpn.net/howto.html#pki), OpenSSL had to be installed: 
# openssl version 
OpenSSL 0.9.8a 11 Oct 2005 
 
OpenSSL was obtained as a binary. Following the OpenVPN documentation (‚Generate 
the master Certificate Authority (CA) certificate & key‛), a certification authority was set 
up: 
. ./vars 
./clean-all 
./build-ca 
./build-dh 
When asked various questions by the build-ca script, the following data was provided:  
C=AT, ST=Vienna, L=Vienna, O=University of Vienna, 
CN=Unigrid-CA/emailAddress=gerald.stampfel@gmail.com 
After this, a key pair and a certificate for the server were created: 
./build-key-server server 
When asked various questions by the build-key-server script, the following data was 
provided: 
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C=AT, ST=Vienna, O=University of Vienna, 
CN=Unigrid OpenVPN Server/emailAddress=gerald.stampfel@gmail.com 
All the generated keys, certificates, and the vars were placed in /unigrid/keys. 
Next, the OpenVPN configuration file and its most important statements are described: 
File name : server.conf 
Location : /usr/local/unigrid/openvpn/etc 
Used by : OpenVPN 
Contents : 
cd /usr/local/unigrid 
daemon 
server 10.8.0.0 255.255.255.0 
port 1194 
proto udp 
dev tun 
ca keys/ca.crt 
cert keys/server.crt 
key keys/server.key 
dh keys/dh1024.pem 
ifconfig-pool-persist openvpn/logs/ipp.txt 
route 10.8.1.0 255.255.255.0 
push "route 10.8.1.0 255.255.255.0" 
client-to-client 
duplicate-cn 
keepalive 10 100 
comp-lzo 
user stampfel 
group nogroup 
verb 3 
status openvpn/logs/openvpn-status.log 
persist-key 
persist-tun 
log openvpn/logs/openvpn.log 
client-connect bin/ovpn_clientconnect.sh 
client-disconnect bin/ovpn_clientdisconnect.sh 
The cd directive tells OpenVPN its working directory, which is the location of the unigrid 
directory in this case. The server directive defines that IPs of the 10.8.0.0/24 subnet should 
be leased to connected clients. ca, cert, key, dh point to the OpenSSL keys, certificates and 
other files we generated and placed under unigrid/keys. The route and push route commands 
are needed for telling the clients that also the subnet 10.8.1.0/24 (used by privileged clients) 
is accessible through the VPN tunnel and has to be entered in their routing tables.  
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In order to allow each client connected to the VPN to communicate with each other client, 
the directive client-to-client has to be stated. Client-to-client communication although is 
very restricted by our firewall rules, see Section A2.8. duplicate-cn allows two clients to 
connect with the same key. keepalive 10 100 tells the client to ping each server every 10 
seconds and to disconnect those not responding after 100 seconds. OpenVPN has to be 
started as root because some operations such as changes to the routing table or networking 
interface configuration need these privileges. After initialization, although, the OpenVPN 
process changes its user ID to the one passed by user. After each connect or disconnect of a 
client, the scripts bin/ovpn_clientconnect.sh and bin/ovpn_clientdisconnect.sh are called by 
OpenVPN. These are further described in the next section. 
The OpenVPN server is started using sudo openvpn unigrid/openvpn/etc/server.conf. The 
command sudo has to be used in order to start OpenVPN with root-privileges which is 
necessary for various network configurations. 
A2.1.2.1 Scripts 
build-key A modified version of the build-key script supplied with OpenVPN is used to 
generate the RSA keys non-interactively: 
Script name : build-key 
Location : /usr/local/unigrid/keys 
Description : Generate RSA keys for OpenVPN 
Workflow : Generate and sign RSA keys using OpenSSL → Fetch Condor local 
config from PostgreSQL → Pack everything into .zip 
Used by : Apache Tomcat 
 
ovpn_clientconnect.sh The script ovpn_clientconnect.sh is responsible for deciding if a 
connecting user is someone with submit privileges and should therefore receive a 
10.8.1.0/24 IP or an execute-only user in the normal IP subnet of 10.8.0.0/24. 
Script name : ovpn-clientconnect.sh 
Location : /usr/local/unigrid/bin 
Description : Authentication of VPN clients and insert of client data into 
database 
Workflow : Query DB if supplied username does exist → Query DB if 
connecting user has submit privileges → Tell OpenVPN to assign 
an IP based on the outcome of the previous query → Insert client 
IP and connect time into DB 
Used by : OpenVPN 
Relies on : PostgreSQL 
 
ovpn_clientdisconnect.sh This is a simple script which deletes the user entry from the 
table ovpn connections which was inserted upon the execution of ovpn_clientconnect.sh 
Script name : ovpn-clientdisconnect.sh 
Location : /usr/local/unigrid/bin 
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Description : Deletes user entry from DB. 
Used by : OpenVPN 
Relies on : PostgreSQL 
 
A2.1.3 PostgreSQL 
We are using PostgreSQL version 7.4.19 which was built from source. The build was 
installed to the directory unigrid/postgresql. 
# postgres -V 
postgres (PostgreSQL) 7.4.19 
 
The tool pgAdmin was very valuable during for the management of the PostgreSQL 
database. 
 
A2.1.3.1 Setup 
After building (./configure --prefix=/usr/local/unigrid/postgresql), adatabase was created via 
postgresql/bin/initdb -D postgresql/data 
The file postgresql/data/pg hba.conf was edited to allow connections from other hosts without 
supplying a password. This temporary measure was necessary in order to remote 
administer the database via pgAdmin: 
# cat postgresql/data/pg_hba.conf 
(more) 
host all all XX.YY.ZZ.AA 255.255.255.255 trust 
(more) 
 
Also the configuration fie postgresql/data/postgresql.conf needed a few (self-explanatory) 
modifications: 
tcpip_socket = true 
virtual_host = '127.0.0.1' 
log_statement = true 
 
Afterwards, the database was started using 
# postgresql/bin/pg_ctl 
-D /usr/local/unigrid/postgresql/data 
-l /usr/local/unigrid/postgresql/logs/log start 
 
Using the tool pgAdmin and authenticating as user postgres (without password), a new 
user ‚gridadmin‛ and various tables and views were created by this user. These tables 
include the following: 
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users: A list of all users and their passwords, e-mail addresses, departments and a boolean 
value telling if they are privileged for submitting jobs to the Condor pool. 
ovpn_connections: A snapshot of the current OpenVPN connection pool. This table is used 
by the scripts bin/ovpn_clientconnect.sh and bin/ovpn_clientdisconnect.sh described in 
Section A2.1.2. 
ovpn_IP_range_submit_privileged: A list of all the possible IP addresses in the 10.8.1.0/24 
subnet. OpenVPN needs two IP addresses for each client, 10.8.1.1 and 10.8.1.2 for 
example. 
condor_local_config_static_user_customized: Not yet used. 
condor_status: An up-to-date dump of the command condor status. This data is used by 
the web interface to display the current status of the pool. 
Additionally, the following views have been created: 
Unused_privileged_submit_IPs: This view joins the tables - ovpn_connections and 
ovpn_IP_range_submit_privileged to find out which IP addresses out of the submit 
privileged subnet are not yet assigned. Used by bin/ovpn_clientconnect.sh. 
condor_local_config: This view's output are two columns, a username and a Condor local 
config which is stored and archived by the script keys/build_key.sh. In its archived form it is 
transported to the client via HTTPS and there extracted to the Condor directory of the user. 
This is therefore a very comfortable way of making additions to clients' local Condor 
configuration files. 
This view integrates the local config directives from the views 
condor_local_config_submit_privileged_users, condor_local_config_submit_non-
privileged_ users and condor_local_config_depts. 
condor_local_config_submit_privileged_users: Outputs Condor config directives for 
submit privileged pool members such as for starting the Condor scheduler. 
condor_local_config_submit_non-privileged_users: 
condor_local_config_depts: This view pastes the information about a user's department 
from the table users and transforms it into a Condor configuration directive in order for 
Condor to know which machine belongs to which department. 
users_online_time: This view joins the tables - users and ovpn_connections and 
additionally displays since when each user is online in seconds. This data is used by the 
web sites to display the current status of the pool. 
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A2.1.4 Tomcat 
We are using Apache Tomcat version 6.0.16 which was built from source. The build was 
installed to the directory unigrid/tomcat6. A Java Virtual Machine version 1.5 was obtained 
from Sun Inc. (www.sun.com). 
# java -showversion 
java version "1.5.0_15" 
Java(TM) 2 Runtime Environment, Standard Edition (build 1.5.0_15-b04) 
Java HotSpot(TM) 64-Bit Server VM (build 1.5.0_15-b04, mixed mode) 
(more) 
 
A2.1.4.1 Setup 
In order to setup a SSL web server, the instructions from the manual were followed 
(http://tomcat.apache.org/tomcat-6.0-doc/ssl-howto.html) 
# $JAVA_HOME/bin/keytool -genkey -alias tomcat -keyalg RSA 
-keystore /usr/local/unigrid/keys/tomcat6/.keystore 
 
The keystore password has to be remembered for the following step. In order to configure 
Tomcat to start a SSL server, the following lines were added to tomcat6/conf/server.xml: 
<Connector port="443" protocol="HTTP/1.1" SSLEnabled="true" 
maxThreads="150" scheme="https" secure="true" 
clientAuth="false" sslProtocol="TLS" 
keystoreFile="/usr/local/unigrid/keys/tomcat6/.keystore" 
keystorePass="PASSWORD" 
/> 
 
 
As mentioned before, the SSL server which is used to access users' RSA keys may only be 
accessed with the right username and password entered into the browser. We therefore 
configured tomcat to authenticate against the PostgreSQL database which is easier to 
handle than a text file. The following lines were added to tomcat6/conf/server.xml: 
<Realm className="org.apache.catalina.realm.JDBCRealm" debug="99" 
driverName="org.postgresql.Driver" 
connectionURL="jdbc:postgresql://127.0.0.1/mydb?user=gridadmin 
&amp;password=PASSWORD" 
userTable="users" userNameCol="user_name" userCredCol="user_pass" 
userRoleTable="users" roleNameCol="role_name" 
/> 
The Tomcat server also needs the PostgreSQL JDBC .jar to connect to the database. Thus, 
postgresql-8.3-603.jdbc3.jar10 (obtained from: http://jdbc.postgresql.org/download.html) was placed 
under tomcat6/lib. 
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A2.1.4.2 JSP Scripts - Webapps 
certs. The RSA generated by OpenSSL are fetched from a SSL web server. The JSP page 
responsible for providing the RSA keys is certs/index.jsp. 
Script name : certs/index.jsp 
Location : /usr/local/unigrid/tomcat6/webapps/ 
Description : Builds (by calling the build-key script, see Section A2.1.2) and 
returns the RSA keys for an authenticated user 
Workow : Call build-key → return generated .zip file 
Used by : Various client scripts such as fetchKeys.sh (Linux) and 
unigrid_fetchkeys.exe (Windows) 
 
unigrid. This web application is the user's interface to the Condor pool. 
Script name : unigrid/*.jsp 
Location : /usr/local/unigrid/tomcat6/webapps/ 
Description : Displays pool status, provides client package downloads, job 
submission, additional information regarding UVieCo, etc. 
 
A2.1.5 Condor 
We are using Condor version 7.0.1 which was obtained in binary form 
(http://www.cs.wisc.edu/condor/). The build was installed to the directory unigrid/condor. 
 
A2.1.5.1 Setup  
The condor/etc/condor_config contains a multitude of settings with a lot of them unchanged 
from the default config. Thus, only the modified ones are provided here. 
File name : condor config 
Location : /usr/local/unigrid/condor/etc 
Description : Condor configuration file 
  Contents : 
RELEASE_DIR    = /usr/local/unigrid/condor 
LOCAL_DIR     = $(RELEASE_DIR) 
LOCAL_CONFIG_FILE    = $(RELEASE_DIR)/etc/condor_config.local 
REQUIRE_LOCAL_CONFIG_FILE = TRUE 
 
NETWORK_INTERFACE   = 10.8.0.1 
CONDOR_HOST    = 10.8.0.1 
 
UID_DOMAIN     = $(FULL_HOSTNAME) 
FILESYSTEM_DOMAIN  = $(FULL_HOSTNAME) 
 
COLLECTOR_NAME    = “UNIVIE Condor Pool" 
DEFAULT_DOMAIN_NAME   = unigrid 
NO_DNS     = True 
 
FLOCK_FROM     = 
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FLOCK_TO     = 
FLOCK_NEGOTIATOR_HOSTS  = $(FLOCK_TO) 
FLOCK_COLLECTOR_HOSTS   = $(FLOCK_TO) 
HOSTALLOW_ADMINISTRATOR  = $(CONDOR_HOST) 
HOSTALLOW_OWNER   = $(FULL_HOSTNAME), 
 
$(HOSTALLOW_ADMINISTRATOR) 
HOSTALLOW_READ    = 10.8.* 
HOSTALLOW_WRITE    = $(CONDOR_HOST), 10.8.1.* 
HOSTALLOW_CONFIG   = $(FULL_HOSTNAME) 
HOSTALLOW_WRITE_COLLECTOR = $(HOSTALLOW_WRITE), 
$(FLOCK_FROM), 10.8.0.* 
HOSTALLOW_WRITE_STARTD  =$(HOSTALLOW_WRITE), 
$(FLOCK_FROM) 
HOSTALLOW_READ_COLLECTOR  = $(HOSTALLOW_READ), 
$(FLOCK_FROM) 
HOSTALLOW_READ_STARTD   = $(HOSTALLOW_READ), 
$(FLOCK_FROM) 
HOSTALLOW_NEGOTIATOR  = $(CONDOR_HOST) 
HOSTALLOW_NEGOTIATOR_SCHEDD = $(CONDOR_HOST), 
$(FLOCK_NEGOTIATOR_HOSTS) 
 
RELEASE_DIR and LOCAL_DIR tell Condor where its software resides. We need Condor 
only to bind to the VPN interface 10.8.0.1 (NETWORK_INTERFACE) as it is not intended 
for machines outside the VPN to join the pool. We are expecting our clients to be a 
heterogeneous mixture of operating systems and usage patterns such as dedicated servers 
or workstations. Therefore, we will not have common UID domain and set UID_DOMAIN 
to $(FULL_ HOSTNAME). This ensures that Condor will not think for any pair of clients to 
share the same UID domain. The same applies to FILESYSTEM_DOMAIN, no common 
filesystem is operated. 
We also do not operate a shared DNS server (NO_DNS) and our default hostnames will be 
IP.unigrid (DEFAULT_DOMAIN_NAME), e.g. ‚10-8-0-1.unigrid‛.  
Flocking is disabled (FLOCK_* directives). Everybody in the VPN is allowed to read from 
the Collector (HOSTALLOW_READ), but only the central manager and the privileged 
subnet 10.8.1.0/24 is by default allowed to perform write operations such as submitting 
jobs (HOSTALLOW_WRITE). Additionally, the 10.8.0.0/24 subnet is allowed to write to the 
collector HOSTALLOW WRITE COLLECTOR. 
 
File name : condor_config.local 
Location : /usr/local/unigrid/condor/etc 
Description : Condor local configuration file 
Contents : 
DAEMON_LIST = COLLECTOR, MASTER, NEGOTIATOR, SCHEDD 
   JAVA = /home/stampfel/jdk1.5/bin/java 
   JAVA_MAXHEAP_ARGUMENT = -Xmx 
   CONDOR_ADMIN=gerald.stampfel@gmail.com 
   LOWPORT=19000 
   HIGHPORT=20050 
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A2.1.6 Logging 
The log files of all the applications running in the server distribution are gathered under 
unigrid/logs as symbolic links. The script tailLogs.sh can be used to monitor all these files 
simultaneously which has proved very useful during debugging. 
 
A2.1.7 Sudo 
In order for a user to issue commands with root-privileges, this user either has to be root or 
use sudo. In our situation it is more convenient to operate non-interactively and use sudo 
which enables root-privileges without entering the root password. The following line has 
to be added (by root) to /etc/sudoers for this to work: 
gridadmin ALL= (root) NOPASSWD: 
/usr/local/unigrid/openvpn/sbin/openvpn 
This can be done using the command visudo. 
 
A2.1.8 Firewall 
Only communication between the Condor daemons running on central manager, submit, 
and execute machines should be allowed to pass through the VPN, all other traffic (with 
the exception of a few ICMP cases) is denied. The Condor daemons use defined port 
ranges (both TCP and UDP): 
Central manager : 19000-20050 and 9618 for condor collector 
Submit machines : 19000-20200 
Execute machines : 19000-19200 
The required size for these port ranges depending on the machine type has been calculated 
using the Condor manual (http://www.cs.wisc.edu/condor/manual/v7.0/). 
Traffic inside the VPN is also filtered according to the involved IP addresses. The following 
scheme is used: 
Central manager : 10.8.0.1 
Submit machines : 10.8.1.* 
Execute machines : 10.8.0.* 
Based on the above port and IP restrictions, iptables rules have been set up to deny all 
other traffic: 
Script name : fwProtect.sh 
Location : /usr/local/unigrid/bin 
Description : Call iptables 
Used by : None. Has to be called manually 
 
A2.1.9 Environment Variables 
Environmental variables used by scripts under unigrid/bin/ are set in the file bin/vars. 
Script name : vars 
Location : /usr/local/unigrid/bin 
Description : The script sets various environment variables which are 
subsequently used by scripts in bin/ 
Used by : scripts in /usr/local/unigrid/bin and Condor 
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A2.1.10 Client Package Generation 
A2.1.10.1 Linux Packages 
The client packages containing all the necessary files to connect a client (execute or submit) 
machine to the Condor pool are generated on goedel. This is done in the directory 
/usr/local/unigrid/pkg_factory. The subdirectories debian+condor and debian-condor contain 
the files for each distribution form. The script preparePackage.sh is used to compress these 
archives into .deb Debian/Ubuntu Packages: 
 
Script name : preparePackage.sh 
Location : /usr/local/unigrid/pkg factory 
Description : Creates .deb packages of the scripts required to connect to the 
Condor pool for a single user 
Workflow : Call build-key script → Call createDeb.sh script which prepares the 
directories and creates the archives → Copy the generated 
packages to a temporary directory from where they can be picked 
up by Tomcat → Store the path of the temporary directory in the 
DB so Tomcat knows where to find them 
Used by : Apache Tomcat 
 
In order to generate the packages for all users in the DB, prepareAllPackages.sh has to be 
called. 
The client package comes in two flavors: With and without Condor. Because the client 
scripts are the same for both packages it would be unnecessary to have the same scripts in 
debian+condor and debian-condor. Therefore, the scripts only exist in debian-condor and 
are copied to debian+condor by createDeb.sh: 
Script name : createDeb.sh 
Location : /usr/local/unigrid/pkg_factory 
Description : Prepares the debian+condor and debian-condor directories and calls 
dpkg-deb 
Workflow : Copy from debian-condor to debian+condor → Chmod and chown 
the package directories → Create archives using the commands 
dpkg-deb and ar 
Used by : fakeCreateDeb.sh 
 
A2.1.10.2 Windows (coLinux) Package 
For the Windows installation, a modified version of the coLinux installer including a 
custom root image was used. The Nullsoft Scriptable Install System (NSIS), open source 
software, was used to generate the client package. The .nsis script used to generate the 
package is located in /usr/local/unigrid/NSIS on goedel. 
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A2.2 Client Machines 
A2.2.1 Directory Structure 
All the necessary files are located in the home directory of the user griduser 
(/home/griduser/unigrid). There are several subdirectories: 
bin: Contains various scripts for starting and stopping the OpenVPN client and 
Condor 
condor: Contains the Condor application or the Condor configuration files only 
(depending on the type of installation package used) 
keys: The RSA keys necessary for accessing the VPN are stored in this directory 
logs: Contains the generated logfiles 
Each of these directories will be described in the following sections. 
 
A2.2.2 Condor 
We are using Condor version 7.0.1. 
The file condor/etc/condor_config is essentially the same as the one for the central manager 
described in Section A2.1.5. condor/etc/condor_config.local is obtained from the central 
manager together with the keys upon every connection. 
condor/etc/condor_config.local.additional is an additional configuration file untouched by the 
various scripts and is therefore an occasion to define persistent machine-specific settings 
not defined in condor/etc/condor_config.local. 
 
A2.2.3 OpenVPN 
We are using OpenVPN 2.0.9. 
# openvpn --help 
OpenVPN 2.0.9 i486-pc-linux-gnu [SSL] [LZO] [EPOLL] 
built on Sep 20 2007 
(more) 
 
A2.2.4 Connection Establishment 
The client connection process is initiated with the script bin/unigrid connect.sh which starts 
the Condor application once the VPN is successfully established. 
Script name : unigrid_connect.sh 
Location : /home/griduser/unigrid/bin 
Description : Connect to the VPN and start Condor 
Workflow : Check if running inside coLinux → Check if RSA keys are present 
→ Check if OpenVPN and Condor are already running and kill them 
if they are → Start unigrid_keepalive.sh in a new thread and tell it to 
keep OpenVPN running → Check if the script got called at bootup 
and exit if it was → Otherwise, check if the connection is coming up 
and tell the user what may be wrong if it does not! 
The OpenVPN binary is started with various parameters. The parameter --user tells 
OpenVPN to change its process owner to $OVPN USER after the connection is established. 
--ca, --cert, and --key tell the client where to find the RSA keys. --route-up tells OpenVPN to 
start Condor as soon as the VPN connection is established. 
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The OpenVPN client is started via sudo. The command sudo has to be used in order to start 
OpenVPN with root-privileges which are necessary for various network configurations. 
 
Once OpenVPN has successfully established a connection, unigrid_startCondor.sh is 
executed. 
Script name : unigrid_startCondor.sh 
Location : /home/griduser/unigrid/bin 
Description : Start Condor 
Used by : unigrid_connect.sh 
 
Another important script in this context is unigrid_keepalive.sh. 
Script name : unigrid_keepalive.sh 
Location : /home/griduser/unigrid/bin 
Description : In an endless loop: Start OpenVPN (which in turn, once 
successfully launched) calls unigrid_startCondor.sh 
Workflow : Check if /dev/null is ready (important at bootup) → keep restarting 
OpenVPN unless it fails in less than two seconds (which would 
mean something is broken) 
Used by : unigrid_connect.sh 
 
Another important use case of the client package is to fetch RSA keys from the SSL web 
server. This is done via unigrid_fetchKeys.sh. 
Script name : unigrid_fetchKeys.sh 
Location : /home/griduser/unigrid/bin 
Description : Ask the user for a username and password and fetch new keys and 
Condor local config from the web server 
Workflow : Ask for a username and password → Fetch the keys using wget → 
Extract the keys → Write to file unigrid_user 
 
Finally, unigrid_user: 
Script name : unigrid_user 
Location : /home/griduser/unigrid 
Description : A textfile holding exactly one line which contains the username 
supplied to unigrid_fetchKeys.sh; this is necessary for 
unigrid_connect.sh to know which keys to use  
Used by : unigrid_connect.sh 
 
A2.2.5 coLinux Package 
The coLinux installer basically contains a Debian 4.0 root image with all the necessary 
auxiliary packages and the client .deb package installed. The scripts are therefore 
essentially the same. 
One difference, however, when running under Windows is for Condor to determine if the 
machine is idle or busy. Under a native Linux, Condor may access the CPU status and the 
keyboard and mouse activity. When running inside coLinux, however, the virtual machine 
has no access to the Windows keyboard and mouse usage. The same applies for the CPU. 
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This problem was solved with a small VBScript script running as a Windows service 
(‚colinux_monitor") which writes the current performance data to a directory shared by 
Windows and the coLinux virtual machine. Inside coLinux, the script unigrid_monitor.sh, 
which is periodically called by Condor, reads out the Windows performance data. 
Script name : unigrid monitor.sh 
Location : /home/griduser/unigrid/bin 
Description : Reads the files non_condor_load.out and idle_ticks.out in /mnt/wininfo. 
Used by : Condor 
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Appendix 3 
Perl script to calculate Pearson correlation coefficient for P-gp transporter 
The gene expression values for NCI’s 60 cell lines in the beginning of the script were taken 
from Szakács et. al. For calculating PCC values of rest of the 47 transporters, these values 
need to be replaced from the same supplementary table for respective gene. 
 
%abcb1=( 'MCF7' => -2.299487776, 
  'MDA-MB-231/ATCC' => -1.703005883, 
  'HS 578T' => 0.129259872, 
  'MDA-N' => -1.136008003, 
  'BT-549' => -0.620474003, 
  'T-47D' => -1.869259753, 
  'SNB-19' => -1.98375456, 
  'SNB-75' => -3.051216652, 
  'U251' => -2.091767493, 
  'SF-268' => -1.937680806, 
  'SF-295' => 2.472240998, 
  'SF-539' => -1.91340836, 
  'HT29' => -1.863403683, 
  'HCC-2998' => -2.134894428, 
  'HCT-116' => -2.389089161, 
  'SW-620' => 3.193448512, 
  'COLO 205' => -1.951550775, 
  'HCT-15' => 11.08019765, 
  'KM12' => -1.544163917, 
  'CCRF-CEM' => 1.916771756, 
  'K-562' => 0.006278353, 
  'MOLT-4' => -1.741896161, 
  'HL-60(TB)' => 0.534639648, 
  'RPMI-8226' => -0.731035406, 
  'SR' => -1.87549267, 
  'MDA-MB-435' => -1.256649441, 
  'LOX IMVI' => -1.591674614, 
  'MALME-3M' => -1.134403827, 
  'SK-MEL-2' => -0.600740128, 
  'SK-MEL-5' => 1.310883616, 
  'SK-MEL-28' => -1.20765274, 
  'M14' => 2.743252037, 
  'UACC-62' => -1.159035406, 
  'UACC-257' => -1.667526634, 
  'NCI-H23' => -1.792915897, 
  'NCI-H522' => -0.602394263, 
  'A549/ATCC' => -1.082718529, 
  'EKVX' => 3.57602469, 
  'NCI-H226' => -2.463504366, 
  'NCI-H322M' => -1.822665326, 
  'NCI-H460' => 3.050689884, 
  'HOP-62' => -1.96839288, 
  'HOP-92' => -2.029790915, 
  'NCI/ADR-RES' => 12.27898868, 
  'OVCAR-3' => -2.635960506, 
  'OVCAR-4' => -2.631633021, 
  'OVCAR-5' => -2.387480974, 
  'OVCAR-8' => 1.940847809, 
  'IGROV1' => 1.90702192, 
  'SK-OV-3' => -1.476238266, 
  'PC-3' => -2.498270448, 
  'DU-145' => -0.599140669, 
  'UO-31' => 4.680844634, 
  'SN12C' => -2.15677922, 
  'A498' => 4.313310008, 
  'CAKI-1' => 8.236607264, 
  'RXF 393' => -1.222590269, 
Appendix 3 (Perl Script for PCC calculation) 
141 
 
  '786-0' => 2.842396738, 
  'ACHN' => 3.689268862, 
  'TK-10' => -1.077225108 ); 
   
@cl_abcb1=keys(%abcb1);   
   
open (FI,"c:\\yogesh\\nci-rawdata_ids.txt") || die "err file 1\n"; 
while ($line=<FI>) 
{ 
 $line =~s/\s+$//; 
 $mol_id=$line; 
 
   
 open (FI2,"c:\\yogesh\\nci-rawdata.txt") || die "err data file\n"; 
 while ($line=<FI2>) 
 { 
  $line =~s/\s+$//; 
  @line=split(/,/,$line); 
   
  $id=$line[0]; 
  chop $id; 
   
  if ($id eq $mol_id) 
  { 
   $ct++; 
   $cl=$line[4]; 
   $conc=$line[7]; 
    
   chop $cl; 
   chop $conc; 
    
   $mol_conc{$cl}=$conc; 
    
  } 
 } 
 close FI2; 
  
 $x=0; 
  
 foreach $k(keys(%mol_conc)) 
 { 
  foreach(@cl_abcb1) 
  { 
   if ($_ eq $k) 
   { 
    $mol_data[$x]=$mol_conc{$k}; 
    $abcb1_data[$x]=$abcb1{$k}; 
     
    $x++; 
   } 
  } 
 } 
  
 %mol_conc=(); 
  
 $tot=@mol_data; 
  
  
 $sum_mol=0; 
 $sum_abcb1=0; 
 $prod1=0; 
  
 for($j=0;$j<@mol_data;$j++) 
 { 
   $sum_mol=$sum_mol+$mol_data[$j]; 
   $sum_abcb1=$sum_abcb1+$abcb1_data[$j]; 
   $prod1=$prod1+$mol_data[$j]*$abcb1_data[$j]; 
 } 
  
 $mean_mol=$sum_mol/$tot; 
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 $mean_abcb1=$sum_abcb1/$tot; 
 $prod1=$prod1/$tot; 
  
 $prod2=$mean_mol*$mean_abcb1; 
  
 $covar=$prod1-$prod2; 
  
 $dev_mol_total=0; 
 $dev_abcb1_total=0; 
  
 for($j=0;$j<@mol_data;$j++) 
 { 
   $dev_mol=$mean_mol-$mol_data[$j]; 
   $dev_mol_total=$dev_mol_total+($dev_mol*$dev_mol); 
    
   $dev_abcb1=$mean_abcb1-$abcb1_data[$j]; 
   $dev_abcb1_total=$dev_abcb1_total+($dev_abcb1*$dev_abcb1); 
 } 
  
 $stdev_mol=sqrt($dev_mol_total/($tot-1)); 
 $stdev_abcb1=sqrt($dev_abcb1_total/($tot-1)); 
  
 if (($stdev_mol !=0) and ($stdev_abcb1 !=0)) 
 { 
  $pcc=$covar/($stdev_mol*$stdev_abcb1);  
 } 
 else 
 { 
  $pcc="Invalid"; 
 } 
  
 @mol_data=(); 
 @abcb1_data=(); 
  
  
 print "$mol_id\t$pcc\n"; 
     
 } 
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Abstract 
In the current drug discovery process, the identification of new target proteins and 
potential ligands is very tedious, expensive and time-consuming. Thus, use of in silico 
techniques is of utmost importance and proved to be a valuable strategy in detecting 
complex structural and bioactivity relationships. Increased demands of computational 
power for tremendous calculations in scientific fields and timely analysis of generated piles 
of data require innovative strategies for efficient utilization of distributed computing 
resources in the form of computational grids. Such grids add a new aspect to the emerging 
information technology paradigm by providing and coordinating the heterogeneous 
resources such as various organizations, people, computing, storage and networking 
facilities as well as data, knowledge, software and workflows. 
The aim of this study was to develop a university-wide applicable grid infrastructure, 
UVieCo (University of Vienna Condor pool) which can be used for implementation of 
standard structure- and ligand-based drug discovery applications using freely available 
academic software. Firewall and security issues were resolved with a virtual private 
network setup whereas virtualization of computer hardware was done using the CoLinux 
concept in a way to run Linux-executable jobs inside Windows machines. The effectiveness 
of the grid was assessed by performance measurement experiments using sequential and 
parallel tasks. 
Subsequently, the association of expression/sensitivity profiles of ABC transporters with 
activity profiles of anticancer compounds was analyzed by mining the data from NCI 
(National Cancer Institute). The datasets generated in this analysis were utilized with 
ligand-based computational methods such as shape similarity and classification algorithms 
to identify and separate P-gp substrates from non-substrates. While developing predictive 
classification models, the problem of imbalanced class distribution was proficiently 
addressed using the cost-sensitive bagging approach. Applicability domain experiment 
revealed that our model not only predicts NCI compounds well, but it can also be applied 
to drug-like molecules. The developed models were relatively simple but precise enough 
to be applicable for virtual screening of large chemical libraries for the early identification 
of P-gp substrates which can potentially be useful to remove compounds of poor ADMET 
properties in an early phase of drug discovery. 
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Additionally, shape-similarity and self-organizing maps techniques were used to screen in-
house as well as a large vendor database for identification of novel selective serotonin 
reuptake inhibitor (SSRI) like compounds to induce apoptosis. The retrieved hits possess 
novel chemical scaffolds and can be considered as a starting point for lead optimization 
studies.  
The work described in this thesis will be useful to create distributed computing 
environment using available resources within an organization and can be applied to 
various applications such as efficient handling of imbalanced data classification problems 
or multistep virtual screening approach. 
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Zusammenfassung 
Im derzeitigen Drug Discovery Prozess ist die Identifikation eines neuen Targetproteins 
und dessen potenziellen Liganden langwierig, teuer und zeitintensiv. Die Verwendung 
von in silico Methoden gewinnt hier zunehmend an Bedeutung  und hat sich als wertvolle 
Strategie zur Erkennung komplexer Zusammenhänge sowohl im Bereich der Struktur von 
Proteinen wie auch bei Bioaktivitäten  erwiesen. Die zunehmende Nachfrage nach 
Rechenleistung im wissenschaftlichen Bereich sowie eine detaillierte  Analyse der 
generierten Datenmengen benötigen innovative Strategien für die effiziente Verwendung 
von verteilten Computerressourcen, wie z.B. Computergrids. Diese Grids ergänzen 
bestehende Technologien  um einen neuen Aspekt, indem sie heterogene Ressourcen zur 
Verfügung stellen und koordinieren. Diese Ressourcen beinhalten verschiedene 
Organisationen, Personen, Datenverarbeitung, Speicherungs- und Netzwerkeinrichtungen, 
sowie Daten, Wissen, Software und Arbeitsabläufe. 
Das Ziel dieser Arbeit war die Entwicklung einer universitätsweit anwendbaren Grid-
Infrastruktur - UVieCo (University of Vienna Condor pool) -, welche für die 
Implementierung von akademisch frei verfügbaren struktur- und ligandenbasierten Drug 
Discovery Anwendungen verwendet werden kann. Firewall- und Sicherheitsprobleme 
wurden mittels eines virtuellen privaten Netzwerkes gelöst, wohingegen die 
Virtualisierung der Computerhardware über das CoLinux Konzept ermöglicht wurde. 
Dieses ermöglicht, dass  unter Linux auszuführende  Aufträge auf Windows Maschinen 
laufen können. Die Effektivität des Grids wurde durch Leistungsmessungen anhand 
sequenzieller und paralleler Aufgaben ermittelt.  
Als Anwendungsbeispiel  wurde die Assoziation der Expression bzw. der 
Sensitivitätsprofile von ABC-Transportern mit den Aktivitätsprofilen von 
Antikrebswirkstoffen durch Data-Mining des NCI (National Cancer Institute) Datensatzes 
analysiert. Die dabei generierten Datensätze wurden für liganden-basierte 
Computermethoden wie Shape-Similarity und Klassifikationsalgorithmen mit dem Ziel 
verwendet,  P-glycoprotein (P-gp) Substrate zu identifizieren und sie von Nichtsubstraten 
zu trennen. Beim Erstellen vorhersagekräftiger Klassifikationsmodelle konnte das Problem 
der extrem unausgeglichenen Klassenverteilung durch Verwendung der „Cost-Sensitive 
Bagging‚ Methode  gelöst werden. Applicability Domain Studien ergaben, dass unser 
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Modell nicht nur die NCI Substanzen gut vorhersagen kann, sondern auch für 
wirkstoffähnliche Moleküle verwendet werden kann. Die entwickelten Modelle waren 
relativ einfach, aber doch präzise genug um für virtuelles Screening einer großen 
chemischen Bibliothek verwendet werden zu können. Dadurch könnten  P-gp Substrate 
schon frühzeitig erkannt werden, was möglicherweise nützlich sein kann zur Entfernung 
von Substanzen mit schlechten ADMET-Eigenschaften bereits in einer frühen Phase der 
Arzneistoffentwicklung. 
Zusätzlich wurden Shape-Similarity  und Self-organizing Map Techniken verwendet um 
neue Substanzen in einer hauseigenen sowie einer großen kommerziellen Datenbank zu 
identifizieren, die ähnlich zu selektiven Serotonin-Reuptake-Inhibitoren (SSRI) sind und 
Apoptose induzieren können. Die erhaltenen Treffer besitzen neue chemische 
Grundkörper und können als Startpunkte für Leitstruktur-Optimierung in Betracht 
gezogen werden. 
Die in dieser Arbeit beschriebenen Studien werden nützlich sein um eine verteilte 
Computerumgebung zu kreieren die vorhandene Ressourcen in einer Organisation nutzt, 
und die für verschiedene Anwendungen geeignet ist, wie etwa die effiziente Handhabung 
der Klassifizierung von unausgeglichenen Datensätzen, oder mehrstufiges virtuelles 
Screening. 
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